<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005944.pub3" GROUP_ID="PREG" ID="918604061019474012" MERGED_FROM="" MODIFIED="2016-04-28 16:55:25 +0100" MODIFIED_BY="Leanne Jones" REVIEW_NO="0476" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2016-04-28 16:55:25 +0100" MODIFIED_BY="Leanne Jones">
<TITLE MODIFIED="2010-08-24 12:08:04 +0100" MODIFIED_BY="[Empty name]">Vitamin A supplementation for postpartum women</TITLE>
<CONTACT MODIFIED="2016-04-28 16:55:25 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="17592" ROLE="AUTHOR"><FIRST_NAME>Julicristie</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Oliveira</LAST_NAME><POSITION>Teacher and researcher</POSITION><EMAIL_1>julicristie.oliveira@fca.unicamp.br</EMAIL_1><EMAIL_2>juli.padma@gmail.com</EMAIL_2><ADDRESS><ORGANISATION>School of Applied Sciences, University of Campinas</ORGANISATION><ADDRESS_1>Rua Pedro Zaccaria, 1300</ADDRESS_1><ADDRESS_2>Limeira</ADDRESS_2><CITY>São Paulo</CITY><ZIP>13484-350</ZIP><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 19 37016720</PHONE_1><FAX_1>+55 19 81747235</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-04-28 16:55:25 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="17592" ROLE="AUTHOR"><FIRST_NAME>Julicristie</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Oliveira</LAST_NAME><POSITION>Teacher and researcher</POSITION><EMAIL_1>julicristie.oliveira@fca.unicamp.br</EMAIL_1><EMAIL_2>juli.padma@gmail.com</EMAIL_2><ADDRESS><ORGANISATION>School of Applied Sciences, University of Campinas</ORGANISATION><ADDRESS_1>Rua Pedro Zaccaria, 1300</ADDRESS_1><ADDRESS_2>Limeira</ADDRESS_2><CITY>São Paulo</CITY><ZIP>13484-350</ZIP><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 19 37016720</PHONE_1><FAX_1>+55 19 81747235</FAX_1></ADDRESS><FOOTNOTE>These authors contributed equally to this work</FOOTNOTE></PERSON><PERSON ID="z1509230952520599057946483679068" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Roman</FIRST_NAME><LAST_NAME>Allert</LAST_NAME><POSITION>Researcher</POSITION><EMAIL_1>allert@cochrane.de</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Germany</DEPARTMENT><ORGANISATION>Medical Center - University of Freiburg</ORGANISATION><ADDRESS_1>Berliner Allee 29</ADDRESS_1><CITY>Freiburg</CITY><ZIP>79110</ZIP><REGION>BW</REGION><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>0049(0)761-203-6718</PHONE_1><FAX_1>0049(0)761-203-6712</FAX_1></ADDRESS><FOOTNOTE>These authors contributed equally to this work</FOOTNOTE></PERSON><PERSON ID="15889" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Christine</FIRST_NAME><MIDDLE_INITIALS>E</MIDDLE_INITIALS><LAST_NAME>East</LAST_NAME><POSITION>Professor of Midwifery/Co-Director of Maternity Services</POSITION><EMAIL_1>christine.east@monash.edu</EMAIL_1><ADDRESS><DEPARTMENT>School of Nursing and Midwifery/Maternity Services</DEPARTMENT><ORGANISATION>Monash University/Monash Health</ORGANISATION><ADDRESS_1>246 Clayton Road</ADDRESS_1><CITY>Clayton</CITY><ZIP>3168</ZIP><REGION>Victoria</REGION><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-02-17 10:38:35 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="12" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="12" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="12" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="10" YEAR="2010"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-04-28 15:29:50 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-04-28 15:29:50 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="4" YEAR="2016"/>
<DESCRIPTION>
<P>The text in the results section on selection bias has been corrected.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-04-28 15:00:38 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-04-28 15:00:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="2" YEAR="2016"/>
<DESCRIPTION>
<P>Search updated and two new studies have been included in this review update (<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>). </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-04-28 15:00:33 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="2" YEAR="2016"/>
<DESCRIPTION>
<P>A new search was conducted. The addition of two studies in the 2016 update of this review did not meaningfully change the conclusions of the original review (<LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-10 11:24:59 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-03-23 14:36:46 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-03-23 14:36:46 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-03-23 14:36:46 +0000" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Editorial Unit</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The Cochrane Editorial Unit, Cochrane Central Executive (Toby Lasserson, Newton Opiyo) assisted in the use of GRADE and in the development of the 'Summary of findings' table.</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-04-28 15:27:56 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-03-23 14:14:21 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-02-12 14:03:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The focus of the review still appears to be in breastfeeding mothers rather than all post-partum women. Please could you confirm the population? If the population is in all post-partum women, please change this heading.&lt;/p&gt;" NOTES_MODIFIED="2016-02-12 14:03:14 +0000" NOTES_MODIFIED_BY="[Empty name]">Vitamin A supplementation for postpartum women</TITLE>
<SUMMARY_BODY MODIFIED="2016-03-23 14:14:21 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>What is the issue?</B>
</P>
<P>Breastfeeding is expected to provide for the infant's needs in the early months of life. However, if the mother is undernourished herself, the infant may not receive all the nutrients they need. Vitamin A is important for immunity and helping the infant stay healthy, so if the mother does not have enough vitamin A intake in her diet, the infant may also not receive enough in the breast milk.</P>
<P>
<B>Why is this important?</B>
</P>
<P>In areas where vitamin A deficiency is a public health concern, the maternal dietary intake of vitamin A may be not sufficient to meet either the maternal nutritional requirements, or those of the breastfed infant, due the low concentrations in breast milk. Many studies have been carried out to address this concern in countries where vitamin A deficiency is common.</P>
<P>
<B>What evidence did we find?</B>
</P>
<P>We reviewed 14 trials. The evidence in general was found was to be of low quality. These studies involved the mothers being given vitamin A or not, within the first six weeks after giving birth, or compared a high dose of vitamin A with a low dose. Our review looked at the overall health of the mothers and their infants, any adverse effects and the levels of retinol, which is a by-product of vitamin A, in the mother's breast milk. There was no change in how many mothers or babies died or were unwell. The mothers and their babies did not experience adverse effects. There was evidence of improved amounts of retinol in breast milk.</P>
<P>
<B>What does this mean?</B>
</P>
<P>In summary, although extra vitamin A given to the mother may slightly improve the amount of this nutrient in her breast milk, it probably makes little or no difference to deaths in the mother or baby. It may lead to little or no difference in any adverse effects to the mother or baby. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-03-23 14:02:16 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-03-17 16:50:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>In areas where vitamin A deficiency (VAD) is a public health concern, the maternal dietary intake of vitamin A may be not sufficient to meet either the maternal nutritional requirements, or those of the breastfed infant, due the low retinol concentrations in breast milk.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-02-11 03:19:27 +0000" MODIFIED_BY="[Empty name]">
<P>To evaluate the effects of vitamin A supplementation for postpartum women on maternal and infant health.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-02-17 10:40:34 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (8 February 2016), LILACS (1982 to December 2015), Web of Science (1945 to December 2015), and the reference lists of retrieved studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-03-17 16:51:23 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised controlled trials (RCTs) or cluster-randomised trials that assessed the effects of vitamin A supplementation for postpartum women on maternal and infant health (morbidity, mortality and vitamin A nutritional status).</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-03-23 14:01:27 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed trials for inclusion, conducted data extraction, assessed risk of bias and checked for accuracy. We assessed the quality of the evidence using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-03-23 14:02:16 +0000" MODIFIED_BY="[Empty name]">
<P>Fourteen trials of mainly low or unclear risk of bias, enrolling 25,758 women and infant pairs were included. The supplementation schemes included high, single or double doses of vitamin A (200,000 to 400,000 internation units (IU)), or 7.8 mg daily beta-carotene compared with placebo, no treatment, other (iron); or higher (400,000 IU) versus lower dose (200,000 IU). In all trials, a considerable proportion of infants were at least partially breastfed until six months.</P>
<P>
<B>Supplement (vitamin A as retinyl, water-miscible or beta-carotene) 200,000 to 400,000 IU versus control (placebo or no treatment)</B>
</P>
<P>
<U>Maternal</U>: We did not find evidence that vitamin A supplementation reduced maternal mortality at 12 months (hazard ratio (HR) 1.01, 95% confidence interval (CI) 0.44 to 2.21; 8577 participants; 1 RCT, <I>moderate-quality evidence</I>). Effects were less certain at six months (risk ratio (RR) 0.50, 95% CI 0.09 to 2.71; 564 participants; 1 RCT; <I>low-quality evidence).</I> The effect on maternal morbidity (diarrhoea, respiratory infections, fever) was uncertain because the quality of evidence was <I>very low</I> (50 participants, 1 RCT). We found insufficient evidence that vitamin A increases abdominal pain (RR 1.28, 95% CI 0.95 to 1.73; 786 participants; 1 RCT; <I>low-quality evidence</I>)<I>. </I>We found <I>low-quality evidence</I> that vitamin A supplementation increased breast milk retinol concentrations by 0.20 µmol/L at three to three and a half months (mean difference (MD) 0.20 µmol/L, 95% CI 0.08 to 0.31; 837 participants; 6 RCTs).</P>
<P>
<U>Infant</U>: We did not find evidence that vitamin A supplementation reduced infant mortality at two to 12 months (RR 1.08, 95% CI 0.77 to 1.52; 6090 participants; 5 RCTs; <I>low-quality evidence</I>)<I>. </I>Effects on morbidity (gastroenteritis at three months) was uncertain (RR 6.03, 95% CI 0.30 to 121.82; 84 participants; 1 RCT; <I>very low-quality evidence</I>). There was <I>low-quality evidence</I> for the effect on infant adverse outcomes (bulging fontanelle at 24 to 48 hours) (RR 2.00, 95% CI 0.61 to 6.55; 444 participants; 1 RCT).</P>
<P>
<B>Supplement (vitamin A as retinyl) 400,000 IU versus 200,000 IU</B>
</P>
<P>Three studies (1312 participants) were included in this comparison. None of the studies assessed maternal mortality, maternal morbidity or infant mortality. Findings from one study showed that there may be little or no difference in infant morbidity between the doses (diarrhoea, respiratory illnesses, and febrile illnesses) (312 participants, data not pooled). No firm conclusion could be drawn on the impact on maternal and infant adverse outcomes (limited data available).The effect on breast milk retinol was also uncertain due to the small amount of information available.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-02-26 12:29:08 +0000" MODIFIED_BY="[Empty name]">
<P>There was no evidence of benefit from different doses of vitamin A supplementation for postpartum women on maternal and infant mortality and morbidity, compared with other doses or placebo. Although maternal breast milk retinol concentrations improved with supplementation, this did not translate to health benefits for either women or infants. Few studies reported on maternal and infant mortality and morbidity. Future studies should include these important outcomes.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-04-28 15:27:56 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-03-23 21:04:41 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-03-23 21:04:41 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Vitamin A functions and sources</B>
</P>
<P>Vitamin A is a common term for a set of fat-soluble substances, such retinol, retinal, retinoic acid, retinyl ester, and pro-vitamin A carotenoids (<LINK REF="REF-Butte-2002" TYPE="REFERENCE">Butte 2002</LINK>; <LINK REF="REF-FNB-2000" TYPE="REFERENCE">FNB 2000</LINK>; <LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>). It has an essential role in visual and immune systems, maintenance and proliferation of epithelial cells, growth and physical development, reproduction and gene expression (<LINK REF="REF-FAO_x002f_WHO-2001" TYPE="REFERENCE">FAO/WHO 2001</LINK>; <LINK REF="REF-FNB-2000" TYPE="REFERENCE">FNB 2000</LINK>; <LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>; <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>), and during all vital stages of pregnancy and lactation (<LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>).</P>
<P>The dietary sources can be divided in pro-vitamin A and pre-formed vitamin A. Some vegetables such as buriti, carrot, papaya, pumpkin, and red palm oil are sources of pro-vitamin A (alfa- and beta-carotene, alfa-cryptoxanthin). Human breast milk, dairy products (whole milk, yogurt, cheese, and milk cream), egg yolk, fish oils and liver are sources of pre-formed vitamin A (<LINK REF="REF-FAO_x002f_WHO-2001" TYPE="REFERENCE">FAO/WHO 2001</LINK>; <LINK REF="REF-FNB-2000" TYPE="REFERENCE">FNB 2000</LINK>).</P>
<P>Newborns and infants, in many countries, can only meet their vitamin A requirements through breastfeeding (<LINK REF="REF-Butte-2002" TYPE="REFERENCE">Butte 2002</LINK>; <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>), which is associated with maternal nutritional status and food consumption (<LINK REF="REF-Butte-2002" TYPE="REFERENCE">Butte 2002</LINK>). Thus, in lactating women with adequate vitamin A status and intake, their breast milk retinol concentrations are sufficient to meet the newborns&#8217; and infants' needs until the sixth month of life (<LINK REF="REF-Butte-2002" TYPE="REFERENCE">Butte 2002</LINK>). On the other hand, in lactating women with vitamin A deficiency (VAD), their breast milk retinol concentrations can be sub-optimal to meet the newborns&#8217; and infants' needs, as well as, to build or preserve hepatic reserves of this micronutrient (<LINK REF="REF-Butte-2002" TYPE="REFERENCE">Butte 2002</LINK>; <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>).</P>
<P>According to the World Health Organization (WHO) (<LINK REF="REF-WHO-2009a" TYPE="REFERENCE">WHO 2009a</LINK>), several risk factors increase the overall burden of disease in low-income countries. The most important of these include infant underweight, low proportion of breastfeeding, and nutrition deficiencies, including iron, vitamin A and zinc, with these factors contributing 20% to the disease burden in these areas, especially of infectious disease.</P>
<P>
<B>Vitamin A indicators</B>
</P>
<P>Specific indicators of VAD can be considered as biological, histological, functional and biochemical (<LINK REF="REF-Tanumihardjo-2004" TYPE="REFERENCE">Tanumihardjo 2004</LINK>; <LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>), and also in its clinical and subclinical manifestations (subdivided in degrees: severe, moderate and mild) (<LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). Xerophthalmia, a biological indicator, is a generic term that comprises all ocular clinical signs of VAD, including conjunctival xerosis, Bitot&#8217;s spots, corneal xerosis, ulceration, keratomalacia, and corneal scars (<LINK REF="REF-Wasantwisut-2002" TYPE="REFERENCE">Wasantwisut 2002</LINK>; <LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). Conjunctival impression cytology (CIC), a histological indicator, is used to assess the morphological changes in the cells on the surface of the eyes in VAD (<LINK REF="REF-Congdon-2002" TYPE="REFERENCE">Congdon 2002</LINK>; <LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>). Night blindness and impaired adaptation to darkness can be considered as functional indicators (<LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>; <LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>).</P>
<P>Serum retinol concentration (cut-off: <U>&lt;</U> 0.7 µmol/L), breast milk retinol concentration (cut-off: <U>&lt;</U> 1.05 µmol/L or 0.28 µmol/g fat), relative dose response (RDR; cut-off: <U>&gt;</U> 20%), and modified relative dose response (MRDR; cut-off: <U>&gt;</U> 0.06) are VAD biochemical and subclinical indicators (<LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). Both RDR and MRDR are indirect methods to estimate vitamin A hepatic reserves (<LINK REF="REF-Tanumihardjo-2004" TYPE="REFERENCE">Tanumihardjo 2004</LINK>; <LINK REF="REF-Tanumihardjo-2011" TYPE="REFERENCE">Tanumihardjo 2011</LINK>).</P>
<P>
<B>Vitamin A and adverse effects</B>
</P>
<P>According to <LINK REF="REF-Rasmussen-1998" TYPE="REFERENCE">Rasmussen 1998</LINK>, the evidence regarding the teratogenic effects of high amounts of pre-formed vitamin A in women at the beginning of pregnancy are scarce. Moreover, case-control and prospective investigations failed to establish an association between maternal vitamin A intake with fetal teratogenicity (<LINK REF="REF-Aza_x00ef_s_x002d_Braesco-2000" TYPE="REFERENCE">Azaïs-Braesco 2000</LINK>). Thus, only case reports have described a link between this adverse outcome and the metabolites, such as trans retinoic acids and 13-cis retinoic acids, until the sixth week of pregnancy (<LINK REF="REF-Rasmussen-1998" TYPE="REFERENCE">Rasmussen 1998</LINK>).</P>
<P>Allen and colleague (<LINK REF="REF-Allen-2002" TYPE="REFERENCE">Allen 2002</LINK>) have reviewed the maternal and infant secondary adverse effects after high doses of vitamin A supplementation and noted that the possible acute symptoms observed were enhanced cerebrospinal fluid pressure, bulging fontanelle, headache, fever, nausea, vomiting, diarrhoea, blurred vision, drowsiness and impaired muscular co-ordination.</P>
<P>
<B>Vitamin A and metabolic interactions </B>
</P>
<P>Zinc probably plays an important role in many steps of vitamin A metabolism, such as absorption, transport, mobilisation and utilisation (<LINK REF="REF-Christian-1998" TYPE="REFERENCE">Christian 1998</LINK>; <LINK REF="REF-Hess-2005" TYPE="REFERENCE">Hess 2005</LINK>).</P>
<P>According to <LINK REF="REF-Christian-1998" TYPE="REFERENCE">Christian 1998</LINK>, who reviewed the interaction between these micronutrients, zinc deficiency may for example: impair synthesis of chylomicrons and the uptake by the lymphatic system; reduce the synthesis of retinol-binding protein (RBP) and, consequently, vitamin A circulation and utilisation; impair the oxidation of retinol to retinal, which is crucial for the visual function; and decrease the synthesis of rhodopsin and rod photosensitivity, leading to night blindness and impaired adaptation to darkness.</P>
<P>Although these associations have been observed in laboratory experimental models, cross-sectional and intervention studies in humans are not conclusive concerning the strength of the metabolic interaction between zinc and vitamin A, and its public health implications (<LINK REF="REF-Christian-1998" TYPE="REFERENCE">Christian 1998</LINK>; <LINK REF="REF-Hess-2005" TYPE="REFERENCE">Hess 2005</LINK>).</P>
<P>In South Africa, a trial conducted in children with HIV and non-HIV, aged six to 24 months, reported no beneficial influence of vitamin A plus zinc supplementation compared to vitamin A or multi-micronutrients on growth. However, in a subgroup analysis, an improvement was noted on reducing the impact of episodes of diarrhoea on non-HIV children growth (<LINK REF="REF-Chhagan-2010" TYPE="REFERENCE">Chhagan 2010</LINK>). In Indonesia, an intervention study carried out with pregnant women reported no positive effect in morbidity, mortality, birth length or weight after vitamin A plus zinc supplementation (<LINK REF="REF-Prawirohartono-2013" TYPE="REFERENCE">Prawirohartono 2013</LINK>).</P>
<P>It is believed that VAD prejudices iron mobilisation, and utilisation (<LINK REF="REF-Hess-2005" TYPE="REFERENCE">Hess 2005</LINK>), but there is disagreement regarding its role in absorption (<LINK REF="REF-Garcia_x002d_Casal-1998" TYPE="REFERENCE">Garcia-Casal 1998</LINK>; <LINK REF="REF-Hess-2005" TYPE="REFERENCE">Hess 2005</LINK>; <LINK REF="REF-Walczyk-2003" TYPE="REFERENCE">Walczyk 2003</LINK>). Some intervention studies in humans were developed with the aim to assess the effect of vitamin A supplementation on iron and haematological parameters, and most of them have shown a positive impact in pregnant women and schoolchildren regarding anaemia, especially when vitamin A was combined with iron (<LINK REF="REF-Michelazzo-2013" TYPE="REFERENCE">Michelazzo 2013</LINK>).</P>
<P>According to <LINK REF="REF-Zimmermann-2006" TYPE="REFERENCE">Zimmermann 2006</LINK> and <LINK REF="REF-Hess-2005" TYPE="REFERENCE">Hess 2005</LINK>, the ways whereby vitamin A may affect iron status also include influences on the erythropoietic process, as well as on immune function, and the consequent reduction of the risk of infection and the associated anaemia.</P>
<P>Regarding absorption, <LINK REF="REF-Garcia_x002d_Casal-1998" TYPE="REFERENCE">Garcia-Casal 1998</LINK> has suggested that vitamin A and iron form a complex, which enhances its uptake, but <LINK REF="REF-Walczyk-2003" TYPE="REFERENCE">Walczyk 2003</LINK> observed no beneficial effect of this vitamin. Some studies have shown that iron deficiency impairs vitamin A metabolism (<LINK REF="REF-Oliveira-2008a" TYPE="REFERENCE">Oliveira 2008a</LINK>), probably through a decrease in hepatic mobilisation and serum retinol concentrations (<LINK REF="REF-Jang-2000" TYPE="REFERENCE">Jang 2000</LINK>; <LINK REF="REF-Strube-2002" TYPE="REFERENCE">Strube 2002</LINK>). In Mexico, a trial developed with pre-school children pointed out that iron supplementation improved the vitamin A nutritional status (<LINK REF="REF-Mu_x00f1_oz-2000" TYPE="REFERENCE">Muñoz 2000</LINK>).</P>
<P>
<B>Vitamin A deficiency (VAD)</B>
</P>
<P>The global distribution of VAD, published by the WHO in 1995, classified countries by its importance as a public health problem, based on clinical (ocular manifestations) and subclinical (serum retinol) indicators. The geographical regions with the highest proportions of VAD were Africa, Asia and Latin America (<LINK REF="REF-WHO-1995" TYPE="REFERENCE">WHO 1995</LINK>).</P>
<P>The most recent report of VAD was presented by WHO in 2009, and included data from 1995 to 2005. According to this document, Africa and South-East Asia were the more affected regions. Although the studies and surveys included to estimate the magnitude of the problem used different methodologies, it is understood that the prevalence of xerophthalmia among pre-school children decreased, but the subclinical VAD (based on low serum retinol concentration) in pre-school children and pregnant women increased, probably due to improved assessment techniques, and larger population samples (<LINK REF="REF-WHO-2009b" TYPE="REFERENCE">WHO 2009b</LINK>). The VAD data from lactating women were not considered in this report.</P>
<P>Studies carried out around the world suggested that VAD is still a public health concern in some regions and countries. In South Asia, the prevalence of subclinical VAD in children under six years ranged from 28% to 57% (<LINK REF="REF-Akhtar-2013" TYPE="REFERENCE">Akhtar 2013</LINK>). In India, the proportion was 62% in pre-school children from rural areas (<LINK REF="REF-Laxmaiah-2012" TYPE="REFERENCE">Laxmaiah 2012</LINK>). In Bangladesh, the prevalence was 18.5% in pregnant women (<LINK REF="REF-Lee-2008" TYPE="REFERENCE">Lee 2008</LINK>) and 37% in lactating women (<LINK REF="REF-Ahmed-2003" TYPE="REFERENCE">Ahmed 2003</LINK>). In South Africa, the proportions were 21.4% and 49.3% in postpartum women and their newborns, respectively (<LINK REF="REF-van-Stuijvenberg-2015" TYPE="REFERENCE">van Stuijvenberg 2015</LINK>).</P>
<P>Regarding Latin American and Caribbean countries, the prevalence of subclinical VAD in children under six years was less than 10% in Central America. However, the proportions were 17.4% and 13.0% in Brazil and Peru, respectively. The prevalence among women was 12.3% in Brazil and 8.7% in Peru (<LINK REF="REF-Cediel-2015" TYPE="REFERENCE">Cediel 2015</LINK>).</P>
<P>The ranges in prevalence of breastfeeding, maternal and infant mortality in countries with VAD are important in the context of any public health program involving maternal postnatal supplementation with vitamin A that aims to improve infant nutrition, through improved maternal health.</P>
<P>
<B>Breastfeeding prevalences</B>
</P>
<P>The global prevalence of exclusive breastfeeding during the first six months of life is estimated by <LINK REF="REF-WHO-2015a" TYPE="REFERENCE">WHO 2015a</LINK> as 36%. The low- and lower-middle-income groups showed the highest proportions, 47% and 33%, respectively.</P>
<P>The prevalences in Asia, Africa, and America vary by the specific country (<LINK REF="REF-WHO-2015a" TYPE="REFERENCE">WHO 2015a</LINK>). In Nepal, Bangladesh, and Indonesia, 70%, 64%, and 42% of infants were exclusively breastfed until the sixth month of life (<LINK REF="REF-WHO-2015a" TYPE="REFERENCE">WHO 2015a</LINK>). In India, the prevalence was 46% (<LINK REF="REF-WHO-2014" TYPE="REFERENCE">WHO 2014</LINK>). In Tanzania, the proportion was 50%, followed by Ghana (46%), Gambia (34%), Kenya (32%), and Zimbabwe (31%) (<LINK REF="REF-WHO-2015a" TYPE="REFERENCE">WHO 2015a</LINK>). The prevalence was 72% in Peru (<LINK REF="REF-WHO-2015a" TYPE="REFERENCE">WHO 2015a</LINK>) and was 40% in Brazil (<LINK REF="REF-WHO-2014" TYPE="REFERENCE">WHO 2014</LINK>).</P>
<P>
<B>Maternal mortality rates (MMR)</B>
</P>
<P>Although there are concerns about the accuracy of maternal mortality estimates, the statistics for 1990 to 2015 presented by <LINK REF="REF-WHO-2015b" TYPE="REFERENCE">WHO 2015b</LINK> pointed out a 44% overall decrease in the maternal mortality ratio (MMR), from 385 to 216 deaths per 100,000 live births in 1990 and 2015, respectively.</P>
<P>In 2015, almost 99% (302,000) of the total maternal deaths occurred in developing areas. Considering the regions, approximately 66% (201,000) and 22% (66,000) of these deaths occurred in Sub-Saharan Africa and Southern Asia, respectively. The MMR was 546 in Sub-Saharan Africa and there were 176 deaths per 100,000 live births in Southern Asia. Oceania did not account for a great number of deaths (500), but the MMR was one of the highest (187) (<LINK REF="REF-WHO-2015b" TYPE="REFERENCE">WHO 2015b</LINK>).</P>
<P>Even though developing areas presented the highest MMR, the estimates are not comparable considering different countries within geographical regions. In 2015, the MMR was higher in Nepal (258 deaths per 100,000 live births) than in Bangladesh (176), India (174) or Indonesia (126). The heterogeneity among African countries is also obvious. In Gambia the MMR was 706, followed by Kenya (510), Zimbabwe (443), Tanzania (398) and Ghana (319) (<LINK REF="REF-WHO-2015b" TYPE="REFERENCE">WHO 2015b</LINK>). This estimate was 13 for both Northern America and Europe (<LINK REF="REF-WHO-2015c" TYPE="REFERENCE">WHO 2015c</LINK>). In Latin America and Caribbean countries, the rates are still relatively high (60 and 175, respectively). The MMR was 68 in Peru and 44 in Brazil (<LINK REF="REF-WHO-2015b" TYPE="REFERENCE">WHO 2015b</LINK>).</P>
<P>
<B>Infant mortality rates (IMR)</B>
</P>
<P>Similarly to maternal mortality, the accuracy of infant mortality estimates is also an important challenge. Even considering this limitation, the statistics for 1990 to 2015 presented by United Nations Children's Fund (<LINK REF="REF-UNICEF-2015" TYPE="REFERENCE">UNICEF 2015</LINK>) described a substantial progress in reducing the infant mortality ratio (IMR) by 50%, from 63 in 1990 to 32 deaths per 1000 live births in 2015.</P>
<P>In 2015, around 98% (4,383,000) of the total infant deaths occurred in developing areas; approximately 46% (2,018,000) and 34% (1,499,000) of these deaths occurred in Sub-Saharan Africa and Southern Asia, respectively. The IMR was 56 in Sub-Saharan Africa and there were 41 deaths per 1000 live births in Southern Asia. Oceania did not account for a considerable number of total deaths (11,000), nevertheless the IMR was one of the highest (40) (<LINK REF="REF-UNICEF-2015" TYPE="REFERENCE">UNICEF 2015</LINK>).</P>
<P>Although developing areas presented the highest IMR, the estimates are not homogenous considering the different countries within geographical regions. In 2015, the IMR was higher in India (38) than in Bangladesh (31), Nepal (29) or Indonesia (23 per 1000 live births). Differences among African countries are also evident. In the Gambia the MMR was 48, followed by Zimbabwe (47), Ghana (43), Kenya (36), and Tanzania (35). This estimate was six and five in Northern America and Europe, respectively. In Latin America and Caribbean countries, the rate was 15. The IMR was 15 in Brazil and 13 in Peru (<LINK REF="REF-UNICEF-2015" TYPE="REFERENCE">UNICEF 2015</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-03-17 17:24:23 +0000" MODIFIED_BY="Heather Maxwell">
<P>Vitamin A supplements may take a number of forms, for example: as Vitamin A, measured in international units (IU) of retinyl palmitate (3.33 IU or 0.003491 micromol of retinol = 1 microgram or 1 retinol equivalent (RE) (<LINK REF="REF-IVACG-2004" TYPE="REFERENCE">IVACG 2004</LINK>), in an oil basis or water-miscible formulation, or as beta-carotene, generally in gelatinous capsules.</P>
<P>In 1998 and in 2002, WHO, UNICEF and the International Vitamin A Consultative Group (IVACG) recommended in areas where VAD was a public health concern, high doses of maternal vitamin A supplementation until the sixth week postpartum as an approach to promote women&#8217;s and infants&#8217; health and adequate nutritional status (<LINK REF="REF-Ross-2002" TYPE="REFERENCE">Ross 2002</LINK>; <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>). However, the most recent WHO guideline (<LINK REF="REF-WHO-2011" TYPE="REFERENCE">WHO 2011</LINK>) that was developed based on systematic reviews (<LINK REF="REF-Gogia-2010" TYPE="REFERENCE">Gogia 2010</LINK>; <LINK REF="REF-Gogia-2011" TYPE="REFERENCE">Gogia 2011</LINK>; <LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK> (the initial version of this review)), did not reinforce this previous recommendation, and highlighted the role of adequate food consumption in order to promote maternal health and nutritional status.</P>
<P>The <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK> guideline described some scenarios that considered safety and frequency of maternal vitamin A supplementation during the postpartum period in countries where VAD is a public health concern. For non-lactating women, a high dose of vitamin A (over 25,000 IU and usually 200,000 IU) during the first four weeks postpartum could be beneficial. After six weeks, for these women a maximum dose of 10,000 IU daily should be administered. For lactating women, a high dose (200,000 IU) administered until 60 days postpartum could be beneficial for them and, as well as, for their infants through higher breast milk retinol concentrations (<LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>). In 2002, WHO (<LINK REF="REF-Ross-2002" TYPE="REFERENCE">Ross 2002</LINK>) suggested that two high doses of vitamin A (200,000 IU each), with a minimum of 24 hours apart, could be administered to women until the sixth week postpartum.</P>
<P>The <LINK REF="REF-WHO-2011" TYPE="REFERENCE">WHO 2011</LINK> guideline made recommendations for future research, including the need to evaluate the impact of vitamin A (200,000 IU), exactly at the sixth week postpartum compared to early supplementation for lactating women on breast milk retinol concentrations. Moreover, the metabolic aspects and body distribution (hepatic reserves and secretion through breast milk) after the administration of the high doses were also cited as priorities for further studies.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-03-17 17:24:29 +0000" MODIFIED_BY="Heather Maxwell">
<P>Hypothetically, vitamin A supplementation for postpartum women from populations where VAD is endemic could reduce maternal and infant mortality and morbidity risks. Moreover, the intervention could contribute to building vitamin A hepatic reserves and promote an adequate nutritional status for both mother and infant, thus impacting on morbidity and mortality.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-03-23 14:18:57 +0000" MODIFIED_BY="[Empty name]">
<P>Considering that VAD remains a public health problem in some countries and regions, intervention studies, public policies and nutrition programs have assessed and recommended vitamin A supplementation during the postpartum period with the aim of improving maternal and infant health. Nevertheless, the countries' and researchers' practices and agendas are not always in agreement with the recommendations of international health agencies, like WHO. Food intake patterns and body composition shifts have occurred globally over the last decades, a phenomenon known as 'nutrition transition', including in regions with a reduction of under-nutrition (<LINK REF="REF-Haddad-2015" TYPE="REFERENCE">Haddad 2015</LINK>) and of VAD (<LINK REF="REF-WHO-2009b" TYPE="REFERENCE">WHO 2009b</LINK>). Therefore, changes in a population's overall health status would be expected over time, thus necessitating constant revisions of food and nutrition strategies, and justifying the update of this systematic review of relevant randomised controlled trials regarding maternal vitamin A supplementation during the six weeks of puerperium, that is the postpartum period.</P>
<P>Other reviews have considered vitamin A supplementation in women of childbearing age, during pregnancy and also provided to the newborn/infant (<LINK REF="REF-Gogia-2010" TYPE="REFERENCE">Gogia 2010</LINK>; <LINK REF="REF-Gogia-2011" TYPE="REFERENCE">Gogia 2011</LINK>; <LINK REF="REF-McCauley-2015" TYPE="REFERENCE">McCauley 2015</LINK>). We have therefore focused this review on vitamin A supplementation for postpartum women only. This is an update of the review originally published in 2010 (<LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-03-21 13:12:49 +0000" MODIFIED_BY="[Empty name]">
<P>To evaluate the effects of vitamin A supplementation, alone or in combination with other micronutrients (e.g. iron, folic acid, vitamin E) for postpartum women, on maternal and infant health.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-03-18 08:31:34 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-03-17 17:35:41 +0000" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2016-03-17 17:32:27 +0000" MODIFIED_BY="Heather Maxwell">
<P>We included randomised controlled trials that evaluated the effects of vitamin A supplementation for postpartum women. Cluster-randomised trials were eligible for inclusion but none were identified. Quasi-randomised trials and cross-over studies were not eligible for inclusion.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-03-17 17:32:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>Studies involving postpartum women, breastfeeding or not, from countries where vitamin A deficiency (VAD) is a concern were eligible. We did not include studies of women with confirmed chronic diseases such as HIV, as we considered these studies to be beyond the scope of this review and have been reviewed elsewhere, for example, <LINK REF="REF-Kongnyuy-2009" TYPE="REFERENCE">Kongnyuy 2009</LINK>. Maternal data from studies conducted in areas with a high prevalence of HIV without individual diagnostics at baseline were not excluded; only the data of HIV-negative women in studies conducted with both HIV-positive and HIV-negative women were considered.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-03-17 17:33:56 +0000" MODIFIED_BY="Heather Maxwell">
<P>Maternal vitamin A supplementation (beta-carotene or retinyl palmitate in oil or water-miscible formulation) alone or in combination with other micronutrients (examples: iron, folic acid, vitamin E) compared with placebo, no intervention, other micronutrient, or a lower dose of vitamin A, commenced at any time during the postpartum period, that is, within 24 hours after birth until the sixth week postpartum were eligible.</P>
<P>Study protocols could include, for example, maternal administration of high doses (given as a single dose of 200,000; 300,000; or 400,000 IU), or two doses (for a total of 400,000 IU), daily (7.8 mg or 4327 IU) doses, or a combination of higher or lower doses.</P>
<P>Trials that involved continuous daily/weekly supplementation for women during their reproductive years (pre-pregnancy or during pregnancy) were not included, as they have been addressed in another systematic review (<LINK REF="REF-McCauley-2015" TYPE="REFERENCE">McCauley 2015</LINK>).</P>
<P>In addition to maternal supplementation, some studies also included infant vitamin A supplementation. In these cases, only maternal outcomes were considered for this review, given that outcomes for infant supplementation have been considered in other reviews (<LINK REF="REF-Gogia-2010" TYPE="REFERENCE">Gogia 2010</LINK>; <LINK REF="REF-Gogia-2011" TYPE="REFERENCE">Gogia 2011</LINK>). However, infant outcomes were included in our review if they had been measured prior to commencement of infant supplementation.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-03-17 17:35:41 +0000" MODIFIED_BY="Heather Maxwell">
<P>We reviewed most outcomes for up to 12 months postpartum, with the exception of adverse effects close to the time of vitamin supplementation.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-02-17 14:20:52 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<OL>
<LI>Mortality.</LI>
<LI>Morbidity (febrile illness, respiratory tract infection, diarrhoea, anaemia and others).</LI>
<LI>Adverse effects of vitamin A within three days after receiving supplement.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Infant outcomes</HEADING>
<OL>
<LI>Mortality.</LI>
<LI>Morbidity (febrile illness, respiratory tract infection, diarrhoea, anaemia and others).</LI>
<LI>Adverse effects of vitamin A supplementation within three days after receiving supplement.</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-03-17 17:35:41 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<OL>
<LI>Serum retinol concentration.</LI>
<LI>Vitamin A hepatic reserves (MRDR or RDR).</LI>
<LI>Breast milk retinol concentration.</LI>
<LI>VAD (clinical: impaired visual adaptation to darkness, night blindness, xerophthalmia; and subclinical: abnormal conjunctival impression cytology (CIC)).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Infant outcomes</HEADING>
<OL>
<LI>Serum retinol concentration.</LI>
<LI>Vitamin A hepatic reserves (relative dose response (RDR) or modified relative dose response (MRDR)).</LI>
<LI>Clinical VAD (clinical: signs of xerophthalmia).</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-03-17 17:35:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-03-17 17:35:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (8 February 2016).</P>
<P>The Register is a database containing over 20,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate the Pregnancy and Childbirth Group's Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A> in <I>The Cochrane Library</I> and select the &#8216;<I>
<B>Specialized Register</B> </I>&#8217; section from the options on the left side of the screen.</P>
<P>Briefly, the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Trials Search Co-ordinator searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (Included, Excluded, Awaiting Classification or Ongoing).</P>
<P>In addition, we searched LILACS - Latin American and Caribbean Health Sciences by Bireme (1982 to December 2015) and Web of Science (1945 to December 2015), using the search strategies detailed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For additional searching carried out in previous versions of this review, see: <LINK REF="REF-Oliveira-2008b" TYPE="REFERENCE">Oliveira 2008b</LINK>; <LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-02-17 10:39:45 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of retrieved studies.</P>
<P>We did not apply any language or date restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-03-18 08:31:34 +0000" MODIFIED_BY="[Empty name]">
<P>For methods used in the previous version of this review, <I>see </I>
<LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK>.</P>
<P>For this current version, the following methods were used for assessing the 691 studies that were identified as a result of the Pregnancy and Childbirth Group register updated search (27) and by the authors additional searches of the LILACS (109) and Web of Science (555) databases.</P>
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<STUDY_SELECTION MODIFIED="2016-03-17 17:39:13 +0000" MODIFIED_BY="Heather Maxwell">
<P>Two review authors (JMO, RA) independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author (CEE). We elected to only include studies reported in brief abstracts if they provided sufficient information to allow us to assess risk of bias; if not, such studies would await further assessment pending publication of the full study report.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-02-10 16:34:27 +0000" MODIFIED_BY="[Empty name]">
<P>For eligible studies identified in this update, two review authors (JMO, RA) extracted the data using the Pregnancy and Childbirth standard form. We resolved discrepancies or uncertainties through discussion or, if required, we consulted the third review author (CEE). Data were entered into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we contacted authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-03-17 17:40:04 +0000" MODIFIED_BY="Heather Maxwell">
<P>Two review authors (JMO, RA) independently assessed risk of bias for each study included in this update using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Any disagreement or uncertainty was resolved by discussion or by involving a third assessor (CEE).</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of the quality of the evidence using the GRADE approach</HEADING>
<P>For this update, we assessed the quality of the evidence using the GRADE approach as outlined in the <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE Handbook</A> in order to estimate the quality of the body of evidence relating to the following outcomes (for the main comparison of vitamin A supplementation versus control (placebo, no treatment, other)):</P>
<OL>
<LI>maternal mortality;</LI>
<LI>maternal morbidity;</LI>
<LI>maternal adverse effects of vitamin A supplementation;</LI>
<LI>breast milk retinol concentration;</LI>
<LI>infant mortality;</LI>
<LI>infant adverse effects of vitamin A supplementation;</LI>
<LI>infant morbidity.</LI>
</OL>
<P>We used the <A HREF="http://www.gradepro.org/">GRADEpro</A> Guideline Development Tool to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create a &#8217;Summary of findings&#8217; table. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-03-17 17:40:09 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>We used the mean difference if outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-03-17 17:40:49 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We will include cluster-randomised trials in the analyses along with individually-randomised trials if any are identified in future updates of this review. We will adjust their sample sizes using the methods described in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cross-over trials</HEADING>
<P>Cross-over trials are unlikely to be an appropriate design for Pregnancy and Childbirth reviews and were therefore not eligible for inclusion in our review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other unit of analysis issues</HEADING>
<P>As trials in Pregnancy and Childbirth may include outcomes for multiple pregnancies, we planned to collect maternal outcome data once for the women and for infant outcomes on the individual babies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials with more than two arms</HEADING>
<P>In the original version of the review (<LINK REF="REF-Oliveira_x002d_Menegozzo--2010" TYPE="REFERENCE">Oliveira-Menegozzo 2010</LINK>), we did not specify how we would deal with trials that reported three or more groups. As methods have evolved in the intervening period (see <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, Section 16.5.4), we retained the process that we had used for the study by <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> in the previous version of the review, but have made an adjustment to the numbers of events and total participants in the control group of the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK> in this update.</P>
<P>The study by <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> involved four groups: two groups of women received vitamin A supplementation and their infants received either vitamin A or placebo. Similarly, two groups of women received the placebo and their infants received either supplemental vitamin A or placebo. The women could only receive either the treatment or placebo, meaning there were effectively only two maternal arms: supplementation or placebo. We therefore reported maternal outcomes from these two groups. As this review did not include infant supplementation within its scope, we only reported infant outcomes if the infant had received the placebo. The women could have received either vitamin A supplementation or placebo. In this way, we avoided any concerns about double-counting.</P>
<P>By contrast, the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>, which involved a total of three groups: two groups each using a different form of vitamin A supplementation (that we reported separately from other studies) and a control arm. We halved the numbers of events and participants (rounding up if an uneven number was noted) in the control arm for dichotomous outcomes. For continuous outcomes, we retained the mean and standard deviation and halved the number of participants, consistent with one of the options for dealing with this unit of analysis issue from <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK> (Section 16.5.4).</P>
<P>We avoided needing to combine data from four arms in the study reported by <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>, as there was sufficient detail available to only include the two postpartum supplementation (or placebo) arms. The other two arms involved supplementation or placebo during pregnancy, which fell outside the scope of this review.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-03-17 17:41:38 +0000" MODIFIED_BY="Heather Maxwell">
<P>For included studies, we noted levels of attrition. In future updates of this review, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>For all outcomes, analyses were carried out, as far as possible, on an intention-to-treat basis i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-03-18 08:31:34 +0000" MODIFIED_BY="[Empty name]">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. Had we identified substantial heterogeneity (above 30%), we planned to explore it by pre-specified subgroup analysis.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-03-17 09:18:00 +0000" MODIFIED_BY="Heather Maxwell">
<P>In future updates, if there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-03-17 17:42:20 +0000" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar.</P>
<P>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average of the range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we would not have combined trials. Where we used random-effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-03-17 17:42:44 +0000" MODIFIED_BY="Heather Maxwell">
<P>If we identified substantial heterogeneity, we investigated it using subgroup analyses. We considered whether an overall summary was meaningful, and it was, we used random-effects analysis to produce it.</P>
<P>We planned to conduct the following subgroup analyses, if sufficient data were available:</P>
<OL>
<LI>type of supplement (vitamin A (retinyl palmitate or water-miscible formulation) or beta-carotene);</LI>
<LI>duration of supplementation (daily, single or double dose);</LI>
<LI>dose of supplement (200,000 to 300,000 IU or 400,000 IU);</LI>
<LI>duration of breastfeeding.</LI>
</OL>
<P>All outcomes were included in the subgroup analysis. It was not possible to conduct subgroup analysis on duration of breastfeeding, but we will include this in future updates, if data become available.</P>
<P>We assessed subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-03-17 17:43:10 +0000" MODIFIED_BY="Heather Maxwell">
<P>We carried out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor-quality studies being excluded from the analyses in order to assess whether this made any difference to the overall result. We also carried out sensitivity analyses to explore the effect of vitamin A dosage and formulation.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-04-28 15:26:14 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-03-23 21:07:05 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2016-03-17 17:43:57 +0000" MODIFIED_BY="Heather Maxwell">
<P>For the updated version of the review, we assessed the eligibility of 691 studies that were identified as a result of the combined searches from the Pregnancy and Childbirth Group's register updated search (n = 27), LILACS (n = 109) and Web of Science (n = 555) databases. After the evaluation, five studies were considered eligible. Two of the studies were included in the review (<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>). Two were added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>, because only the trial registry information and abstracts were available, which would not have permitted us to perform a robust data extraction and 'Risk of bias' assessment (<LINK REF="STD-Nga-2013" TYPE="STUDY">Nga 2013</LINK>; <LINK REF="STD-Wang-2012" TYPE="STUDY">Wang 2012</LINK>). One was added to <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK>, because only the trial registry and the protocol were available and published (<LINK REF="STD-Ahmad-2015" TYPE="STUDY">Ahmad 2015</LINK>). See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-03-23 21:07:05 +0000" MODIFIED_BY="[Empty name]">
<P>We included a total of 14 studies that enrolled 25,758 women and infant pairs residing in low-income settings in India, Bangladesh, Indonesia, Tanzania, Gambia, Zimbabwe, Kenya, Ghana, Peru and Brazil, countries in which women in the studies were likely to have low vitamin A levels and low nutritional status. The <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table provides further information on these trials. Although all studies reported or implied that postpartum women breastfed their infants, the available details made it impractical to perform subgroup or sensitivity analyses by duration of breastfeeding.</P>
<SUBSECTION>
<HEADING LEVEL="4">Dosage and duration of vitamin A supplementation</HEADING>
<P>Ten studies (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Bhaskaram-2000" TYPE="STUDY">Bhaskaram 2000</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>) involved the administration of a single dose of vitamin A in the form of retinyl palmitate or water-miscible formulation (200,000; 300,000 or 400,000 IU) supplementation for women within the first days or weeks postpartum. Nine of the trials compared vitamin A supplementation with placebo (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Bhaskaram-2000" TYPE="STUDY">Bhaskaram 2000</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>; <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>). In two studies, women in the control group received no intervention (<LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>) or were given iron supplementation (as were those in that study's intervention group) (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>). The <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK> used a three-group approach of single postpartum dose of vitamin A (as retinyl palmitate) followed by placebo for nine months, placebo at enrolment followed by daily beta-carotene supplementation for nine months, or placebo at enrolment and daily for nine months. Three trials compared a lower dose of vitamin A (200,000 IU) with a higher dose (400,000 IU) (<LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK>; <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>).</P>
<P>The studies reported the dosage in a variety of units: for the purpose of this review, dosages have generally been presented as international units (IU), based on the calculation of 3.33 IU or 0.003491 micromol of retinol = 1 microgram or 1 retinol equivalent (RE) (<LINK REF="REF-IVACG-2004" TYPE="REFERENCE">IVACG 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Breastfeeding patterns</HEADING>
<P>Ten of the included studies reported that women breastfed their infants, with several studies noting that all or most of the infants were exclusively breastfed (<LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK> for the duration of the study, <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK> for the first month, <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK> most until three months), and others indicating that all or most of infants were at least partially breastfed to six months (<LINK REF="STD-Bhaskaram-2000" TYPE="STUDY">Bhaskaram 2000</LINK>; <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>). All four studies that did not specify details of breastfeeding provided strong surrogate evidence to support the likelihood of at least partial breastfeeding. The studies by <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> and <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK> reported breast milk retinol levels at six months postpartum, whilst the study title, background and/or discussion material suggested that the reports from <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK> and <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK> related to breastfeeding, although the duration or extent cannot be estimated.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-03-18 10:05:04 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty-six studies were excluded because they used:</P>
<OL>
<LI>alternate allocation to intervention or control groups (six studies: <LINK REF="STD-Ala_x002d_Houhala-1988" TYPE="STUDY">Ala-Houhala 1988</LINK>; <LINK REF="STD-Basu-2003" TYPE="STUDY">Basu 2003</LINK>; <LINK REF="STD-Bezerra-2009" TYPE="STUDY">Bezerra 2009</LINK>; <LINK REF="STD-Garcia-2010" TYPE="STUDY">Garcia 2010</LINK>; <LINK REF="STD-Lima-2012" TYPE="STUDY">Lima 2012</LINK>; <LINK REF="STD-Tchum-2006" TYPE="STUDY">Tchum 2006</LINK>);</LI>
<LI>supplementation for women during pregnancy (one study: <LINK REF="STD-Ahmad-2009" TYPE="STUDY">Ahmad 2009</LINK>), long-term supplementation during reproductive age (three studies: <LINK REF="STD-ObaapaVitA" TYPE="STUDY">ObaapaVitA</LINK>; <LINK REF="STD-NNIPS_x002d_2" TYPE="STUDY">NNIPS-2</LINK>; <LINK REF="STD-West-2011" TYPE="STUDY">West 2011</LINK>), or after the first six weeks postpartum (four to 12 months postpartum) (three studies: <LINK REF="STD-Haskell-2013a" TYPE="STUDY">Haskell 2013a</LINK>; <LINK REF="STD-Haskell-2013b" TYPE="STUDY">Haskell 2013b</LINK>; <LINK REF="STD-Turner-2013" TYPE="STUDY">Turner 2013</LINK>);</LI>
<LI>provision of fat (one study: <LINK REF="STD-Alam-2010" TYPE="STUDY">Alam 2010</LINK>), of vitamin A rich foods alone (nine studies: <LINK REF="STD-Atalhi-2011" TYPE="STUDY">Atalhi 2011</LINK>; <LINK REF="STD-Canfield-2001" TYPE="STUDY">Canfield 2001</LINK>; <LINK REF="STD-De-Pee-1995" TYPE="STUDY">De Pee 1995</LINK>; <LINK REF="STD-El-Hamdouchi-2013" TYPE="STUDY">El Hamdouchi 2013</LINK>; <LINK REF="STD-Filteau-1999" TYPE="STUDY">Filteau 1999</LINK>; <LINK REF="STD-Khan-2007" TYPE="STUDY">Khan 2007</LINK>; <LINK REF="STD-Lietz-2001" TYPE="STUDY">Lietz 2001</LINK>; <LINK REF="STD-Lietz-2006" TYPE="STUDY">Lietz 2006</LINK>; <LINK REF="STD-Ncube-2001" TYPE="STUDY">Ncube 2001</LINK>), or combined with nutrition counselling (one study: <LINK REF="STD-Swaminathan-2015" TYPE="STUDY">Swaminathan 2015</LINK>) rather than vitamin A supplements;</LI>
<LI>vitamin A supplementation for women who live with HIV (one study: <LINK REF="STD-Humphrey-2006" TYPE="STUDY">Humphrey 2006</LINK>);</LI>
<LI>a study designed to evaluate circulating levels of immune factors following supplementation or placebo, not maternal or infant mortality/morbidity (one study: <LINK REF="STD-Gossage-2000" TYPE="STUDY">Gossage 2000</LINK>). (<I>See</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.)</LI>
</OL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-04-28 15:26:14 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the overall risk of bias in the 14 included trials as being low or unclear (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<ALLOCATION MODIFIED="2016-04-28 15:26:14 +0100" MODIFIED_BY="[Empty name]">
<P>We rated eight studies as being of low risk of selection bias (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK>; <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>; <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>). In most studies, women and infant pairs were individually randomised in blocks by a computer random number generator and allocation schedules were concealed by being held centrally for the duration of the trial.</P>
<P>The remaining reports from the trials by <LINK REF="STD-Bhaskaram-2000" TYPE="STUDY">Bhaskaram 2000</LINK>, <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>, <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>, <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>, <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>, and <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>, provided no information about the method of randomisation and concealment and were therefore rated as being of unclear risk of selection bias.</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-03-17 17:45:03 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Blinding of participants and personnel (performance bias)</HEADING>
<P>For most studies, the vitamin A and placebo capsules were identical or similar in appearance and/or investigators were not aware of the allocation code (see 'Risk of bias' tables in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>In the study by <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>, the two different doses of vitamin A were manufactured by the same company, but it was unclear if they were identical in appearance and there was not enough detail to judge whether participants were blinded. In the studies by <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK> and <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>, no placebo was used (high risk of bias).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding of outcome assessment (detection bias)</HEADING>
<P>For most studies, allocation codes were kept concealed during the trial duration, field workers were not aware of the aim of the trial or were blinded to the arms, or the outcomes assessed were unlikely to be influenced by blinding (see 'Risk of bias' tables in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). In the study by <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>, there was not enough detail to judge about blinding of outcome assessment.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-03-18 10:03:29 +0000" MODIFIED_BY="[Empty name]">
<P>In the <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK> trial, there was a 24.2% overall loss of follow-up, distributed similarly between the three groups and attributed to post-randomisation exclusions for medical reasons such as congenital abnormalities or jaundice, migration, and miscellaneous. In the study by <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>, no losses to follow-up were discussed, but data from the tables indicate 100% follow-up. In the <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK> clinical trial, the loss of follow-up rate was 22.9%. In the trial by <LINK REF="STD-Bhaskaram-2000" TYPE="STUDY">Bhaskaram 2000</LINK>, the rates of loss to follow-up were 13% and 54% until three and six months postpartum, respectively. <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> reported a 12.6% loss to follow-up by three and half months and a 22.9% loss by six and a half months postpartum. In the trial by <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK>, 89.5% of women and infants were followed up until 12 months. <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK> reported 19%, 20.5%, 22.8% of loss by three, six, and nine months, respectively. Attrition was 11.3% (in both the vitamin A and placebo groups) for HIV-negative women (985/9562) in the report from the <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>. <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK> reported an attrition of 34.6%.</P>
<P>Twenty-three of the total 220 women in the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK> missed one or more visits, resulting in follow-up rates of 98%, 95%, and 92% at three, six, and nine months postpartum, respectively, with data reported for these participants in most outcomes. The exception was for maternal hepatic stores of vitamin A and serum retinol concentrations, for which approximately 50% of women were sampled: the report does not specify why all women were not tested. The study by <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK> had a 9% loss to follow-up in each group by three months and 13% and 5% losses in the vitamin A and control groups respectively by six months - however, the reasons for attrition and exclusions were not reported and ITT analysis was not performed.</P>
<P>Loss of follow-up at nine months for the <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK> study was 783 (17%) in the intervention group and 770 (16%) in the placebo group. This increased to 25% and 24.5% in the intervention and control groups respectively by 12 months. Infant death was the only outcome of interest for this review at this time, therefore it was recorded in this review for the nine-month follow-up time, rather than at 12 months. Biochemical markers had been measured in a subgroup of approximately 100 women and their infants from each of the three participating countries: the exact number sampled increased from the first to the second timeframe, which meant we were unable to determine loss to follow-up from the report.</P>
<P>In the trial by <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>, different losses of follow-up were reported according to the outcome, however at least 60.45% of women and infant pairs remained until the end of the study. For infant serum and breast milk retinol concentrations, the withdrawals and dropouts were comparable between arms. Regarding maternal serum retinol concentration and infant illness, the withdrawals and dropout differences between the arms were almost 10%.</P>
<P>The losses to follow-up were similar in the intervention and control group in the <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK> study. A high rate of follow-up (89.39%) until three months postpartum was observed.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-03-17 17:46:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>We judged all but one trial to be at high risk of selective reporting (<LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>) as they did not provide detail on clinical outcomes that would be considered fundamental to a study design; for example, only five of the 14 trials reported infant mortality and only two reported maternal mortality.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-02-11 09:06:59 +0000" MODIFIED_BY="[Empty name]">
<P>We judged most trials as unclear for risk of other bias, mostly due to a lack of clarity about any influence of funding bodies or not having published protocols.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-03-23 14:21:29 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: Supplement (vitamin A as retinyl, water-miscible or beta-carotene) versus control (placebo, no treatment)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary maternal outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal mortality</HEADING>
<P>Two randomised controlled trials (RCTs) evaluated maternal mortality for a total of 9141 women (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>). The study by <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> reported no difference in maternal mortality to six months (risk ratio (RR) 0.50, 95% confidence interval (CI) 0.09 to 2.71; 564 participants, <I>low-quality evidence</I>), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>. There were no reported differences in maternal mortality after vitamin A supplementation or placebo in HIV-negative women followed to 12 months (hazard ratio (HR) 1.01, 95% CI 0.44 to 2.21; 8577 participants; 1 RCT, <I>moderate-quality evidence</I>) in the <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>. The adjusted HR and CI were estimated based on the Kaplan-Meier curve reported in the study using Cox model.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal morbidity</HEADING>
<P>One small study of 50 women (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>) reported no differences in cumulative episodes of fever, respiratory tract infection or diarrhoea (<I>very low-quality evidence</I>, see <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse effects of vitamin A supplementation</HEADING>
<P>In a subset of 786 women from the <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>, there was no evidence of differences in adverse effects within 30 hours of supplementation, including abdominal pain (RR 1.28, 95% CI 0.95 to 1.73; 786 participants; 1 RCT; <I>low-quality evidence</I>), vomiting, headache, blurred vision, drowsiness, nausea or poor appetite following a single dose of 400,000 IU vitamin A or placebo, <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary maternal outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal serum retinol</HEADING>
<P>Five studies reported maternal serum retinol values, measured between three and nine months postpartum. In some studies, women were evaluated at three to three and a half (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>), six to six and a half (<LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>), and nine months postpartum (<LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>), as described in the following analysis: <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>, respectively.</P>
<P>Maternal serum retinol concentrations were enhanced by doses of between 200,000 to 400,000 IU when measured at three to three and half months (mean difference (MD) 0.11 µmol/L, 95% CI 0.03 to 0.19; 704 participants; 5 RCTs), but were not enhanced by the largest single dose (400,000 IU) (MD 0.04 µmol/L, 95% CI -0.01 to 0.09; 402 participants; 1 RCT), or by the daily postpartum administration of 7.8 mg beta-carotene dose (MD 0.10 µmol/L, 95% CI -0.14 to 0.34; 54 participants; 1 RCT), <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>. In the subgroup analysis regarding doses of 200,000 to 300,000 IU, a significant increase was also observed (MD 0.17 µmol/L, 95% CI 0.07 to 0.26; 302 participants; 4 RCTs). There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction test (test for subgroup differences: Chi² = 6.41, df = 3 (P = 0.09), I² = 53.2%).</P>
<P>Maternal serum retinol concentrations were not enhanced by doses of between 200,000 to 400,000 IU, a single dose (400,000 IU), or by beta-carotene at a 7.8 mg daily dose when measured at six to six and half months (MD 0.06, 95% CI -0.06 to 0.18; 533 participants; 4 RCTs; MD -0.02, 95% CI -0.08 to 0.04; 291 participants; 1 RCT; MD 0.05, 95% CI -0.28 to 0.38; 50 participants; 1 RCT; respectively), but were enhanced by doses between 200,000 to 300,000 (MD 0.13, 95% CI 0.03 to 0.23; 242 participants; 3 RCTs), <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>. There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction test (test for subgroup differences: Chi² = 6.67, df = 3 (P = 0.08), I² = 55.0%).</P>
<P>Maternal serum retinol concentrations were not enhanced at nine months by doses of between 200,000 to 300,000 IU or by beta-carotene at a 7.8 mg daily dose (MD 0.00, 95% CI -0.16 to 0.17; 98 participants; 2 RCTs; MD 0.19, 95% CI -0.08 to 0.46; 51 participants; 1 RCT), <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>. There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction test (test for subgroup differences: Chi² = 1.34, df = 1 (P = 0.25), I² = 25.6%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vitamin A hepatic reserves</HEADING>
<P>Two studies analysed vitamin A hepatic reserves (reported as relative dose response (RDR) greater than 20% or modified relative dose response (MRDR) <U>&gt;</U> 0.06) at three, six, and nine months postpartum (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11)</LINK>. No improvement in the proportion of women with low hepatic reserves at three months, (RR 0.58, 95% CI 0.16 to 2.08; 191 participants; 2 RCTs; I² = 73%), <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>, following a single 200,000 to 300,000 IU dose of vitamin A, compared with placebo, neither at six or nine months postpartum. As the data from studies that administrated different doses of vitamin A were pooled, we used a random-effects model because it is not possible to assume that the results would be similar among the trials.</P>
<P>No differences were reported in the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK> for this outcome within nine months of daily beta-carotene supplementation and placebo at any times, for example, when measured at nine months (RR 0.59, 95% CI 0.27 to 1.30; 51 participants), <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Breast milk retinol</HEADING>
<P>Breast milk retinol concentrations were reported in several formats (retinol concentration, proportion of breast milk retinol &lt; 1.05 µmol/L or &lt; 0.28 µmol/g of fat) in seven studies (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK> to <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>). There was<I> low-quality evidence</I> that vitamin A supplementation (200,000 to 400,000 IU) was associated with an increased breast milk retinol concentration at three to three and a half months (MD 0.20 µmol/L, 95% CI 0.08 to 0.31; 837 participants; 6 RCTs). This association was also observed in the subgroup analysis with the lower doses (200,000 to 300,000 IU) (MD 0.25 µmol/L, 95% CI 0.12 to 0.37; 415 participants; 5 RCTs; <I>low-quality evidence</I>), <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK> (test for subgroup differences: Chi² = 9.16, df = 3 (P = 0.03), I² = 67.2%), but this improvement was not sustained by six to six and a half months postpartum. The subgroup heterogeneity observed in the <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK> could be explained by the different effects in the breast milk retinol concentrations. After sensitive analysis, it was possible to observe that the sources of heterogeneity were the <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> and <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK> trials. Both of them used the higher doses, 400,000 IU and 300,000 IU, respectively, but the MD breast milk retinol concentrations between intervention and control group after supplementation vary substantially: 0.08 µmol/L for <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> and 0.63 µmol/L for <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>. Moreover, the MD for the remaining studies were more homogeneous and varied by 0.17 to 0.37 µmol/L. Thus, the random-effects model was applied.</P>
<P>Subgroup heterogeneity was also found in the following analysis: 1.13.1, 1.13.2, 1.14.1, 1.15.1, 1.16.1 and 1.17.1. As the data from studies that administered different doses of vitamin A were pooled, we used a random-effects model because it is not possible to assume that the results would be similar among the trials.</P>
<P>Daily doses of beta-carotene to nine months postpartum did not improve breast milk retinol at three or six months, but did demonstrate improvement for this outcome by nine months postpartum (MD 0.21 µmol/L, 95% CI 0.01 to 0.41, 103 participants; test for subgroup differences: Chi² = 0.11, df = 1 (P = 0.74), I² = 0%), <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>, in the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>, compared with placebo.</P>
<P>Supplementation with a single dose of vitamin A (200,000 to 300,000 IU) reduced the proportion of women with low retinol concentration (&lt; 1.05 µmol/L) in breast milk at three months (average RR 0.56, 95% CI 0.37 to 0.84; 304 participants; 3 RCTs; heterogeneity - Tau² = 0.07, I²= 55%; test for subgroup differences: Chi² = 4.88, df = 1 (P = 0.03), I² = 79.5%), <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>, but not at six months after delivery (RR 0.65; 95% CI 0.22 to 1.94; 241 participants; 2 RCTs; test for subgroup differences: Chi² = 0.20, df = 1 (P = 0.66), I² = 0%), <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>, compared with placebo.</P>
<P>Two studies (<LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>) reported the proportion of women with low breast milk retinol levels (&lt; 0.28 µmol/g of fat). Supplementation with a single dose of vitamin A (200,000 IU) or daily beta-carotene 7.8 mg daily for nine months did not improve this measure at three, six, and nine months postpartum (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>; <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>).</P>
<P>Although no improvements were noted at three and six months following daily administration of beta-carotene, an improvement was noted by nine months (RR 0.76, 95% CI 0.60 to 0.97; 102 participants; test for subgroup differences: Chi² = 0.79, df = 1 (P = 0.37), I² = 0%) in the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>, <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinical and subclinical vitamin A deficiency (VAD)</HEADING>
<P>One study, <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>, measured abnormal conjunctival impression cytology (CIC) in one or both eyes as the criterion for VAD. There was no difference in the proportion of women with abnormal CIC at three or six months postpartum, following supplementation with vitamin A or placebo (RR 1.00, 95% CI 0.55 to 1.80; 148 participants; RR 0.56, 95% CI 0.27 to 1.17; 142 participants), <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>; <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary infant outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant mortality</HEADING>
<P>Infant mortality was assessed at different times in each of the five trials that examined this outcome, ranging from up to two months to up to 12 months (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>, <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>), with no differences for vitamin A compared with placebo (RR 1.08, 95% CI 0.77 to 1.52; 6090 participants; 5 RCTs; <I>low-quality evidence</I>) (<LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>). The measure of overall effect did not change meaningfully when we conducted the planned sensitivity analysis of excluding the findings from <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK> and <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>, where there was uncertainty around risk of selection bias and high risk for attrition bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Infant morbidity</HEADING>
<P>Three studies (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>) evaluated and reported infant morbidity (<LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK> to <LINK REF="CMP-001.30" TYPE="ANALYSIS">Analysis 1.30</LINK>) <I>very low-quality evidence</I>. Although the methods of the <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK> study indicated that infant morbidity was evaluated, the authors did not report this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Diarrhoea</HEADING>
<P>None of the three studies that considered diarrhoea or gastroenteritis reported any significant differences between the vitamin A supplementation or control groups (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK> (diarrhoea episodes, 50 participants, P = 0.59), <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>, (RR 1.02, 95% CI 0.98 to 1.06; 456 participants), <LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>, and <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK> (RR 6.03, 95% CI 0.03 to 121.82; 84 participants; <I>very low-quality evidence</I>), <LINK REF="CMP-001.26" TYPE="ANALYSIS">Analysis 1.26</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Respiratory illnesses</HEADING>
<P>The reduced mean duration of acute respiratory tract infection (3.1 versus 3.7, 50 participants, P &lt; 0.03) in the treatment group reported by <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK> was not noted in the larger study by <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>, which reported no evidence of a difference in overall incidence of one or more episodes to 12 months of age of acute respiratory infection (RR 1.00, 95% CI 0.96 to 1.03; 456 participants), <LINK REF="CMP-001.27" TYPE="ANALYSIS">Analysis 1.27</LINK>, between the supplemented and placebo groups. There was also no evidence of a difference in infant upper respiratory infection to three months (RR 0.91, 95% CI 0.22 to 3.81; 84 participants), <LINK REF="CMP-001.28" TYPE="ANALYSIS">Analysis 1.28</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Febrile illness</HEADING>
<P>One small study (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>) reported a lower mean number of febrile illness episodes (0.1 versus 0.3, 50 participants, P &lt; 0.002) in the vitamin A group compared to the control group, <LINK REF="CMP-001.30" TYPE="ANALYSIS">Analysis 1.30</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse effects of vitamin A supplementation</HEADING>
<P>No differences were detected in the potential for developing the adverse effect of bulging fontanelle following vitamin A supplementation (400,000 IU) (RR 2.00, 95% CI 0.61 to 6.55; 444 participants; 1 RCT; <I>low-quality evidence</I>) <LINK REF="CMP-001.31" TYPE="ANALYSIS">Analysis 1.31</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary infant outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant serum retinol</HEADING>
<P>Four studies reported infant serum retinol between three to three and a half, and six to six and a half months. There was no beneficial effect observed in two of the dosing regimens (200,000 to 400,000 IU, or 200,000 IU) used at three to three and half months (MD 0.11 µmol/L, 95% CI -0.05 to 0.26; 379 participants; 4 RCTs; Tau² = 0.02, I² = 87%; MD 0.20 µmol/L, 95% CI 0.00 to 0.39; 215 participants; 3 RCTs; Tau² = 0.01, I² = 47%), <LINK REF="CMP-001.32" TYPE="ANALYSIS">Analysis 1.32</LINK>, and there was evidence of substantial heterogeneity. Similarly, no beneficial effect was observed with the use of 400,000 IU dose versus placebo at three to three and half months, (MD of 0.02 µmol/L, 95% CI -0.03 to 0.07, 164 participants) (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>). There were no differences at six to six and a half months in any of the four studies that reported this outcome (<LINK REF="CMP-001.33" TYPE="ANALYSIS">Analysis 1.33</LINK>), for example, the subgroup analysis of 200,000 to 300,000 IU versus placebo yielded a MD 0.03 µmol/L (95% CI -0.02 to 0.09; 289 participants; 3 RCTs), although again there was evidence of substantial heterogeneity. After sensitive analysis, it was observed that the source of heterogeneity was the <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK> study that used a water-miscible vitamin A formulation, which probably explains the highest enhancement in serum concentration (MD 0.29 µmol/L) compared to the others studies (MD varying from 0.02 to 0.05 µmol/L).</P>
<P>There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction test.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vitamin A hepatic reserves</HEADING>
<P>Three studies reported low hepatic vitamin A reserves (<LINK REF="CMP-001.34" TYPE="ANALYSIS">Analysis 1.34</LINK>), but vitamin A hepatic reserves analysed at six to six and half months of infancy were not enhanced by any vitamin A dosing regimens, compared with placebo. Substantial heterogeneity was found in these analyses. As the data from studies that administrated different doses of vitamin A were pooled, we used a random-effects model because its not possible to assume that the results would be similar among the trials.</P>
<P>There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction test.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinical vitamin A deficiency (VAD)</HEADING>
<P>No study addressed infant clinical VAD.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2: Supplement (vitamin A as retinyl) 400,000 IU versus 200,000 IU</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary maternal outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal mortality</HEADING>
<P>No study addressed maternal mortality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal morbidity</HEADING>
<P>No study addressed maternal morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse effects of vitamin A supplementation</HEADING>
<P>
<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK> noted that the women did not report any adverse effects related to the double (400,000 IU) or single (200,000 IU) doses of vitamin A supplementation, however, no data about this were presented in the publication.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary maternal outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal serum retinol</HEADING>
<P>Two studies presented maternal serum retinol values, assessed between two and six months postpartum, as described in the <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>. There was no evidence that a higher dose of maternal vitamin A supplementation (400,000 IU) made any difference to serum retinol concentrations at two months (MD 0.04 µmol/L, 95% CI -0.06 to 0.14; 429 participants; 2 RCTs; test for subgroup differences: Chi² = 3.37, df = 2 (P = 0.19), I² = 40.7%) compared to the standard dose (200,000 IU). The means were not different at four, and six months postpartum (1 RCT, <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vitamin A hepatic reserves</HEADING>
<P>No study addressed maternal vitamin A hepatic reserves.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Breast milk retinol concentration</HEADING>
<P>Breast milk retinol concentrations were reported by three studies, but it was only possible to pool the data from two of them (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). A double dose of vitamin A supplementation (400,000 IU) was not associated with an increased breast milk retinol concentration at two months (MD -0.01 µmol/L, 95% CI -0.14 to 0.11; 377 participants; 2 RCTs), and at four months (MD -0.03 µmol/L, 95% CI -0.13 to 0.08; 348 participants; 2 RCTs) postpartum, (test for subgroup differences: Chi² = 1.07, df = 3 (P = 0.78), I² = 0%). No difference in breast milk retinol concentration was observed in the trial by <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK> (780 women randomised) at six months (higher dose: mean = 1.82 µmol/L (standard deviation (SD) = 1.09); lower dose: mean = 1.88 µmol/L (SD = 1.09); P = 0.49) or at nine months postpartum (higher dose: mean = 1.86 µmol/L (SD = 1.19); lower dose: mean = 1.95 µmol/L (SD = 0.97); P = 0.33).</P>
<P>Regarding the proportion of women with low breast milk retinol concentrations, only <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK> assessed this outcome, and no significant effect was observed (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinical and subclinical vitamin A deficiency (VAD)</HEADING>
<P>No study addressed maternal clinical and subclinical VAD outcomes.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary infant outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant mortality</HEADING>
<P>No study addressed infant mortality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Infant morbidity</HEADING>
<P>Only one study (<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>) assessed the impact of the maternal double dose of vitamin A supplementation on infant morbidity. The rates and RR and CIs were reported for the following infant morbidities (diarrhoea, respiratory illnesses, febrile illness), but the data were not presented in a way that could be used for pooled analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Diarrhoea</HEADING>
<P>No differences were observed for diarrhoea episode rates per 100 children per month (400,000 IU: number of episodes = 98, rate = 13.8; 200,000 IU: number of episodes = 89, rate = 13.3; RR 0.96, 95% CI 0.72 to 1.28, P = 0.80) during the six months postpartum.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Respiratory illnesses</HEADING>
<P>The effects of the double dose was evaluated on acute respiratory infection in episode rates per 100 children per month (<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012)</LINK> until six months postpartum, however no differences were described (400,000 IU: number of episodes = 319, rate = 44.8; 200,000 IU: number of episodes = 310, rate = 46.2; RR 1.03, 95% CI 0.88 to 1.21, P = 0.70).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Febrile illness</HEADING>
<P>For fever episode rates per 100 children per month, no beneficial impact was noted with the maternal double or single doses of vitamin A supplementation (400,000 IU: number of episodes = 185, rate = 26.0; 200,000 IU: number of episodes = 161, rate = 24.0; RR 0.92, 95% CI 0.75 to 1.14, P = 0.46) (<LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012)</LINK> during the six months postpartum.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse effects of vitamin A supplementation</HEADING>
<P>In the trial by <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK>, the field workers questioned the women about infant adverse effects (fever, nausea, and bulging fontanelle) at one day before supplementation and on the following three days after supplementation, but no reactions were noted. <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK> did not report any infant adverse effects after the double (400,000 IU) or single (200,000 IU) doses.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary infant outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant serum retinol</HEADING>
<P>Two studies, <LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK> and <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK> (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>), assessed the effects of maternal double (400,000 IU) or single (200,000 IU) doses of vitamin A supplementation on infant serum retinol concentrations at two months postpartum; no significant difference between the regimens was noted (MD 0.01 µmol/L, 95% CI -0.05 to 0.07; 362 participants; 2 RCTs; test for subgroup differences: Chi² = 0.70, df = 2 (P = 0.71), I² = 0%). For the following endpoints, four and six months, the absence of effects was maintained.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vitamin A hepatic reserve</HEADING>
<P>No study addressed infant vitamin A hepatic reserves.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinical vitamin A deficiency (VAD)</HEADING>
<P>No signs of xerophthalmia were observed in the trial by <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>.</P>
<P>There was no evidence of a subgroup difference by dose as indicated by the subgroup interaction tests for any of the comparisons (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). Fixed-effect models were used in these analysis.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-04-28 15:27:56 +0100" MODIFIED_BY="[Empty name]">
<P>There was no evidence that different doses of vitamin A supplementation for postpartum women could improve maternal and infant mortality and morbidity, compared with other doses, no treatment or placebo. Although maternal serum and breast milk retinol concentrations improved with supplementation, this did not translate to health benefits for either women or infants.</P>
<P>The possible explanations for the absence of a definitive finding are as follows: the limited power of some study samples to detect an effect on mortality and morbidity; the differing maternal mortality rate (MMR) and infant mortality ratio (IMR) at different time points when each trial was developed; the overall positive shift in the MMR and IMR over the decades; the absence of vitamin A deficiency (VAD) or different degrees of severity amongst countries, affected by long-term under nutrition that a single or short course of vitamin A supplementation was unable to redress, as well as, the overall positive shift over the years; the heterogeneity of vitamin A regimens assessed amongst trials; the coexistence of other micronutrient deficiencies, and their interactions; low-quality control of vitamin A content capsules; and the limitations of the biochemical indicators.</P>
<SUMMARY_OF_RESULTS MODIFIED="2016-04-28 15:27:56 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Supplement (vitamin A as retinyl, water-miscible or beta-carotene) 200,000 to 400,000 IU versus control (placebo, no treatment, other)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary maternal outcomes</HEADING>
<P>
<B>Maternal mortality</B> was not influenced by single high-dose vitamin A supplementation (400,000 IU) in two studies, <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK> and <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>, conducted between 1999 to 2001, and 1997 to 2001, respectively, in areas of high MMR. In contrast to our findings, one large study carried out in Nepal, between 1994 and 1997, that evaluated weekly long-term low-dose supplementation with vitamin A or beta carotene (23,300 IU) for women during pregnancy and the postpartum period demonstrated a protective effect of vitamin A for maternal mortality (<LINK REF="STD-NNIPS_x002d_2" TYPE="STUDY">NNIPS-2</LINK>). However, other subsequent large studies that assessed similar vitamin A supplementation doses in Bangladesh (<LINK REF="REF-JivitA_x002d_1-Trial" TYPE="REFERENCE">JivitA-1 Trial</LINK>), carried out between 2001 to 2007, and Ghana (<LINK REF="STD-ObaapaVitA" TYPE="STUDY">ObaapaVitA</LINK>), between 2000 to 2008, have not been able to replicate this effect.</P>
<P>In the trial by <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>, 564 women were enrolled, compared with the larger sample in the <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>, for which 14,110 women were randomised, but only data regarding 8577 HIV-negative women with vital status were known, and were included in the present systematic review. Even so, these sample sizes are considerably smaller when compared with the 207,781 women of reproductive age enrolled in the <LINK REF="STD-ObaapaVitA" TYPE="STUDY">ObaapaVitA</LINK> study. In this trial, the authors estimated that 82,000 pregnancies would be necessary to detect a 33% reduction in the associated mortality in the intervention arm. However, as the investigators noted, not even in this large sample size study could vitamin A prevent maternal mortality. The differences in MRR by the time each trial was conducted could also have influenced the various study's potential for effect. For example, in Zimbabwe, the MRR was 590 deaths/100,000 live births in 2000, lower than the rate observed in Nepal in 1995 (660) (<LINK REF="REF-WHO-2016" TYPE="REFERENCE">WHO 2016</LINK>). Moreover, the overall shifts in MMR over the years (<LINK REF="REF-WHO-2015b" TYPE="REFERENCE">WHO 2015b</LINK>; <LINK REF="REF-WHO-2015c" TYPE="REFERENCE">WHO 2015c</LINK>) could limited the impact.</P>
<P>Several <B>maternal morbidities </B>are more prevalent in populations known to be vitamin A deficient than in industrialised countries. However, we did not observe a reduction in maternal morbidity after postnatal supplementation. Only a protective effect of vitamin A (300,000 IU) supplementation was observed for the prevalence of abnormal conjunctival impression cytology (CIC) from baseline to six months. This measure of VAD is useful when there is limited access to laboratory assessment of vitamin A status, but not an ideal stand-alone indicator of this micronutrient deficiency (<LINK REF="REF-Stoltzfus-1993c" TYPE="REFERENCE">Stoltzfus 1993c</LINK>). Although the countries in which the studies were conducted would be considered to be areas of VAD, the reduction of its severity over a number of years could explain the present results (<LINK REF="REF-WHO-2009b" TYPE="REFERENCE">WHO 2009b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary maternal outcomes</HEADING>
<P>Maternal supplementation with a single postpartum dose of 200,000 to 300,000 IU vitamin A enhanced the<B> breast milk retinol </B>concentration at three to three and a half months postpartum, a more responsive indicator of vitamin A supplementation than serum retinol concentration (<LINK REF="REF-Stoltzfus-1993b" TYPE="REFERENCE">Stoltzfus 1993b</LINK>). Moreover, serum retinol has some limitations as an indicator of vitamin A status, because retinol binding protein is a negative acute phase reactant protein (<LINK REF="REF-Filteau-1993" TYPE="REFERENCE">Filteau 1993</LINK>; <LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). <LINK REF="REF-Dancheck-2005" TYPE="REFERENCE">Dancheck 2005</LINK> investigated the influence of acute phase reaction in breast milk retinol concentration in women from Malawi. The authors observed no significant differences in retinol concentration between lactating women with or without signs of inflammation. Thus, the meta-analyses of breast milk retinol in this review are probably more informative than serum retinol in assessing the impact of vitamin A supplementation.</P>
<P>There is concern that maternal administration of 400,000 IU in a single dose may cause a transient rise in breast milk retinoic acids and toxicity (<LINK REF="REF-Ross-2002" TYPE="REFERENCE">Ross 2002</LINK>). For this reason, the International Vitamin A Consultative Group (<LINK REF="REF-Ross-2002" TYPE="REFERENCE">Ross 2002</LINK>) recommends an interval of at least 24 hours between the two doses (200,000 IU each) for a total 400,000 IU vitamin A. Despite this recommendation, the full 400,000 IU was administered as one dose in two studies (<LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>; <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>), with no reports of breast milk retinoic acid concentration immediately after supplementation.</P>
<P>No included studies demonstrated differences in the proportion of those with signs or symptoms likely to be associated with the potential <B>adverse effects</B> from vitamin A supplementation, such as abdominal pain, vomiting, poor appetite, headaches, drowsiness, nausea or blurred vision.</P>
<P>Although <B>serum retinol concentration</B> has some limitations as an indicator, the Global WHO database on VAD, a part of the Vitamin and Mineral Nutrition Information System (VMNIS), compiles data on the prevalence of clinical VAD (night blindness and ocular manifestation) and blood retinol concentration regularly from scientific literature and collaborators to estimate the prevalence of VAD around the world. These estimates provide valuable information for monitoring global progress and for evaluating current strategies to reduce VAD (<LINK REF="REF-WHO-2009b" TYPE="REFERENCE">WHO 2009b</LINK>). The pooled analysis of the reviewed studies showed that maternal supplementation (200,000 to 300,000 IU) is associated with reduced proportions of low <B>vitamin A hepatic reserves </B>and significantly higher <B>serum retinol concentration</B> only until three months postpartum.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary infant outcomes</HEADING>
<P>There was no evidence that postpartum maternal vitamin A supplementation influenced <B>infant mortality</B> in the five studies that each measured this outcome at different times (between two and 12 months) (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>). Only one small study included in the present review observed an impact on <B>infant morbidity </B>(duration of acute respiratory illness, number of febrile illnesses) (<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>). Our results corroborate with the body of evidence presented in the systematic review by <LINK REF="REF-Gogia-2011" TYPE="REFERENCE">Gogia 2011</LINK>, which observed no association between maternal and/or infant vitamin A supplementation on infant morbidity and mortality up to 12 months postpartum.</P>
<P>The coexistence of multiple micronutrient deficiencies could also be a factor that influenced the results. In a systematic review by <LINK REF="REF-Haider-2015" TYPE="REFERENCE">Haider 2015</LINK> that assessed the effects of multiple-micronutrient supplementation for pregnant women, a significant decrease in the low birthweight, small-for-gestational age, and stillbirth rate was observed. Nonetheless, no beneficial impact on maternal, perinatal, or neonatal mortality was noted. Thus, further studies that consider fetal/neonatal/infant outcomes, as morbidities, following maternal multiple-micronutrient supplementation during pregnancy, breastfeeding, or both, may therefore be of interest.</P>
<P>Concern has been expressed about <B>adverse effects</B> from infant supplementation with high doses of vitamin A (more than 50,000 IU; <LINK REF="REF-Allen-2002" TYPE="REFERENCE">Allen 2002</LINK>), however studies included in this review did not report increased adverse signs and symptoms among infants after high-dose postpartum maternal supplementation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary infant outcomes</HEADING>
<P>Regarding the<B> infant serum retinol</B> and <B>hepatic vitamin A reserves,</B> no protective effect of maternal vitamin A supplementation (200,000 to 400,000 IU) was observed (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>, <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>; <LINK REF="STD-WHO_x002f_CHD-IVASSG" TYPE="STUDY">WHO/CHD IVASSG</LINK>).</P>
<P>A case-control study by <LINK REF="REF-Rond_x00f3_-1997" TYPE="REFERENCE">Rondó 1997</LINK> conducted with Brazilian infants observed that cord blood retinol concentration was higher in infants with adequate growth for gestational age at the time of birth compared with infants with intrauterine growth restriction. According to the authors, one possible explanation for this result is maternal VAD. In our review, we included one study (<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>) that investigated the interaction of birthweight in the response to the vitamin A supplementation, but the authors found no evidence of effect. The studies included in this present systematic review did not provide data in a format that would allow us to perform subgroup analysis considering birthweight, although future studies may consider this.</P>
<P>The absence of effect can also be influenced by the low-quality control of the supplements. Only one study monitored the vitamin A content in the capsules during the trial and demonstrated that the vitamin content was stable in the capsules administered to the women. However, the lower-dose capsules administered to infants (results not included in this review) were subject to deterioration over time by up to 32% of expected content (<LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>). Thus, the stability of vitamin A capsules should be considered in further studies and routine supplementation programmes (<LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>; <LINK REF="REF-Newton-2008" TYPE="REFERENCE">Newton 2008</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Supplement (vitamin A as retinyl) 400,000 IU versus 200,000 IU</HEADING>
<P>A total of three studies (<LINK REF="STD-Darboe-2007" TYPE="STUDY">Darboe 2007</LINK>; <LINK REF="STD-Fernandes-2012" TYPE="STUDY">Fernandes 2012</LINK>; <LINK REF="STD-Idindili-2007" TYPE="STUDY">Idindili 2007</LINK>) evaluated the effects of two high doses of 200,000 IU vitamin A (400,000 IU) versus one dose (200,000 IU) and no improvements in maternal and infant health were observed. In these studies, women were supplemented with two doses of 200,000 IU with an interval of 24 hours, eight to 10 days, or one month, respectively, and no data regarding breast milk retinoic acid concentration were reported.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-03-17 17:53:46 +0000" MODIFIED_BY="Heather Maxwell">
<P>We are confident that the search strategy was conducted in a robust and structured format to ensure capture of relevant studies for this review. The evidence was generated from studies that were conducted in areas of VAD (<LINK REF="REF-WHO-2009b" TYPE="REFERENCE">WHO 2009b</LINK>). Even so, in most of the studies the baseline mean maternal serum concentrations were above the cut-off point proposed by WHO (<LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). Despite this, our findings may be interpreted to represent chronic inadequate vitamin A reserves for women's health needs in these populations, which translated to infants born with inadequate reserves. This sub-optimal 'starting point' could not be corrected by postpartum administration of vitamin A to women, specifically when breastfeeding. Other systematic reviews of long-term supplementation to women during their reproductive years (including the postpartum period) and of infant supplementation may examine whether long-term preventive supplementation confers greater benefits than postpartum supplementation, that is, after the time when the infant has already received inadequate provision of vitamin A during pregnancy (<LINK REF="REF-Haider-2015" TYPE="REFERENCE">Haider 2015</LINK>; <LINK REF="REF-McCauley-2015" TYPE="REFERENCE">McCauley 2015</LINK>). As noted by <LINK REF="REF-Sommer-2012" TYPE="REFERENCE">Sommer 2012</LINK>, the limited evidence to date on the value of vitamin A supplementation needs to be further explored before widespread implementation of carotenoid supplementation.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-03-17 17:53:52 +0000" MODIFIED_BY="Heather Maxwell">
<P>We judged the included trials to provide moderate- and low-quality evidence for the lack of differences in maternal and infant mortality, respectively; very low-quality evidence for maternal or infant morbidity; low-quality evidence for the lack of adverse effects of supplementation; and low-quality evidence that supplementation improved breast milk retinol levels (See: <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The quality ratings were influenced by a number of factors, including the risk of bias: inadequate reporting of randomisation and allocation concealment or reasons for attrition. The studies were considered overall as being at low or unclear risk of bias, although some ratings of high risk were considered, for example where the control group was unblinded. Many of the studies enrolled small numbers, with few events, with wide 95% confidence intervals crossing the line of no effect and so were downgraded for imprecision. There was also some evidence of inconsistency as indicated by high statistical heterogeneity. In addition, some studies were sponsored by industry (or did not report funding) and undertook measures of mortality, morbidity and biological assays at a wide range of time points, limiting the potential for meta-analysis. However, we also judged that any bias was unlikely to have obscured a true effect of vitamin A (should it have existed).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-03-17 17:53:52 +0000" MODIFIED_BY="Heather Maxwell">
<P>We used several approaches in an attempt to minimise bias. The search strategy incorporated both the trials register of the Cochrane Pregnancy and Childbirth Group and other databases that were likely to include publications from less well-developed countries that may not be identified through standard searches. The review authors independently assessed eligibility for inclusion, conducted data extraction and negotiated on areas of concern or uncertainty. Considering the high number of meta-analyses, there is a risk of spuriously significant results.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-03-17 17:53:59 +0000" MODIFIED_BY="Heather Maxwell">
<P>Although the studies included in this review did not report increased adverse signs and symptoms among infants after high-dose postpartum maternal supplementation, the systematic review by <LINK REF="REF-Gogia-2011" TYPE="REFERENCE">Gogia 2011</LINK>, reported that meta-analysis of two studies demonstrated an increase in the risk of bulging fontanelle after a second or third dose of vitamin A given directly to the infant. In view of this, future studies of maternal supplementation still need to consider the potential for this adverse effect that may be associated with cumulative or high doses of supplements.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-03-17 17:54:10 +0000" MODIFIED_BY="Heather Maxwell">
<IMPLICATIONS_PRACTICE MODIFIED="2016-03-17 17:54:06 +0000" MODIFIED_BY="Heather Maxwell">
<P>In countries with widespread breastfeeding practices and high prevalences of vitamin A deficiency (VAD), the transient improvement in maternal serum retinol concentration and breast milk retinol represent at least a limited benefit of vitamin A supplementation for postpartum women. These findings need to be considered in the context of the potential for follow-up with longer-term supplementation to ultimately improve maternal and infant health outcomes.</P>
<P>No vitamin A supplementation regimens report adverse effects for women or their infants, in regions of VAD.</P>
<P>This review has not evaluated vitamin A supplementation in non-deficient populations.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-03-17 17:54:10 +0000" MODIFIED_BY="Heather Maxwell">
<P>This review's focus on postpartum supplementation needs to be considered as part of a wider focus on vitamin A status during infancy and for women, across their reproductive years, including the ideal dosing regimen to achieve improved maternal and infant health for those residing in countries of VAD, where there are also high rates of maternal and infant mortality. Moreover, the stability of vitamin A content in capsules needs consideration.</P>
<P>Further research may consider the potential interaction between vitamin A and other micronutrients, including iron and zinc. Other sustainable long-term strategies to achieve food and nutrition security, as increased access to local vitamin A rich foods, through agriculture- and nutrition-based interventions, and food and nutrition education, are also warranted.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-03-23 14:44:39 +0000" MODIFIED_BY="[Empty name]">
<P>Toby Lasserson and Newton Opiyo at the Cochrane Editorial Unit, Cochrane Central Executive, assisted in the use of GRADE and in the development of the 'Summary of findings' table for the 2016 update.</P>
<P>We thank Philippa Middleton and Denise Bergamaschi for their involvement in the original version of this review.</P>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-07-10 15:01:34 +0100" MODIFIED_BY="[Empty name]">
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-02-22 12:21:28 +0000" MODIFIED_BY="[Empty name]">
<P>JM Oliveira, R Allert (new to the authorship for the 2016 update) and CE East updated this review. </P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-02-24 15:21:02 +0000" MODIFIED_BY="[Empty name]">
<P>Considerable collaborative input from referees, authors and other Cochrane personnel during preparation of the original review resulted in a focus specifically on postpartum supplementation, rather than widening to include long-term supplementation during women's reproductive years or of infant supplementation (these were covered by separate reviews). At that time, we also added the potential for including cluster-randomised trials, which were considered important for the purpose of the review, although none were ultimately included.</P>
<P>In the 2016 update, we have edited the methods to incorporate changes over time to the methodology of the Pregnancy and Chidlbirth Group. Specifically, and to avoid double counting, we adjusted the numbers of events (dichotomous outcomes) and total numbers (continuous or dichotomous outcomes) contributing to the control group of the <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>, as there were two comparisons made with different forms of vitamin A supplementation.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2009-03-03 07:13:56 +0000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-03-18 10:05:08 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2016-03-18 10:05:08 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-03-16 11:36:06 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Ayah-2007" MODIFIED="2010-09-06 11:12:16 +0100" MODIFIED_BY="Lynn Hampson" NAME="Ayah 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-09-06 11:12:16 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ayah RA, Mwaniki DL, Magnussen P, Tedstone AE, Marshall T, Alusala D, et al</AU>
<TI>The effects of maternal and infant supplementation on vitamin A status: a randomised trial in Kenya</TI>
<SO>British Journal of Nutrition</SO>
<YR>2007</YR>
<VL>98</VL>
<PG>422-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bhaskaram-2000" MODIFIED="2009-05-01 13:59:16 +0100" MODIFIED_BY="[Empty name]" NAME="Bhaskaram 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-03-07 02:13:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bhaskaram P, Balakrishna N, Nair M, Sivakumar B</AU>
<TI>Vitamin A deficiency in infants: effects of postnatal maternal vitamin A supplementation on the growth and vitamin A status</TI>
<SO>Nutrition Research</SO>
<YR>2000</YR>
<VL>20</VL>
<PG>769-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-01 13:59:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhaskaram P, Balakrishna N</AU>
<TI>Effect of administration of 200,000 IU of vitamin A to women within 24 hrs after delivery on response to PPV administered to the newborn</TI>
<SO>Indian Pediatrics</SO>
<YR>1998</YR>
<VL>35</VL>
<PG>217-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Darboe-2007" MODIFIED="2010-09-06 11:12:54 +0100" MODIFIED_BY="Lynn Hampson" NAME="Darboe 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-09-06 11:12:54 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darboe MK, Thurnham DI, Morgan G, Adegbola RA, Secka O, Solon JA, et al</AU>
<TI>Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2007</YR>
<VL>369</VL>
<PG>2088-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandes-2012" MODIFIED="2016-03-16 11:23:08 +0000" MODIFIED_BY="Heather Maxwell" NAME="Fernandes 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-03-16 11:14:37 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andreto LM, Arruda IKG, Souza AI, Figueiroa JN, Diniz AS</AU>
<TI>The effects of two maternal vitamin A supplementation regimens on serum retinol in postpartum mothers: a randomised controlled trial in Brazil</TI>
<SO>ISRN Public Health</SO>
<YR>2012</YR>
<VL>Article ID 121697</VL>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:22:06 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fernandes TFDS, Figueiroa JN, Grande de Aruda IK, Diniz ADS</AU>
<TI>Effect on infant illness of maternal supplementation with 400 000 IU vs 200 000 IU of vitamin A</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<NO>4</NO>
<PG>e960-e966</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:23:08 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santos CS, Kruze I, Fernandes T, Andreto LM, Figueiroa JN, Diniz AS</AU>
<TI>The effect of a maternal double megadose of vitamin A supplement on serum levels of retinol in children aged under six months</TI>
<SO>Journal of Nutrition and Metabolism</SO>
<YR>2013</YR>
<VL>Article ID 876308</VL>
<PG>1-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-02-10 11:02:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Tomiya MT, de Arruda IK, da Silva Diniz A, Santana RA, da Silveira KC, Andreto LM</AU>
<TI>The effect of vitamin A supplementation with 400 000 IU vs 200 000 IU on retinol concentrations in the breast milk: A randomized clinical trial</TI>
<SO>Clinical Nutrition</SO>
<YR>2015 [Epub ahead of print]</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="26725194"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Idindili-2007" MODIFIED="2010-09-06 11:12:28 +0100" MODIFIED_BY="Lynn Hampson" NAME="Idindili 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-09-06 11:12:28 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Idindili B, Masanja H, Urassa H, Bunini W, Van Jaarsveld P, Aponte JJ, et al</AU>
<TI>Randomized controlled safety and efficacy trial of 2 vitamin A supplementation schedules in Tanzania infants</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>85</VL>
<PG>1312-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martins-2010" MODIFIED="2015-12-15 13:33:51 +0000" MODIFIED_BY="[Empty name]" NAME="Martins 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-12-15 13:33:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martins TM, Ferraz IS, Daneluzzi JC, Martinelli CE, Del Ciampo LA, Ricco RG, et al</AU>
<TI>Impact of maternal vitamin A supplementation on the mother-infant pair in Brazil</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>64</VL>
<NO>11</NO>
<PG>1302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newton-2005" MODIFIED="2010-09-06 11:12:34 +0100" MODIFIED_BY="Lynn Hampson" NAME="Newton 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-09-06 11:12:34 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newton S, Cousens S, Owusu-Agyei S, Filteau S, Stanley C, Linsell L, et al</AU>
<TI>Vitamin A supplementation does not affect infants' immune responses to polio and tetanus vaccines</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<PG>2669-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RETIBETA-Project" MODIFIED="2016-03-16 11:27:42 +0000" MODIFIED_BY="Heather Maxwell" NAME="RETIBETA Project" YEAR="1999">
<REFERENCE MODIFIED="2016-03-16 11:26:31 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Filteau SM, Rice AL, Ball JJ, Chakraborty J, Stoltzfus R, De Francisco A, et al</AU>
<TI>Breast milk immune factors in Bangladeshi women supplemented postpartum with retinol or beta-carotene</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<NO>5</NO>
<PG>953-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:27:42 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rice AL, Stoltzfus RJ, De Francisco A, Chakraborty J, Kjolhede CL, Wahed MA</AU>
<TI>Maternal vitamin A or beta-carotene supplementation in lactating Bangladeshi women benefits mothers and infants but does not prevent subclinical deficiency</TI>
<SO>Journal of Nutrition</SO>
<YR>1999</YR>
<VL>129</VL>
<NO>2</NO>
<PG>356-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:21:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rice AL, Stoltzfus RJ, De Francisco A, Kjolhede CL</AU>
<TI>Evaluation of serum retinol, the modified-relative-dose-response ratio, and breast-milk vitamin A as indicators of response to postpartum maternal vitamin A supplementation [see comments]</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<PG>799-806</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:21:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rice AL, Stoltztus RJ, De Francisco A, Kjolhede CL</AU>
<TI>Low breast milk vitamin A concentration reflects an increased risk of low liver vitamin A stores in women</TI>
<SO>Advances in Experimental Medicine and Biology</SO>
<YR>2000</YR>
<VL>478</VL>
<PG>375-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roy-1997" MODIFIED="2010-09-06 11:13:23 +0100" MODIFIED_BY="Lynn Hampson" NAME="Roy 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-09-06 11:13:23 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roy SK, Islam A, Molla A, Akramuzzaman SM, Jahan F, Fuchs G</AU>
<TI>Impact of single megadose of vitamin A at delivery on breastmilk of mothers and morbidity of their infants</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1997</YR>
<VL>51</VL>
<NO>5</NO>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stoltzfus-1993a" MODIFIED="2016-03-16 11:31:07 +0000" MODIFIED_BY="Heather Maxwell" NAME="Stoltzfus 1993a" YEAR="1993">
<REFERENCE MODIFIED="2016-03-16 11:30:32 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stoltzfus RJ, Hakimi M, Miller KW, Rasmussen KM, Dawiesh S, Habicht J, et al</AU>
<TI>High dose vitamin A supplementation of breast-feeding Indonesian mothers: effects on the vitamin A status of mother and infant</TI>
<SO>Journal of Nutrition</SO>
<YR>1993</YR>
<VL>123</VL>
<NO>4</NO>
<PG>666-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:31:07 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stoltzfus RJ, Miller KW, Hakimi M, Rasmussen KM</AU>
<TI>Conjunctival impression cytology as an indicator of vitamin A status in lactating Indonesian women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>58</VL>
<NO>2</NO>
<PG>167-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venkatarao-1996" MODIFIED="2010-09-06 11:13:31 +0100" MODIFIED_BY="Lynn Hampson" NAME="Venkatarao 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-09-06 11:13:31 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Venkatarao T, Ramakrishnan R, Nair NGK, Radhakrishnan S, Sundaramoorthy L, Koya PKM, et al</AU>
<TI>Effect of vitamin A supplementation to mother and infant on morbidity in infancy</TI>
<SO>Indian Pediatrics</SO>
<YR>1996</YR>
<VL>33</VL>
<NO>4</NO>
<PG>279-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vinutha-2000" MODIFIED="2016-03-16 11:32:07 +0000" MODIFIED_BY="Heather Maxwell" NAME="Vinutha 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-03-16 11:32:07 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vinutha B, Mehta MN, Shanbag P</AU>
<TI>Vitamin A status of pregnant women and effect of post partum vitamin A supplementation</TI>
<SO>Indian Pediatrics</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>11</NO>
<PG>1188-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-WHO_x002f_CHD-IVASSG" MODIFIED="2016-03-16 11:33:09 +0000" MODIFIED_BY="Heather Maxwell" NAME="WHO/CHD IVASSG" YEAR="1998">
<REFERENCE MODIFIED="2009-06-01 11:13:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bahl R, Bhandari N, Kant S, Molbak K, Ostergaard E, Bhan MK</AU>
<TI>Effect of vitamin A administered at expanded program on immunization contacts on antibody response to oral polio vaccine</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>56</VL>
<NO>4</NO>
<PG>321-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:33:09 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bahl R, Bhandari N, Wahed MA, Kumar GT, Bhan MK</AU>
<TI>Vitamin A supplementation of women postpartum and their infants at immunization alters breast milk retinol and infant vitamin A status</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<NO>11</NO>
<PG>3243-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-01 11:14:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bahl R, Frost C, Kirkwood BR, Edmond K, Martines J, Bhandari N, et al</AU>
<TI>Infant feeding patterns and risks of death and hospitalization in the first half of infancy multicentre cohort study</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>6</NO>
<PG>1-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>WHO/CDC IVASSG</AU>
<TI>Randomised trial to assess benefits and safety of vitamin A supplementation linked to immunisation in early infancy. WHO/CHD Immunisation-Linked Vitamin A Supplementation Study Group</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9136</NO>
<PG>1257-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-ZVITAMBO-Study-Group" MODIFIED="2016-03-16 11:36:06 +0000" MODIFIED_BY="Heather Maxwell" NAME="ZVITAMBO Study Group" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Humphrey JH, Hargrove JW, Malaba LC, Iliff PJ, Moulton LH, Mutasa K, et al</AU>
<TI>HIV incidence among post-partum women in Zimbabwe: risk factors and effect of vitamin A supplementation</TI>
<SO>AIDS</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>10</NO>
<PG>1437-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-28 06:28:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iliff PJ, Humphrey JH, Mahomva AI, Zvandasara P, Bonduelle M, Malaba L, et al</AU>
<TI>Tolerance of large doses of vitamin A given to mothers and their babies shortly after delivery</TI>
<SO>Nutrition Research</SO>
<YR>1999</YR>
<VL>19</VL>
<PG>1437-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-27 23:30:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Malaba LC, Iliff PJ, Nathoo KJ, Marinda E, Moulton LH, Zijenah LS, et al</AU>
<TI>Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<PG>454-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller MF, Stoltzfus RJ, Iliff PJ, Malaba LC, Mbuya NV, the Zimbabwe Vitamin A for Mothers and Babies Project (ZVITAMBO) Study Group et al</AU>
<TI>Effect of maternal and neonatal vitamin a supplementation and other postnatal factors on anemia in Zimbabwean infants: a prospective, randomized study</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>84</VL>
<NO>1</NO>
<PG>212-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:36:06 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zvandasara P, Hargrove JW, Ntozini R, Chidawanyika H, Mutasa K, Iliff PJ, et al</AU>
<TI>Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation</TI>
<SO>Journal of Acquired Immune Deficiency Syndromes</SO>
<YR>2006</YR>
<VL>43</VL>
<NO>1</NO>
<PG>107-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-03-18 10:05:08 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ahmad-2009" MODIFIED="2015-12-15 12:49:46 +0000" MODIFIED_BY="[Empty name]" NAME="Ahmad 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-12-15 12:49:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ahmad SM</AU>
<TI>Vitamin A and maternal-infant flu vaccine response</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 1 November 2014]</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT00817661"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ala_x002d_Houhala-1988" MODIFIED="2010-09-06 11:25:55 +0100" MODIFIED_BY="Lynn Hampson" NAME="Ala-Houhala 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ala-Houhala M, Koskinen T, Mäki R, Rinkari S</AU>
<TI>Serum vitamin A levels in mothers and their breast-fed term infants with or without supplemental vitamin A</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1988</YR>
<VL>77</VL>
<PG>198-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alam-2010" MODIFIED="2015-12-15 12:50:07 +0000" MODIFIED_BY="[Empty name]" NAME="Alam 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-12-15 12:50:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alam DS, van Raaij JM, Hautvast JG, Yunus M, Wahed MA, Fuchs GJ</AU>
<TI>Effect of dietary fat supplementation during late pregnancy and first six months of lactation on maternal and infant vitamin A status in rural Bangladesh</TI>
<SO>Journal of Health, Population &amp; Nutrition</SO>
<YR>2010</YR>
<VL>28</VL>
<NO>4</NO>
<PG>333-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Atalhi-2011" MODIFIED="2015-12-15 12:50:59 +0000" MODIFIED_BY="[Empty name]" NAME="Atalhi 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-12-15 12:50:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atalhi N, Choua G, Elhamdouchi A, Elhaloui N, Elmzibri M, Haskell M, et al</AU>
<TI>Impact of daily consumption of Vitamin A fortified oil on human milk Vitamin A concentration in lactating Moroccan women</TI>
<SO>Annals of Nutrition and Metabolism</SO>
<YR>2011</YR>
<VL>58</VL>
<NO>Suppl 3</NO>
<PG>6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Basu-2003" MODIFIED="2009-07-23 14:06:15 +0100" MODIFIED_BY="[Empty name]" NAME="Basu 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-07-23 14:06:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Basu S, Sengupta B, Paladhi PK</AU>
<TI>Single megadose vitamin A supplementation of Indian mothers and morbidity in breastfed young infants</TI>
<SO>Postgraduate Medical Journal</SO>
<YR>2003</YR>
<VL>79</VL>
<PG>397-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bezerra-2009" MODIFIED="2016-03-18 10:05:08 +0000" MODIFIED_BY="[Empty name]" NAME="Bezerra 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-09-06 11:14:15 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bezerra DS, Araujo KF, Azevedo GM, Dimenstein R</AU>
<TI>Maternal supplementation with retinyl palmitate during immediate postpartum period: potential consumption by infants</TI>
<SO>Revista de Saude Publica</SO>
<YR>2009</YR>
<VL>43</VL>
<NO>4</NO>
<PG>572-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:23:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bezerra DS, de Araujo KF, Azevedo GM, Dimenstein R</AU>
<TI>A randomized trial evaluating the effect of 2 regimens of maternal vitamin a supplementation on breast milk retinol levels</TI>
<SO>Journal of Human Lactation</SO>
<YR>2010</YR>
<VL>26</VL>
<NO>2</NO>
<PG>148-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:23:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ribeiro KDS, Araújo KF, Dimenstein R</AU>
<TI>The effect of vitamin A supplementation upon retinol concentration in the colostrum of women in a public maternity hospital</TI>
<SO>Revista da Associação Médica Brasileira</SO>
<YR>2009</YR>
<VL>55</VL>
<NO>4</NO>
<PG>452-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canfield-2001" MODIFIED="2010-09-06 05:23:30 +0100" MODIFIED_BY="[Empty name]" NAME="Canfield 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-09-06 05:23:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canfield LM, Kaminsky RG, Taren DL, Shaw E, Sander JK</AU>
<TI>Red palm oil in the maternal diet increases provitamin A carotenoids in breastmilk and serum of the mother-infant dyad</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>40</VL>
<PG>30-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Pee-1995" MODIFIED="2010-09-06 05:23:52 +0100" MODIFIED_BY="[Empty name]" NAME="De Pee 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-09-06 05:23:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Pee S, West CE, Muhilal Karyadi D, Hautvast JG</AU>
<TI>Lack of improvement in vitamin A status with increased consumption of dark-green leafy vegetables</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>346</VL>
<NO>8967</NO>
<PG>75-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El-Hamdouchi-2013" MODIFIED="2015-12-15 13:31:44 +0000" MODIFIED_BY="[Empty name]" NAME="El Hamdouchi 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-12-15 13:31:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El Hamdouchi A, Ekari K, Mokhtar N, Rjimati E, El haloui N, Aguenaou H</AU>
<TI>Vitamin A intake in breastfed babies from mothers consuming daily vitamin A fortified oil during six months</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>93-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Filteau-1999" NAME="Filteau 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Filteau SM, Lietz G, Mulokozi G, Bilotta S, Henry CJ, Tomkins AM</AU>
<TI>Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation</TI>
<SO>Immunology</SO>
<YR>1999</YR>
<VL>97</VL>
<PG>595-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia-2010" MODIFIED="2015-12-15 13:32:20 +0000" MODIFIED_BY="[Empty name]" NAME="Garcia 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-12-15 13:32:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia L, Ribeiro K, Araujo K, Pires J, Azevedo G, Dimenstein R</AU>
<TI>Alpha-tocopherol concentration in the colostrum of nursing women supplemented with retinyl palmitate and alpha-tocopherol</TI>
<SO>Journal of Human Nutrition and Dietetics</SO>
<YR>2010</YR>
<VL>23</VL>
<NO>5</NO>
<PG>529-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gossage-2000" MODIFIED="2016-03-16 11:44:13 +0000" MODIFIED_BY="Heather Maxwell" NAME="Gossage 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-03-16 11:44:13 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gossage C, Deyhim M, Moser-Veillon PB, Douglas LW, Kramer TR</AU>
<TI>Effect of beta-carotene supplementation and lactation on carotenoid metabolism and mitogenic T lymphocyte proliferation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>4</NO>
<PG>950-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haskell-2013a" MODIFIED="2016-02-17 10:52:25 +0000" MODIFIED_BY="[Empty name]" NAME="Haskell 2013a" YEAR="2013">
<REFERENCE MODIFIED="2016-02-14 12:42:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Haskell M</AU>
<TI>Effect of daily consumption of b-carotene biofortified maize on milk retinol concentration in lactating zambian women</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 19 August 2015]</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT01922713"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haskell-2013b" MODIFIED="2015-12-20 10:38:43 +0000" MODIFIED_BY="[Empty name]" NAME="Haskell 2013b" YEAR="2013">
<REFERENCE MODIFIED="2015-12-20 10:38:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Haskell 2013b</AU>
<TI>Effect of small daily doses of b-carotene or vitamin a on breast milk retinol concentration in lactating Filipino women</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 19 August 2015]</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT01803659"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Humphrey-2006" MODIFIED="2015-12-15 13:20:34 +0000" MODIFIED_BY="[Empty name]" NAME="Humphrey 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-12-15 13:20:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, et al</AU>
<TI>Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>2006</YR>
<VL>193</VL>
<NO>6</NO>
<PG>860-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khan-2007" MODIFIED="2010-09-06 05:24:25 +0100" MODIFIED_BY="[Empty name]" NAME="Khan 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-09-06 05:24:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan NC, West CE, De Pee S, Bosch D, Phuong HD, Hulshof PJ, et al</AU>
<TI>The contribution of plant foods to the vitamin A supply of lactating women in Vietnam: a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>4</NO>
<PG>1112-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lietz-2001" MODIFIED="2010-09-06 05:24:37 +0100" MODIFIED_BY="[Empty name]" NAME="Lietz 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-09-06 05:24:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lietz G, Henry CJK, Mulokozi G, Mugyabuso JKL, Ballart A, Ndossi GD, et al</AU>
<TI>Comparison of the effects of supplemental red palm oil and sunflower oil on maternal vitamin A status</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>74</VL>
<NO>4</NO>
<PG>501-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lietz-2006" NAME="Lietz 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lietz G, Mulokozi G, Henry JC, Tomkins AM</AU>
<TI>Xanthophyll and hydrocarbon carotenoid patterns differ in plasma and breast milk of women supplemented with red palm oil during pregnancy and lactation</TI>
<SO>Journal of Nutrition</SO>
<YR>2006</YR>
<VL>136</VL>
<NO>7</NO>
<PG>1821-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lima-2012" MODIFIED="2015-12-15 13:20:58 +0000" MODIFIED_BY="[Empty name]" NAME="Lima 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-12-15 13:20:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lima MS, Ribeiro PP, Medeiros JM, Silva IF, Medeiros AC, Dimenstein R</AU>
<TI>Influence of postpartum supplementation with vitamin A on the levels of immunoglobulin A in human colostrum</TI>
<SO>Jornal de Pediatria</SO>
<YR>2012</YR>
<VL>88</VL>
<NO>2</NO>
<PG>115-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ncube-2001" MODIFIED="2016-03-16 11:46:00 +0000" MODIFIED_BY="Heather Maxwell" NAME="Ncube 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-03-16 11:46:00 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ncube TN, Greiner T, Malaba LC, Gebre-Medhin M</AU>
<TI>Supplementing lactating women with pureed papaya and grated carrots improved vitamin A status in a placebo-controlled trial</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<PG>1497-502</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NNIPS_x002d_2" MODIFIED="2016-03-16 11:47:15 +0000" MODIFIED_BY="Heather Maxwell" NAME="NNIPS-2" YEAR="1999">
<REFERENCE MODIFIED="2010-09-06 05:25:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, West KP Jr, Khatry SK, Katz J, LeClerq S, Pradhan EK, et al</AU>
<TI>Vitamin A or beta-carotene supplementation reduces but does not eliminate maternal night blindness in Nepal</TI>
<SO>Journal of Nutrition</SO>
<YR>1998</YR>
<VL>128</VL>
<PG>1458-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:25:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, West KP Jr, Khatry SK, Katz J, LeClerq SC, Pradhan EK, et al</AU>
<TI>Vitamin A or beta-carotene supplementation reduces symptoms of illness in pregnant and lactating Nepali women</TI>
<SO>Journal of Nutrition</SO>
<YR>2000</YR>
<VL>130</VL>
<PG>2675-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-28 06:21:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P</AU>
<TI>Effects of prenatal micronutrient supplementation on complications of labor and delivery and puerperal morbidity in rural Nepal</TI>
<SO>International Journal of Gynecology and Obstetrics</SO>
<YR>2009</YR>
<VL>106</VL>
<NO>1</NO>
<PG>3-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:25:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Congdon NG, Dreyfuss ML, Christian P, Navitsky RC, Sanchez AM, Wu LSF, et al</AU>
<TI>Responsiveness of dark adaptation threshold to vitamin A and beta-carotene supplementation in pregnant and lactating women in Nepal</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>72</VL>
<PG>1004-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:25:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz J, West KP Jr, Khatry SK, Pradhan EK, LeClerq SC, Christian P, et al</AU>
<TI>Maternal low-dose vitamin A or beta-carotene supplementation has no effect on fetal loss and early infant mortality: a randomized cluster trial in Nepal</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<PG>1570-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:47:15 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stewart CP, Christian P, Katz J, Schulze KJ, Wu LSF, LeClerq SC, et al</AU>
<TI>Maternal supplementation with vitamin A or B-carotene and cardiovascular risk factors among pre-adolescent children in rural Nepal</TI>
<SO>Journal of Developmental Origins of Health and Disease</SO>
<YR>2010</YR>
<VL>1</VL>
<NO>4</NO>
<PG>262-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 11:15:53 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>West JP Jr, Katz J, Khatry SK, LeClerq S, Pradhan EK, Shrestha SR, et al</AU>
<TI>Double blind, cluster randomised trial of low dose supplementation with vitamin a or beta carotene on mortality related to pregnancy in Nepal The NNIPS-2 Study Group</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>317</VL>
<NO>7183</NO>
<PG>570-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-09-06 05:25:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamini S, West KP Jr, Wu L, Dreyfuss ML,Yang DX, Khatry SK</AU>
<TI>Circulating levels of retinol, tocopherol and carotenoid in Nepali pregnant and postpartum women following long-term beta-carotene and vitamin A supplementation</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>55</VL>
<PG>252-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-ObaapaVitA" MODIFIED="2010-09-06 11:15:38 +0100" MODIFIED_BY="Lynn Hampson" NAME="ObaapaVitA" YEAR="2010">
<REFERENCE MODIFIED="2010-09-06 11:15:38 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirkwood BR, Hurt L, Amenga-Etego S, Tawiah C, Zandoh C, Danso S, et al</AU>
<TI>Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial</TI>
<SO>Lancet</SO>
<YR>2010</YR>
<VL>375</VL>
<PG>1640-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swaminathan-2015" MODIFIED="2015-12-15 13:33:38 +0000" MODIFIED_BY="[Empty name]" NAME="Swaminathan 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-12-15 13:33:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Swaminathan S</AU>
<TI>Effectiveness of a maternal food based intervention in the 3rd trimester till one month post partum to increase vitamin A intakes through breast milk in early infancy</TI>
<SO>Clinical Trials Registry - India (http://ctri.nic.in) [accessed 19 August 2015]</SO>
<YR>2015</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="CTRI/2015/06/005834"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tchum-2006" MODIFIED="2010-09-06 05:26:23 +0100" MODIFIED_BY="[Empty name]" NAME="Tchum 2006" YEAR="2007">
<REFERENCE MODIFIED="2010-09-06 05:26:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tchum SK, Tanumihardjo SA, Newton S, Benoist B, Owusu-Agyei S, Arthur FKN, et al</AU>
<TI>Evaluation of vitamin A supplementation regimens in Ghanaian postpartum mothers with the use of modified-relative-dose-response test</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>84</VL>
<PG>1344-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turner-2013" MODIFIED="2016-02-17 10:50:16 +0000" MODIFIED_BY="[Empty name]" NAME="Turner 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-12-20 08:34:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burri BJ, Haskell M, Jamil KM, Jamil M, Turner T</AU>
<TI>Breast milk creamatocrit and fat content of lactating Bangladeshi women recruited for dietary-based interventions to improve vitamin A status</TI>
<SO>FASEB Journal</SO>
<YR>2011</YR>
<VL>25</VL>
<PG>975.7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-20 16:37:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Burri BJ</AU>
<TI>Vitamin A bioavailability in lactating women with marginal vitamin A status</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 19 August 2015]</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-20 08:34:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Turner T, Burri BJ, Haskell M, Jamil K, Jamil M</AU>
<TI>Impact of daily feeding of carotenoid-rich foods on plasma carotenoid and vitamin A concentrations in lactating women with marginal vitamin A status</TI>
<SO>FASEB journal</SO>
<YR>2012</YR>
<VL>26 Suppl</VL>
<PG>27.5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-02-17 10:50:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Turner T, Burri BJ, Jamil KM, Jamil M</AU>
<TI>The effects of daily consumption of beta-cryptoxanthin-rich tangerines and beta-carotene-rich sweet potatoes on vitamin A and carotenoid concentrations in plasma and breast milk of Bangladeshi women with low vitamin A status in a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2013</YR>
<VL>98</VL>
<NO>5</NO>
<PG>1200-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT01420406"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-West-2011" MODIFIED="2016-03-16 11:55:01 +0000" MODIFIED_BY="Heather Maxwell" NAME="West 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-03-16 11:55:01 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Labrique AB, Ali H, Richman MJ, Wu L, Rashid M, et al</AU>
<TI>Maternal vitamin A and beta-carotene supplementation and risk of bacterial vaginosis: a randomized controlled trial in rural Bangladesh</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2011</YR>
<VL>94</VL>
<NO>6</NO>
<PG>1643-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-20 17:35:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Labrique AB, Christian P, Klemm RDW, Rashid M, Shamim AA, Massie A, et al.</AU>
<TI>A cluster-randomized, placebo-controlled, maternal vitamin A or beta-carotene supplementation trial in Bangladesh: design and methods</TI>
<SO>Trials</SO>
<YR>2011</YR>
<VL>12</VL>
<NO>102</NO>
<PG>1-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-20 08:35:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>West KPJ, Christian P, Labrique AB, Rashid M, Shamim AA, Klemm RD, et al</AU>
<TI>Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial</TI>
<SO>JAMA</SO>
<YR>2011</YR>
<VL>305</VL>
<NO>19</NO>
<PG>1986-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-03-16 11:55:50 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Nga-2013" MODIFIED="2016-03-16 11:55:50 +0000" MODIFIED_BY="Heather Maxwell" NAME="Nga 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-02-17 10:50:39 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nga TT, Dijkhuizen MA, Tu NS, Friis H, Berger J, Hop LT, et al</AU>
<TI>Post-partum high-dose vitamin A supplementation to improve vitamin A status of mother and infant: The role of timing and inflammation</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>755-6, Abstract no: PO1041</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-16 11:55:50 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="OTHER">
<AU>Wieringa FT</AU>
<TI>Making maternal post-partum vitamin A supplementation effective: the role of timing and inflammation</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/)</SO>
<YR>2009 [accessed 19 August 2015]</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2012" MODIFIED="2016-01-25 13:01:13 +0000" MODIFIED_BY="[Empty name]" NAME="Wang 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-01-25 13:01:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang Z</AU>
<TI>Effects of vitamin A supplementation during lactation on infants&#8217; antibody response to Hepatitis B vaccine in china</TI>
<SO>Chinese Clinical Trial Registry (http://www.chictr.org/en/) [accessed 19 August 2015]</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="ChiCTR-TRC-12001914"/>
</IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2016-02-17 10:51:49 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ahmad-2015" MODIFIED="2016-02-17 10:51:49 +0000" MODIFIED_BY="[Empty name]" NAME="Ahmad 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-12-20 08:52:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahmad SM, Hossain MI, Bergman P, Kabir Y, Raqib R</AU>
<TI>The effect of postpartum vitamin A supplementation on breast milk immune regulators and infant immune functions: study protocol of a randomized, controlled trial</TI>
<SO>Trials</SO>
<YR>2015</YR>
<VL>16</VL>
<NO>1</NO>
<PG>129</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-20 08:52:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ahmad SM</AU>
<TI>Stopping postpartum vitamin A supplementation: are we missing concealed benefit?</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 19 August 2015]</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT02043223"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-03-16 12:09:54 +0000" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_REFERENCES MODIFIED="2016-03-16 12:08:50 +0000" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Ahmed-2003" MODIFIED="2010-09-06 05:26:33 +0100" MODIFIED_BY="[Empty name]" NAME="Ahmed 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ahmed F, Azim A, Akhtaruzzaman M</AU>
<TI>Vitamin A deficiency in poor, urban, lactating women in Bangladesh: factors influencing vitamin A status</TI>
<SO>Public Health Nutrition</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>5</NO>
<PG>447-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Akhtar-2013" MODIFIED="2016-03-16 11:57:07 +0000" MODIFIED_BY="Heather Maxwell" NAME="Akhtar 2013" TYPE="JOURNAL_ARTICLE">
<AU>Akhtar S, Ahmed A, Randhawa MA, Atukorala S, Arlappa N, Ismail T, et al</AU>
<TI>Prevalence of vitamin A deficiency in South Asia: causes, outcomes, and possible remedies</TI>
<SO>Journal of Health, Population and Nutrition</SO>
<YR>2013</YR>
<VL>31</VL>
<NO>4</NO>
<PG>413-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Allen-2002" MODIFIED="2016-01-28 09:17:36 +0000" MODIFIED_BY="[Empty name]" NAME="Allen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Allen LH, Haskell M</AU>
<TI>Estimating the potential for vitamin A toxicity in women and young children</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<NO>9 Suppl</NO>
<PG>2907S-2919S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aza_x00ef_s_x002d_Braesco-2000" MODIFIED="2016-02-17 11:25:09 +0000" MODIFIED_BY="[Empty name]" NAME="Azaïs-Braesco 2000" TYPE="JOURNAL_ARTICLE">
<AU>Azaïs-Braesco V, Pascal G</AU>
<TI>Vitamin A in pregnancy: requirements and safety limits</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>5S</NO>
<PG>1325S-1333S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Butte-2002" MODIFIED="2016-02-17 11:24:51 +0000" MODIFIED_BY="[Empty name]" NAME="Butte 2002" TYPE="BOOK">
<AU>Butte NF, Lopez-Alarcon MG, Garza C</AU>
<SO>Nutrient Adequacy of Exclusive Breastfeeding for the Term Infant During the First Six months of Life. Expert Consultation on the Optimal Duration of Exclusive Breastfeeding</SO>
<YR>2002</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cediel-2015" MODIFIED="2016-01-19 11:47:05 +0000" MODIFIED_BY="[Empty name]" NAME="Cediel 2015" TYPE="JOURNAL_ARTICLE">
<AU>Cediel G, Olivares M, Brito A, Lòpez de Romaña D, Cori H, La Frano MR</AU>
<TI>Interpretation of serum retinol data from Latin America and the Caribbean</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2015</YR>
<VL>36</VL>
<NO>2S</NO>
<PG>98S-108S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chhagan-2010" MODIFIED="2016-01-19 11:50:01 +0000" MODIFIED_BY="[Empty name]" NAME="Chhagan 2010" TYPE="JOURNAL_ARTICLE">
<AU>Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Tomkins A, Bennish ML</AU>
<TI>Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months</TI>
<SO>BMC Public Health</SO>
<YR>2010</YR>
<VL>10</VL>
<NO>45</NO>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Christian-1998" MODIFIED="2016-01-28 09:18:02 +0000" MODIFIED_BY="[Empty name]" NAME="Christian 1998" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, West KP Jr</AU>
<TI>Interactions between zinc and vitamin A: an update</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1998</YR>
<VL>68</VL>
<NO>2S</NO>
<PG>435S-441S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Congdon-2002" MODIFIED="2016-01-28 09:18:08 +0000" MODIFIED_BY="[Empty name]" NAME="Congdon 2002" TYPE="JOURNAL_ARTICLE">
<AU>Congdon NG, West KP Jr</AU>
<TI>Physiologic indicators of vitamin A status</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<NO>9S</NO>
<PG>2889S-2894S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dancheck-2005" MODIFIED="2010-09-06 05:26:57 +0100" MODIFIED_BY="[Empty name]" NAME="Dancheck 2005" TYPE="JOURNAL_ARTICLE">
<AU>Dancheck B, Nussenblatt V, Ricks MO, Kumwenda N, Neville MC, Moncrief DT, et al</AU>
<TI>Breast milk retinol concentrations are not associated with systemic inflammation among breast-feeding women in Malawi</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<NO>2</NO>
<PG>223-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FAO_x002f_WHO-2001" MODIFIED="2016-02-17 11:23:22 +0000" MODIFIED_BY="[Empty name]" NAME="FAO/WHO 2001" TYPE="BOOK">
<AU>Food and Agriculture Organization of United Nations/World Health Organization</AU>
<SO>Human Vitamin and Mineral Requirements. Report of a Joint FAO/WHO Expert Consultation, Bangkok, Thailand</SO>
<YR>2001</YR>
<PB>FAO</PB>
<CY>Bangkok</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Filteau-1993" MODIFIED="2010-08-09 02:00:10 +0100" MODIFIED_BY="[Empty name]" NAME="Filteau 1993" TYPE="JOURNAL_ARTICLE">
<AU>Filteau SM, Morris SS, Abbott RA, Tomkins AM, Kirkwood BR, Arthur P, et al</AU>
<TI>Influence of morbidity on serum retinol of children in a community-based study in northern Ghana</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>58</VL>
<PG>192-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FNB-2000" MODIFIED="2016-02-17 11:04:24 +0000" MODIFIED_BY="[Empty name]" NAME="FNB 2000" TYPE="BOOK_SECTION">
<AU>Food and Nutrition Board</AU>
<TI>Vitamin A</TI>
<SO>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</SO>
<YR>2000</YR>
<PB>National Academy Press</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garcia_x002d_Casal-1998" MODIFIED="2010-08-04 13:27:23 +0100" MODIFIED_BY="[Empty name]" NAME="Garcia-Casal 1998" TYPE="JOURNAL_ARTICLE">
<AU>García-Casal MN, Layrisse M, Solano L, Baron MA, Arguello F, Llovera D, et al</AU>
<TI>Vitamin A and beta-carotene can improve nonheme iron absorption from rice, wheat and corn by humans</TI>
<SO>Journal of Nutrition</SO>
<YR>1998</YR>
<VL>128</VL>
<NO>3</NO>
<PG>646-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gogia-2010" MODIFIED="2016-02-14 12:15:20 +0000" MODIFIED_BY="[Empty name]" NAME="Gogia 2010" TYPE="JOURNAL_ARTICLE">
<AU>Gogia S, Sachdev HS</AU>
<TI>Maternal postpartum vitamin A supplementation for the prevention of mortality and morbidity in infancy: a systematic review of randomized controlled trials</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2010</YR>
<VL>39</VL>
<NO>5</NO>
<PG>1217&#8211;26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gogia-2011" MODIFIED="2016-02-17 11:25:31 +0000" MODIFIED_BY="[Empty name]" NAME="Gogia 2011" TYPE="COCHRANE_REVIEW">
<AU>Gogia S, Sachdev HS</AU>
<TI>Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2016-02-17 11:25:31 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2016-02-15 11:05:04 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007480.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haddad-2015" MODIFIED="2016-02-17 11:28:13 +0000" MODIFIED_BY="[Empty name]" NAME="Haddad 2015" TYPE="JOURNAL_ARTICLE">
<AU>Haddad L, Achadi E, Bendech MA, Ahuja A, Bhatia K, Bhutta Z, et al</AU>
<TI>The Global Nutrition Report 2014: actions and accountability to accelerate the world's progress on nutrition</TI>
<SO>Journal of Nutrition</SO>
<YR>2015</YR>
<VL>145</VL>
<PG>663&#8211;71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haider-2015" MODIFIED="2016-02-15 11:01:29 +0000" MODIFIED_BY="[Empty name]" NAME="Haider 2015" TYPE="COCHRANE_REVIEW">
<AU>Haider BA, Bhutta ZA</AU>
<TI>Multiple-micronutrient supplementation for women during pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2016-02-15 11:01:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2016-02-15 11:01:29 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004905.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hess-2005" MODIFIED="2016-02-17 11:26:41 +0000" MODIFIED_BY="[Empty name]" NAME="Hess 2005" TYPE="BOOK">
<AU>Hess SY, Thurnham DI, Hurrell RF</AU>
<SO>Influence of Provitamin A Carotenoids on Iron, Zinc, and Vitamin A Status [HarvestPlus Technical Monograph 6]</SO>
<YR>2015</YR>
<PG>1-31</PG>
<PB>International Food Policy Research Institute (IFPRI) and International Center for Tropical Agriculture (CIAT)</PB>
<CY>Washington, DC and Cali</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-01-28 09:16:45 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-IVACG-2004" MODIFIED="2016-02-17 11:31:16 +0000" MODIFIED_BY="[Empty name]" NAME="IVACG 2004" TYPE="BOOK">
<AU>International Vitamin A Consultative Group (IVACG)</AU>
<SO>Conversion Factors for Vitamin A and Carotenoids</SO>
<YR>2004</YR>
<PB>IVACG Secretariat</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jang-2000" MODIFIED="2010-09-06 05:29:21 +0100" MODIFIED_BY="[Empty name]" NAME="Jang 2000" TYPE="JOURNAL_ARTICLE">
<AU>Jang JT, Green JB, Beard JL, Green MH</AU>
<TI>Kinetic analysis shows that iron deficiency decreases liver vitamin A mobilization in rats</TI>
<SO>Journal of Nutrition</SO>
<YR>2000</YR>
<VL>130</VL>
<PG>1291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-JivitA_x002d_1-Trial" MODIFIED="2016-02-17 10:58:36 +0000" MODIFIED_BY="[Empty name]" NAME="JivitA-1 Trial" TYPE="JOURNAL_ARTICLE">
<AU>West KP Jr, Christian P, Labrique AB, Rashid M, Shamim AA, Klemm RD, et al</AU>
<TI>Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in ruralBangladesh: a cluster randomized trial</TI>
<SO>JAMA</SO>
<YR>2011</YR>
<VL>305</VL>
<NO>19</NO>
<PG>1986-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kongnyuy-2009" MODIFIED="2016-01-21 21:09:49 +0000" MODIFIED_BY="[Empty name]" NAME="Kongnyuy 2009" TYPE="JOURNAL_ARTICLE">
<AU>Kongnyuy EJ, Wiysonge CS, Shey MS</AU>
<TI>A systematic review of randomized controlled trials of prenatal and postnatal vitamin A supplementation of HIV-infected women</TI>
<SO>International Journal of Gynecology and Obstetrics</SO>
<YR>2009</YR>
<VL>104</VL>
<NO>1</NO>
<PG>5-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laxmaiah-2012" MODIFIED="2016-03-16 12:03:12 +0000" MODIFIED_BY="Heather Maxwell" NAME="Laxmaiah 2012" TYPE="JOURNAL_ARTICLE">
<AU>Laxmaiah A, Nair MK, Arlappa N, Raghu P, Balakrishna N, Rao KM, et al</AU>
<TI>Prevalence of ocular signs and subclinical vitamin A deficiency and determinants among rural pre-school children in India</TI>
<SO>Public Health Nutrition</SO>
<YR>2012</YR>
<VL>15</VL>
<NO>4</NO>
<PG>568-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-2008" MODIFIED="2016-03-16 12:03:34 +0000" MODIFIED_BY="Heather Maxwell" NAME="Lee 2008" TYPE="JOURNAL_ARTICLE">
<AU>Lee V, Ahmed F, Wada S, Ahmed T, Ahmed AS, Parvin Banu C, et al</AU>
<TI>Extent of vitamin A deficiency among rural pregnant women in Bangladesh</TI>
<SO>Public Health Nutrition</SO>
<YR>2008</YR>
<VL>11</VL>
<NO>12</NO>
<PG>1326-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCauley-2015" MODIFIED="2016-02-17 11:31:42 +0000" MODIFIED_BY="[Empty name]" NAME="McCauley 2015" TYPE="COCHRANE_REVIEW">
<AU>McCauley ME, van den Broek N, Dou L, Othman M</AU>
<TI>Vitamin A supplementation during pregnancy for maternal and newborn outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2016-02-17 11:31:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2016-02-15 11:03:55 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD008666.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Michelazzo-2013" MODIFIED="2016-01-19 12:38:10 +0000" MODIFIED_BY="[Empty name]" NAME="Michelazzo 2013" TYPE="JOURNAL_ARTICLE">
<AU>Michelazzo FB, Oliveira JM, Stefanello J, Luzia LA, Rondó PH</AU>
<TI>The influence of vitamin A supplementation on iron status</TI>
<SO>Nutrients</SO>
<YR>2013</YR>
<VL>5</VL>
<NO>11</NO>
<PG>4399-413</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mu_x00f1_oz-2000" MODIFIED="2016-03-16 12:04:50 +0000" MODIFIED_BY="Heather Maxwell" NAME="Muñoz 2000" TYPE="JOURNAL_ARTICLE">
<AU>Muñoz EC, Rosado JL, Lopez P, Furr HC, Allen LH</AU>
<TI>Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>3</NO>
<PG>789-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newton-2008" MODIFIED="2010-09-06 05:30:08 +0100" MODIFIED_BY="[Empty name]" NAME="Newton 2008" TYPE="JOURNAL_ARTICLE">
<AU>Newton S, Owusu-Agyei S, Kirkwood B</AU>
<TI>Is there any monitoring of the quality of vitamin A capsules used in supplementation programs?</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>86</VL>
<NO>4</NO>
<PG>1254</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oliveira-2008a" MODIFIED="2010-09-06 05:30:16 +0100" MODIFIED_BY="[Empty name]" NAME="Oliveira 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira JM, Michelazzo F, Stefanello J, Rondó PH</AU>
<TI>Influence of iron on vitamin A nutritional status</TI>
<SO>Nutrition Reviews</SO>
<YR>2008</YR>
<VL>66</VL>
<PG>141-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prawirohartono-2013" MODIFIED="2016-01-19 12:39:19 +0000" MODIFIED_BY="[Empty name]" NAME="Prawirohartono 2013" TYPE="JOURNAL_ARTICLE">
<AU>Prawirohartono EP, Nyström L, Nurdiati DS, Hakimi M, Lind T</AU>
<TI>The impact of prenatal vitamin A and zinc supplementation on birth size and neonatal survival - a double-blind, randomized controlled trial in a rural area of Indonesia</TI>
<SO>International Journal for Vitamin and Nutrition Research</SO>
<YR>2013</YR>
<VL>83</VL>
<NO>1</NO>
<PG>14-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rasmussen-1998" MODIFIED="2016-02-14 12:17:42 +0000" MODIFIED_BY="[Empty name]" NAME="Rasmussen 1998" TYPE="OTHER">
<AU>Rasmussen K</AU>
<TI>Vitamin A needs during pregnancy and lactation for the health of the mother and her fetus or infant</TI>
<SO>Safe vitamin A dosage during pregnancy and lactation: recommendations and report of a consultation. Micronutrient Initiative</SO>
<YR>1998</YR>
<PG>8-12</PG>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-08-27 14:47:34 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rond_x00f3_-1997" MODIFIED="2010-09-06 05:30:55 +0100" MODIFIED_BY="[Empty name]" NAME="Rondó 1997" TYPE="JOURNAL_ARTICLE">
<AU>Rondó PH, Abbott R, Tomkins AM</AU>
<TI>Vitamin A and intrauterine growth retardation</TI>
<SO>Journal of Pediatrics</SO>
<YR>1997</YR>
<VL>73</VL>
<PG>335-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ross-2002" MODIFIED="2009-06-01 11:27:57 +0100" MODIFIED_BY="[Empty name]" NAME="Ross 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ross DA</AU>
<TI>Recommendations for vitamin A supplementation</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>131</VL>
<PG>2902S-2906S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sommer-2012" MODIFIED="2016-02-17 11:03:14 +0000" MODIFIED_BY="[Empty name]" NAME="Sommer 2012" TYPE="JOURNAL_ARTICLE">
<AU>Sommer A, Vyas KS</AU>
<TI>A global clinical view on vitamin A and carotenoids</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>96</VL>
<NO>5S</NO>
<PG>1204S-1206S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stoltzfus-1993b" MODIFIED="2010-09-06 05:31:18 +0100" MODIFIED_BY="[Empty name]" NAME="Stoltzfus 1993b" TYPE="JOURNAL_ARTICLE">
<AU>Stoltzfus RJ, Habicht JP, Rasmussen KM, Hakimi M</AU>
<TI>Evaluation of indicators for use in vitamin A intervention trials targeted at women</TI>
<SO>International Journal of Epidemiology</SO>
<YR>1993</YR>
<VL>123</VL>
<NO>4</NO>
<PG>666-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stoltzfus-1993c" MODIFIED="2010-09-06 11:26:50 +0100" MODIFIED_BY="Lynn Hampson" NAME="Stoltzfus 1993c" TYPE="JOURNAL_ARTICLE">
<AU>Stoltzfus RJ, Miller KW, Hakimi M, Rasmussen KM</AU>
<TI>Conjunctival impression cytology as an indicator of vitamin A status in lactating Indonesian women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>58</VL>
<NO>2</NO>
<PG>167-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strube-2002" NAME="Strube 2002" TYPE="JOURNAL_ARTICLE">
<AU>Strube YNJ, Beard JL, Ross AC</AU>
<TI>Iron deficiency and marginal vitamin A deficiency affect growth, hematological indices and the regulation of iron metabolism genes in rats</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<PG>3607-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tanumihardjo-2004" MODIFIED="2016-01-19 12:41:55 +0000" MODIFIED_BY="[Empty name]" NAME="Tanumihardjo 2004" TYPE="JOURNAL_ARTICLE">
<AU>Tanumihardjo SA</AU>
<TI>Assessing vitamin A status: past, present and future</TI>
<SO>Journal of Nutrition</SO>
<YR>2004</YR>
<VL>134</VL>
<NO>1S</NO>
<PG>290S-3S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tanumihardjo-2011" MODIFIED="2016-02-11 03:06:30 +0000" MODIFIED_BY="[Empty name]" NAME="Tanumihardjo 2011" TYPE="JOURNAL_ARTICLE">
<AU>Tanumihardjo SA</AU>
<TI>Vitamin A: biomarkers of nutrition for development</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2011</YR>
<VL>94</VL>
<NO>2S</NO>
<PG>658S-65S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNICEF-2015" MODIFIED="2016-02-17 11:03:36 +0000" MODIFIED_BY="[Empty name]" NAME="UNICEF 2015" TYPE="BOOK">
<AU>United Nations Children&#8217;s Fund</AU>
<SO>Levels &amp; Trends in Child Mortality [Report 2015]</SO>
<YR>2015</YR>
<PB>UNICEF</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Stuijvenberg-2015" MODIFIED="2016-01-19 12:45:39 +0000" MODIFIED_BY="[Empty name]" NAME="van Stuijvenberg 2015" TYPE="JOURNAL_ARTICLE">
<AU>van Stuijvenberg ME, Schoeman SE, Nel J, Lombard CJ, Dhansay MA</AU>
<TI>Serum retinol in post-partum mothers and newborns from an impoverished South African community where liver is frequently eaten and vitamin A deficiency is absent</TI>
<SO>Maternal &amp; Child Nutrition</SO>
<YR>2015</YR>
<VL>12</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walczyk-2003" NAME="Walczyk 2003" TYPE="JOURNAL_ARTICLE">
<AU>Walczyk T, Davidsson L, Rossander-Hulthen L, Hallberg L, Hurrell RF</AU>
<TI>No enhancing effect of vitamin A on iron absorption in humans</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>77</VL>
<NO>1</NO>
<PG>144-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wasantwisut-2002" MODIFIED="2016-02-17 11:33:52 +0000" MODIFIED_BY="[Empty name]" NAME="Wasantwisut 2002" TYPE="JOURNAL_ARTICLE">
<AU>Wasantwisut E</AU>
<TI>Recommendations for monitoring and evaluating Vitamin A programs: outcome indicators</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<PG>2940S&#8211;2942S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1995" MODIFIED="2016-02-17 11:52:46 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 1995" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Global prevalence of vitamin A deficiency. Micronutrient Deficiency Information System, No 2 (WHO/NUT/95.3)</SO>
<YR>1995</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1996" MODIFIED="2016-02-17 11:53:34 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 1996" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Indicators for Assessing vitamin A Deficiency and their Application in Monitoring and Evaluating Intervention Programmes. (WHO/NUT/96.1)</SO>
<YR>1996</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1998" MODIFIED="2016-02-17 11:54:16 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 1998" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Safe Vitamin A Dosage During Pregnancy and Lactation: Recommendations and Report of a Consultation. Micronutrient Initiative</SO>
<YR>1998</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009a" MODIFIED="2016-03-16 12:07:45 +0000" MODIFIED_BY="Heather Maxwell" NAME="WHO 2009a" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks</SO>
<YR>2009</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009b" MODIFIED="2016-02-17 11:55:40 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2009b" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Global Prevalence of vitamin A Deficiency in Population at Risk 1995-2005: WHO Database of Vitamin A Deficiency</SO>
<YR>2009</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2011" MODIFIED="2016-02-17 11:56:09 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2011" TYPE="BOOK">
<AU>Wordl Health Organization</AU>
<SO>Guideline: Vitamin A Supplementation in Postpartum Women</SO>
<YR>2011</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2014" MODIFIED="2016-02-17 11:56:30 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2014" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>World Health Statistics 2014</SO>
<YR>2014</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS MODIFIED="2016-02-11 02:53:02 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2015a" MODIFIED="2016-02-17 10:54:41 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2015a" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>World Health Statistics 2015</SO>
<YR>2015</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2015b" MODIFIED="2016-02-17 10:55:03 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2015b" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Trends in Maternal Mortality 1990 to 2015. [Executive Summary]</SO>
<YR>2015</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2015c" MODIFIED="2016-02-17 10:55:35 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2015c" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Trends in Maternal Mortality 1990 to 2015</SO>
<YR>2015</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2016" MODIFIED="2016-02-17 10:58:00 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2016" TYPE="OTHER">
<AU>WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division</AU>
<TI>Maternal mortality country profiles</TI>
<SO>http://www.who.int/gho/maternal_health/countries/en/ [accessed 17 February 2016]</SO>
<YR>2016</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zimmermann-2006" MODIFIED="2016-03-16 12:08:50 +0000" MODIFIED_BY="Heather Maxwell" NAME="Zimmermann 2006" TYPE="JOURNAL_ARTICLE">
<AU>Zimmermann MB, Biebinger R, Rohner F, Dib A, Zeder C, Hurrell RF, et al</AU>
<TI>Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>84</VL>
<PG>580-6</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-03-16 12:09:54 +0000" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Oliveira-2008b" MODIFIED="2009-06-26 11:11:44 +0100" MODIFIED_BY="[Empty name]" NAME="Oliveira 2008b" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira JM, East CE, Bergamashi DP</AU>
<TI>Vitamin A supplementation for breastfeeding mothers: a systematic review</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>2008</YR>
<VL>44</VL>
<NO>Suppl 1</NO>
<PG>A88</PG>
<PB>12th Annual Congress: Perinatal Society of Australia &amp; New Zealand , 20-23 April 2008</PB>
<IDENTIFIERS MODIFIED="2009-03-03 07:11:41 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Oliveira_x002d_Menegozzo--2010" MODIFIED="2016-03-16 12:09:54 +0000" MODIFIED_BY="Heather Maxwell" NAME="Oliveira-Menegozzo  2010" TYPE="COCHRANE_REVIEW">
<AU>Oliveira-Menegozzo JM, Bergamaschi DP, Middleton P, East CE</AU>
<TI>Vitamin A supplementation for postpartum women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2015-08-27 14:49:25 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-27 14:49:25 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005944.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-03-18 09:02:13 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-03-18 09:02:13 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-03-17 13:41:28 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Ayah-2007">
<CHAR_METHODS MODIFIED="2016-03-17 13:40:12 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled, 2 by 2 factorial trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:08:23 +0000" MODIFIED_BY="[Empty name]">
<P>Women giving birth to a live single baby and their infants.<BR/>Bondo, Kenya.<BR/>N = 564 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:04:26 +0000" MODIFIED_BY="[Empty name]">
<P>Single dosage administered to women within 24 hours of birth; single dosage to infant at 1-4 weeks of age.</P>
<P>All infants received 100,000 IU vitamin A at 8 months of age (after trial).</P>
<P>4 intervention groups:<BR/>1. Women received 400,000 IU vitamin A and infant received 100,000 IU vitamin A as retinyl palmitate (n = 142).<BR/>2. Women received 400,000 IU vitamin A and infant received placebo (n = 140).<BR/>3. Women received placebo and infant received 100,000 IU vitamin A (n = 143).<BR/>4. Women received placebo and infant received placebo (n = 139).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal serum and breast milk retinol concentrations. Infant serum retinol concentration and vitamin A hepatic stores (MRDR).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:41:28 +0000" MODIFIED_BY="Heather Maxwell">
<P>No information regarding breastfeeding pattern was provided. However, at least some breastfeeding is implied by the analysis of breast milk retinol at 6 months for 63% of the women originally enrolled.</P>
<P>87.4% of follow-up until 14 weeks, 77.1% of follow-up until 26 weeks postpartum.</P>
<P>The prevalence of HIV infection among antenatal attendees was above 28% at the time of the study. However, the trial was conducted prior to availability of HIV testing and anti-retrovirals for antenatal women in western Kenya. Thus, it was not possible to know the prevalence of HIV among recruited women.</P>
<P>Sample size calculation reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:42:29 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Bhaskaram-2000">
<CHAR_METHODS MODIFIED="2016-03-17 13:41:57 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-17 13:42:07 +0000" MODIFIED_BY="Heather Maxwell">
<P>Hospital-based study with postpartum women who did not receive any vitamin A supplements during pregnancy and had uncomplicated full-term births.</P>
<P>Hyderabad, India.</P>
<P>N = 102 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 14:55:21 +0000" MODIFIED_BY="[Empty name]">
<P>Single high dose to women within 24 hours after birth.</P>
<P>2 intervention groups:<BR/>1. Women received 200,000 IU vitamin A as retinyl palmitate (n = 50).<BR/>2. Women received placebo (n = 52).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Infant serum retinol concentration, corneal lesions and breast milk retinol concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:42:29 +0000" MODIFIED_BY="Heather Maxwell">
<P>All infants given OPV within 72 hours after birth.<BR/>All infants breastfed, followed up at 6 months.</P>
<P>100% of follow-up until 6 weeks, 87% followed up until 3 months, 46% followed up until 6 months.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:43:37 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Darboe-2007">
<CHAR_METHODS MODIFIED="2016-03-17 13:43:05 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:06:55 +0000" MODIFIED_BY="[Empty name]">
<P>Postpartum women without severe peripartum difficulties or preterm birth, with newborns &#8805; 2200 g with no congenital defects at birth.</P>
<P>Keneba and West Kiang, Gambia.</P>
<P>N = 220 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:06:26 +0000" MODIFIED_BY="[Empty name]">
<P>Single or double high dose to women at delivery (first dose) and within a week (second dose); and 3 high doses to infant at 2, 3 or 4 months.</P>
<P>All infants received 100,000 IU vitamin A at 9 months and 200,000 IU at 12 months postpartum.</P>
<P>2 intervention groups:</P>
<P>1. Women received 400,000 IU vitamin A as retinyl palmitate and infant received 150,000 IU vitamin A (3 doses of 50,000 IU) (n = 110).<BR/>2. Women received 200,000 IU and infant received placebo (3 doses) (n = 110).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal morbidity, serum and breast milk retinol concentrations. Infant morbidity, haemoglobin and serum retinol concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:43:37 +0000" MODIFIED_BY="Heather Maxwell">
<P>No information regarding breastfeeding pattern was provided. However, at least partial breastfeeding is implied by the reported analysis of breast milk retinol to 6 months in 88% of those enrolled.</P>
<P>89.5% of follow-up until 12 months.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:45:18 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Fernandes-2012">
<CHAR_METHODS MODIFIED="2016-03-17 13:44:11 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, triple-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-17 13:44:18 +0000" MODIFIED_BY="Heather Maxwell">
<P>Women with 13 to 42 years of age, low obstetric risk, no gemelar and at-term gestation and their infants.</P>
<P>Recife, Permambuco, Brazil.</P>
<P>N = 312 pairs of women and infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:07:07 +0000" MODIFIED_BY="[Empty name]">
<P>Single or double high dose to women at delivery (first dose) and within 8-10 days (second dose).</P>
<P>2 intervention groups:</P>
<P>1. Women received 200,000 IU immediately postpartum + 200,000 IU vitamin A as retinyl palmitate at 8-10 postpartum (n = 152).<BR/>2. Mother received 200,000 IU vitamin A as retinyl palmitate immediately postpartum + placebo as soy oil capsules at 8-10 postpartum (n = 160).</P>
<P>(All capsules had 40 mg vitamin E.)&#8194;&#8194;</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-03-17 13:45:12 +0000" MODIFIED_BY="Heather Maxwell">
<P>Infant sides effects (vitamin A toxicity); duration and severity of episode of diarrhoea, fever, acute respiratory infection, otitis, VAD (signs of xerophthalmia), hospitalisations, severity signs (venous rehydration, antibiotic therapy) and serum retinol concentration. Maternal side effects (vitamin A toxicity), serum and breast milk retinol concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:45:18 +0000" MODIFIED_BY="Heather Maxwell">
<P>At least 60.45% of follow-up until 6 months. &#8194;</P>
<P>At least 70.6% of breastfeeding until 6 months.</P>
<P>Registered at Clinical Trials: NCT00742937.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:46:48 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Idindili-2007">
<CHAR_METHODS MODIFIED="2016-03-17 13:46:21 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:06:20 +0000" MODIFIED_BY="[Empty name]">
<P>Women resident in the study area that brought their infants for vaccination.</P>
<P>Ifakara, Tanzania.</P>
<P>N = 780 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:04:28 +0000" MODIFIED_BY="[Empty name]">
<P>Single or double high dose to women within 1 week after delivery; and 3 standard or higher doses to infant at 1, 2 or 3 months (DPT/OPV vaccination).</P>
<P>All infants received 100,000 IU vitamin A at measles vaccination (9 months).</P>
<P>2 intervention groups:</P>
<P>1. Women received 200,000 IU vitamin A as retinyl palmitate and infant received 75 000 IU vitamin A (3 doses of 25 000 IU) (n = 390).<BR/>2. Women received 400,000 IU vitamin A and infant received 150,000 IU vitamin A (3 doses of 50,000 IU) (n = 390).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Infant morbidity, anaemia (packed cell volume), serum retinol concentration, vitamin A hepatic stores (MRDR) and breast milk retinol concentration.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:46:48 +0000" MODIFIED_BY="Heather Maxwell">
<P>At least 86% of infants were exclusively breastfed until 1 month.</P>
<P>81% of follow-up until 3 months; 79.5% until 6 months; and 77.2% until 9 months.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:47:51 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Martins-2010">
<CHAR_METHODS MODIFIED="2016-02-10 19:58:22 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-10 19:58:30 +0000" MODIFIED_BY="[Empty name]">
<P>Women and their infants from a community attended at a Basic Health Unit.</P>
<P>Ribeirão Preto, São Paulo, Brazil.</P>
<P>N = 66 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-17 13:47:37 +0000" MODIFIED_BY="Heather Maxwell">
<P>Single high dose to women between the 20 and 30th days postpartum compared with placebo.</P>
<P>2 intervention groups:</P>
<P>1. Women received 200,000 IU (retinyl palmitate) between the 20 and 30th days postpartum (n = 33).<BR/>2. Women received a placebo as soy oil capsules between the 20 and 30th days postpartum (n = 33).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Infant febrile and/or diarrhoeic episode during the preceding 15 days (collected from the medical records) and at 3 months of life and serum retinol concentration. Maternal serum and breast milk retinol concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:47:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>89.39% of follow-up until 3 months.</P>
<P>75.4% of exclusive breastfeeding until 3 months.</P>
<P>No trial register.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:48:47 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Newton-2005">
<CHAR_METHODS MODIFIED="2016-03-17 13:48:30 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled 2 x 2 factorial design trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-17 15:08:21 +0000" MODIFIED_BY="[Empty name]">
<P>Women 3-4 weeks postpartum and their infants.</P>
<P>Kintampo, Brong Ahafo Region, Ghana.</P>
<P>N = 1085 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:08:32 +0000" MODIFIED_BY="[Empty name]">
<P>4 intervention groups:</P>
<P>1. Women received 200,000 IU of vitamin A as retinyl palmitate at 3-4 weeks and infant received total of 75,000 IU (25 000 IU at 6, 10 and 14 weeks) (n = 274).</P>
<P>2. Women received placebo at 3-4 weeks and infant received total of 75 000 IU (25,000 IU at 6, 10 and 14 weeks) (n = 265).</P>
<P>3. Women received 200,000 IU of vitamin A as retinyl palmitate and infant received total of placebo (n = 269).</P>
<P>4. Women received placebo and infant received placebo at 6, 10 and 14 weeks (n = 277).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-03-17 13:48:47 +0000" MODIFIED_BY="Heather Maxwell">
<P>Infant mortality, infant serum antibody titres for polio and tetanus at 6 months of age.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-12 13:35:24 +0100" MODIFIED_BY="[Empty name]">
<P>No information supplied regarding breastfeeding rates. The report's background outlined the evaluation of whether maternal supplementation alone could achieve adequate vitamin A status, without the need for infant supplementation. This suggests that women were breastfeeding.</P>
<P>Infant supplementation linked to time of administration of diphtheria pertussis tetanus and polio vaccinations.</P>
<P>It was confirmed with the first author that the mortality data in the study referred to infants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:49:29 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-RETIBETA-Project">
<CHAR_METHODS MODIFIED="2016-03-17 13:49:29 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:04:20 +0000" MODIFIED_BY="[Empty name]">
<P>Community-based study with women at 1-3 weeks after birth.<BR/>Matlab, Bangladesh.<BR/>N = 220 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:09:03 +0000" MODIFIED_BY="[Empty name]">
<P>Single high dose to women within 1-3 weeks postpartum or beta-carotene daily for 9 months.</P>
<P>3 intervention groups:<BR/>1. Women received 200,000 IU of vitamin A as retinyl palmitate and placebo daily for 9 months postpartum (n = 74).<BR/>2. Women received placebo and 7.8 mg (1 300 µg RE or 4327 IU) of beta-carotene daily until 9 months postpartum (n = 73).<BR/>3. Women received placebo and placebo daily until 9 months postpartum (n = 73).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:23 +0000" MODIFIED_BY="[Empty name]">
<P>Maternl vitamin A hepatic stores (MRDR), serum and breast milk retinol concentrations. Infant serum retinol concentrations and vitamin A hepatic stores (MRDR), Both in a subsample of women and infants.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 05:40:55 +0100" MODIFIED_BY="[Empty name]">
<P>All Infants at least partially breastfed to 6 months of age.</P>
<P>87% ate complementary food during this period.</P>
<P>98% follow-up rates until 3 months, 95% until 6 months, and 92% until 9 months postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-17 14:55:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roy-1997">
<CHAR_METHODS MODIFIED="2010-07-27 23:33:26 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:03:32 +0000" MODIFIED_BY="[Empty name]">
<P>Postpartum women.<BR/>Dhaka, Bangladesh.<BR/>N = 50 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 14:55:29 +0000" MODIFIED_BY="[Empty name]">
<P>Single high dose to women within 24 hours after birth.</P>
<P>2 intervention groups:</P>
<P>1. Women received 200,000 IU vitamin A as retinyl palmitate plus 60 mg of iron daily for 9 months (n = 25).<BR/>2. Women received 60 mg of iron daily for 9 months (n = 25).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:24 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal serum and breast milk retinol concentrations. Infant morbidity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 05:40:56 +0100" MODIFIED_BY="[Empty name]">
<P>All babies were breastfed until 6 months postpartum.</P>
<P>No information regarding breastfeeding pattern was provided.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:51:27 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Stoltzfus-1993a">
<CHAR_METHODS MODIFIED="2016-03-17 13:50:46 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:02:12 +0000" MODIFIED_BY="[Empty name]">
<P>Women at 1-3 weeks postpartum.<BR/>Java, Indonesia.<BR/>N = 153 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 14:56:15 +0000" MODIFIED_BY="[Empty name]">
<P>Single high dose to women within 1-3 weeks after birth.</P>
<P>2 intervention groups:</P>
<P>1. Women received 300,000 IU vitamin A as retinyl palmitate (n = 77).</P>
<P>2. Women received placebo (n = 76).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-17 15:14:00 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal abnormal CIC, serum and breast milk retinol concentrations. Infant serum retinol concentration and vitamin A hepatic stores (RDR).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:51:27 +0000" MODIFIED_BY="Heather Maxwell">
<P>No specific information regarding breastfeeding pattern was provided. However, the report's title, background and analysis of breast milk retinol to 8 months postpartum strongly suggest that infants received at least some breast milk for the duration of the study. Additionally, it is noted that the 3 women who stopped breastfeeding were not included in the 6-month follow-up.</P>
<P>88.9% follow-up rate until 6 months postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:52:05 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Venkatarao-1996">
<CHAR_METHODS MODIFIED="2016-03-17 13:51:55 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:02:24 +0000" MODIFIED_BY="[Empty name]">
<P>Women at 1-2 weeks after birth.<BR/>Tamil Nadu, India.<BR/>N = 909 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 14:56:16 +0000" MODIFIED_BY="[Empty name]">
<P>Single high dose to women within 1-2 weeks after birth and high dose to infant at 6 months .</P>
<P>3 intervention groups:</P>
<P>1. Women received 300,000 IU vitamin A as retinyl palmitate and Infant received 200,000 IU vitamin A (n = 301).</P>
<P>2. Women received 300,000 IU vitamin A and Infant received placebo (n = 297).</P>
<P>3. Women received placebo and Infant received placebo at 6 months of age (n = 311).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-02 01:48:47 +0000" MODIFIED_BY="[Empty name]">
<P>Infant morbidity and adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:52:05 +0000" MODIFIED_BY="Heather Maxwell">
<P>99.7% of infants were breastfed for at least 6 months. No information regarding breastfeeding pattern was provided.</P>
<P>75.8% follow-up rate until 12 months postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:53:11 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Vinutha-2000">
<CHAR_METHODS MODIFIED="2010-08-08 06:25:50 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-01 22:02:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Where in India are the participants from?&lt;/p&gt;" NOTES_MODIFIED="2016-02-01 22:02:31 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>Postpartum women (primigravid and second-gravid).<BR/>Mumbai, India.<BR/>N = 109 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-17 13:53:11 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;From your characteristics of included studies, it looks as though no placebo was received; therefore it seems this study should be excluded.&lt;/p&gt;" NOTES_MODIFIED="2016-03-17 13:53:11 +0000" NOTES_MODIFIED_BY="Heather Maxwell">
<P>Single high dose to women within 48 hours after delivery.</P>
<P>2 intervention groups:</P>
<P>1. Women received 200,000 IU vitamin A as Aquasol water-miscible (n = 53).</P>
<P>2. Women did not receive vitamin A or placebo (n = 56).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:24 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal serum and breast milk retinol concentrations. Infant serum retinol concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 05:40:58 +0100" MODIFIED_BY="[Empty name]">
<P>All babies were exclusively breastfed.</P>
<P>77.1% follow-up rate until 3 months postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-17 13:54:47 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<CHAR_METHODS MODIFIED="2016-03-17 13:53:39 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;Was there more than one randomised controlled trial in this reference? Please clarify.&lt;/p&gt;" NOTES_MODIFIED="2016-03-17 13:53:39 +0000" NOTES_MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled, multicentre trial (India, Ghana, and Peru).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-17 15:10:38 +0000" MODIFIED_BY="[Empty name]">
<P>Postpartum women and their infants.<BR/>New Delhi, India; Brong Ahafo, Ghana; Lima, Peru.<BR/>N = 7078 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-17 13:54:10 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;I think the interventions need to be clarified. If there were three RCTs reported in this paper, please state something like &amp;quot;RCT 1, Peru: Group 1: ... Group 2:...&amp;quot; and so on for the other two RCTs. If any of these studies do not compare vitamin A with placebo, the interventions should be reported here, but the data should not be included in the analyses.&lt;/p&gt;" NOTES_MODIFIED="2016-03-17 13:54:10 +0000" NOTES_MODIFIED_BY="Heather Maxwell">
<P>Single high dose to women within 21-42 days after birth in Ghana and 18-28 days after birth in Peru and India.</P>
<P>3 doses to infant during their DPT or OPV immunization (6, 10, 14 weeks) in Ghana, India and (2, 3 and 4 months) in Peru.</P>
<P>Multicentre trial - at 9 months, infants received 25,000 IU vitamin A with measles immunisation and infants from the control group received single high dose 100,000 IU vitamin A.</P>
<P>Ghana trial - at 6 months, infants received 25,000 IU vitamin A and infants from the control group received single high dose 100,000 IU vitamin A.</P>
<P>Multicentre trial - 2 intervention groups:</P>
<P>1. Women received 200,000 IU vitamin A as retinyl palmitate and Infants received 100,000 IU vitamin A (4 doses 25,000 IU) (n = 3522).</P>
<P>2. Women received placebo and Infants received placebo (3 doses) plus 100,000 IU vitamin A at 9 months (equivalent total dose received by group 1) (n = 3556).</P>
<P>Ghana - 4 intervention groups:</P>
<P>1. Women received 200,000 IU vitamin A as retinyl palmitate and Infants received 100,000 IU vitamin A (4 doses 25,000 IU) (n = 196).<BR/>2. Women received placebo and Infants received vitamin A as per group 1 (n = 192).<BR/>3. Women received vitamin A as per group 1 and Infants received placebo at times of immunisation, plus 100,000 IU vitamin A at 6 months (equivalent total dose received by groups 1 and 2) (n = 185).<BR/>4. Women received placebo and Infants received placebo (3 doses), plus 100,000 IU vitamin A at 6 months (equivalent total dose received by groups 1 and 2) (n = 194).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:24 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal serum and breast milk retinol concentrations. Infant mortality, morbidity, acute toxic effects, serum retinol concentration and vitamin A hepatic stores (MRDR).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-03-17 13:54:47 +0000" MODIFIED_BY="Heather Maxwell">
<P>At least 99.4% of infants were breastfed at enrolment. The sub-study that reported breast milk retinol gave these findings for 570 women, compared with 631 at 2 months, suggesting that the majority of infants were at least partially breastfed to 9 months.</P>
<P>74.9% follow-up rate until 12 months postpartum.</P>
<P>Before and periodically during the study standardisation exercises to assess agreement within and between observers were conducted for the main outcome variables.</P>
<P>Standardisation across sites (Ghana, India and Peru) was ensured by exchange visits.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-18 09:02:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-ZVITAMBO-Study-Group">
<CHAR_METHODS MODIFIED="2016-03-17 13:55:15 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled, 2 by 2 factorial trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-17 15:13:21 +0000" MODIFIED_BY="[Empty name]">
<P>Postpartum women without a life-threatening condition and their infants with birthweight &#8805; 1500 g from urban maternity centres.<BR/>Harare, Zimbabwe.<BR/>N = 14,110 women and their infants (n = 9562 HIV-negative women).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-18 09:02:13 +0000" MODIFIED_BY="[Empty name]">
<P>Double high dose to women within 96 hours of birth and single high dose to infant.</P>
<P>4 treatment groups:</P>
<P>1. Women received 400,000 IU vitamin A as retinyl palmitate and infant received 50,000 IU vitamin A (n = 3529).</P>
<P>2. Women received 400,000 IU vitamin A and infant received placebo (n = 3529).</P>
<P>3. Women received placebo and infant received 50,000 IU vitamin A (n = 3530).</P>
<P>4. Women received placebo and infant received placebo (n = 3522).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-02 01:47:47 +0000" MODIFIED_BY="[Empty name]">
<P>Maternal mortality, morbidity, serum retinol concentration and haemoglobin concentration. Infant mortality, acute adverse effects (for 788 women-infant pairs only) and serum retinol concentration.</P>
<P>Infant cause of death was determined from medical records when the death occurred in the hospital or from a review of verbal autopsy information by study paediatrician.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 05:41:07 +0100" MODIFIED_BY="[Empty name]">
<P>All women initiated breastfeeding (97% started breastfeeding within 12 hours postpartum). 99.5% were still breastfeeding at 6 months and 85.8% at 12 months postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CIC: conjunctival impression cytology<BR/>CRP: C-reactive protein<BR/>DPT: diphtheria, pertussis, tetanus vaccine<BR/>ITT: intention-to-treat<BR/>IU: international unit<BR/>MRDR: modified relative dose response<BR/>OPV: oral polio vaccine<BR/>RE: Retinol equivalent<BR/>RDR: relative dose response<BR/>VAD: vitamin A deficiency<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-03-16 11:11:20 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ahmad-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:11 +0000" MODIFIED_BY="[Empty name]">
<P>Supplementation for women during pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 19:34:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ala_x002d_Houhala-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 19:34:34 +0000" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the intervention or control groups. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alam-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:19 +0000" MODIFIED_BY="[Empty name]">
<P>Provision of fat rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Atalhi-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:22 +0000" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 19:34:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Basu-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 19:34:44 +0000" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the intervention or control groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bezerra-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:28 +0000" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the intervention or control groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Canfield-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Pee-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El-Hamdouchi-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:36 +0000" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Filteau-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:02:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:02:43 +0000" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the intervention or control groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-03-16 11:11:20 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Gossage-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-03-16 11:11:20 +0000" MODIFIED_BY="Heather Maxwell">
<P>Participants were lactating and non-lactating women (paired) who were then randomised to either supplement or placebo. The study was "designed to explore possible interactions between short-term &#946;-carotene supplementation and lactation on mitogenic DNA synthesis in immune-related peripheral blood T lymphocytes as well as to determine the effects of &#946;-carotene supplementation on concentrations of other major carotenoids in the plasma of lactating and nonlactating women." p.950. It was not designed to consider maternal or infant mortality or morbidity, where were the focus of our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-17 15:03:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haskell-2013a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-17 15:03:19 +0000" MODIFIED_BY="[Empty name]">
<P>Supplementation after the first 6 weeks postpartum (4-12 months postpartum).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-17 15:03:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haskell-2013b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-17 15:03:21 +0000" MODIFIED_BY="[Empty name]">
<P>Supplementation after the first 6 weeks postpartum (4-12 months postpartum).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-15 13:46:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Humphrey-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-15 13:46:25 +0000" MODIFIED_BY="[Empty name]">
<P>Vitamin A supplementation for women who live with HIV.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khan-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lietz-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lietz-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:30 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:03:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lima-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:03:12 +0000" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the intervention or control groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-27 23:33:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ncube-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-27 23:33:30 +0100" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 06:25:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NNIPS_x002d_2">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 06:25:51 +0100" MODIFIED_BY="[Empty name]">
<P>Long-term supplementation for women of reproductive age.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-28 06:25:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-ObaapaVitA">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-28 06:25:55 +0100" MODIFIED_BY="[Empty name]">
<P>Long-term supplementation for women of reproductive age.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:03:20 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Swaminathan-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:03:20 +0000" MODIFIED_BY="[Empty name]">
<P>Provision of vitamin A rich foods and nutrition counselling rather than vitamin A supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-06 05:13:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tchum-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-06 05:13:47 +0100" MODIFIED_BY="[Empty name]">
<P>Alternate allocation to the control or test group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-17 15:03:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turner-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-17 15:03:21 +0000" MODIFIED_BY="[Empty name]">
<P>Supplementation after the first 6 weeks postpartum (4-12 months postpartum).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-10 20:03:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-West-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-10 20:03:29 +0000" MODIFIED_BY="[Empty name]">
<P>Long-term supplementation for women of reproductive age.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2016-03-17 13:38:14 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2016-03-17 13:38:14 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Nga-2013">
<CHAR_METHODS MODIFIED="2016-03-17 13:30:57 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-17 13:38:14 +0000" MODIFIED_BY="Heather Maxwell">
<P>Healthy women, 18 to 50 years of age, with no gemelar gestation.</P>
<P>Hanoi, Vietnam.</P>
<P>N = 400 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:16:36 +0000" MODIFIED_BY="[Empty name]">
<P>1. Single high dose of vitamin A supplementation (200,000 IU) within 3 days plus a placebo at 6 weeks postpartum.*</P>
<P>2. A placebo within 3 days plus a single high dose of vitamin A supplementation (200,000 IU) at 6 weeks postpartum.*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-14 10:49:24 +0000" MODIFIED_BY="[Empty name]">
<P>Infant acute phase proteins (CRP, AGP), morbidities, nutritional status (anthropometry), hepatic vitamin A reserves and plasma retinol concentrations. Maternal acute phase proteins, serum and breast milk retinol concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-10 20:04:45 +0000" MODIFIED_BY="[Empty name]">
<P>We emailed the author questioning about the research publications and we received no answer.</P>
<P>*As stated in the Clinical Trials Register.</P>
<P>Registered at Clinical Trials Register: NCT00952640.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2016-03-17 13:35:53 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Wang-2012">
<CHAR_METHODS MODIFIED="2016-03-17 13:34:39 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-17 13:35:44 +0000" MODIFIED_BY="Heather Maxwell">
<P>Healthy women, negative for Hepaptitis-B antigen, with no gemelar gestation, no complicated pregnancy, no breastfeeding restriction; infant with adequate newborn weight.</P>
<P>Linyi, Shandong, China.</P>
<P>N = 150 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-17 13:35:53 +0000" MODIFIED_BY="Heather Maxwell">
<P>1. 2 high doses of vitamin A supplementation (200,000 IU) at 2 weeks and 3 months (total: 400,000 IU) postpartum plus daily doses of 10 mg alpha-tocopherol and 10 mcg cholecalciferol.*</P>
<P>2. Daily doses of vitamin A supplementation (4000 IU) plus daily doses of 10 mg alpha-tocopherol and 10 mcg cholecalciferol for 6 months during postpartum.*</P>
<P>3. No vitamin A supplementation plus daily doses of 10 mg alpha-tocopherol and 10 mcg cholecalciferol for 6 months during postpartum.*</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-17 15:17:27 +0000" MODIFIED_BY="[Empty name]">
<P>Infant plasma anti hepatitis-B antibody, plasma retinol concentrations, plasma C-reactive protein and plasma alpha-acid glycoprotein. Maternal plasma and breast milk retinol concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-10 20:05:37 +0000" MODIFIED_BY="[Empty name]">
<P>We emailed the author questioning about the research publications and the answer was: "The experimental results you mentioned has not been published yet".</P>
<P>*As stated in the protocol register. </P>
<P>Chinese Clinical Trial Register: ChCTR-TRC-12001914.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>AGP: alpha acid glycoprotein<BR/>CRP: C-reactive protein<BR/>IU: international unit</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-03-17 13:30:23 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-03-17 13:30:23 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Ahmad-2015">
<CHAR_STUDY_NAME MODIFIED="2016-02-17 15:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Stopping postpartum vitamin A supplementation: are we missing concealed benefit?</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-03-17 13:27:09 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised, double-blind, placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-17 13:27:27 +0000" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women 18 to 32 years of age with low obstetric risk.</P>
<P>Dhaka, Bangladesh.</P>
<P>N = 128 women and their infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-17 15:18:11 +0000" MODIFIED_BY="[Empty name]">
<P>1. Single high dose of vitamin A supplementation (200,000 IU) within 3 days plus a placebo at 6 weeks postpartum.</P>
<P>2. A placebo within 3 days plus single high dose of vitamin A supplementation (200,000 IU) at 6 weeks postpartum.</P>
<P>3. 2 high doses of vitamin A supplementation (200,000 IU) within 3 days and at 6 weeks (total: 400,000 IU) postpartum.<BR/>4. 2 placebos within 3 days and at 6 weeks postpartum.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-03-17 13:30:23 +0000" MODIFIED_BY="Heather Maxwell">
<P>Breast milk sIgA, sCD14, TGF-beta, IL-7, GM-CSF, maternal plasma and breast milk retinol concentrations. Microbial pattern recognition receptors (Toll-like receptor, TLR) and stimulated TNF-&#945;, IL-10, and IFN-&#945; responses; epitope-independent mitogen (PHA) stimulated T cell polarisation: IFN-&#947; (Th1), IL-13 (Th2), IL-17 (Th17), and IL-10 (Tr1); pertussis toxin and hepatitis B surface antigen-specific and IgG antibody-secreting plasma cell responses. Infant morbidities, anthropometry (growth and weight-for-age z-score) and plasma retinol concentration.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-02-10 20:06:36 +0000" MODIFIED_BY="[Empty name]">
<P>October, 2013.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-02-10 20:06:30 +0000" MODIFIED_BY="[Empty name]">
<P>smeahmad@icddrb.org</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-02-10 20:06:41 +0000" MODIFIED_BY="[Empty name]">
<P>Clinical Trials Register: NCT02043223.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>IU: international unit</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-03-17 13:56:10 +0000" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-03-17 13:49:04 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-17 15:02:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>"Two random sequences of X and Y were prepared, one for the mothers and one for the infants. Identification numbers from 1 to 700 were assigned consecutively to each of the two lists and mother-infant pairs of capsules were packaged in zip-lock bags numbered from 1 to 700 and kept in batches of ten."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-17 13:42:36 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>Randomised, no details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>"An independent senior scientist packed and labelled the supplements, and did a block randomisation procedure (16 per block) to allow for possible effects of season of<BR/>birth."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-10 19:56:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>&#8221;Mother&#8211;child pairs were assigned, through a simple randomization process by using a random number table into 2 treatment groups.&#8221;</P>
<P>&#8220;[&#8230;] using a random number table generated by EPI INFO [&#8230;]&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-15 13:09:36 +0000" MODIFIED_BY="Nancy  Medley" RESULT="YES" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>"Individual randomization was achieved by using a list of study numbers that had been randomly assigned to an intervention arm in blocks of 10, generated by the Data and Safety Monitoring Board."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-17 13:47:56 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>No explicit randomisation procedure reported.<BR/>&#8220;[&#8230;] assigned at random [&#8230;]&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-17 13:49:04 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>"Mothers and infants were allocated to 1 of 4 treatment groups, using a blocked randomization scheme."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 09:59:27 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>"Before beginning the study, individual treatment codes and follow-up schedules were assigned to a sequence of identification numbers in blocks of 18 using a random number table"..."Each block contained all possible combinations of three treatment groups."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>Women were randomly allocated to either the intervention or control group. No further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-24 14:41:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>"Individual randomization to treatment codes A and B was done in blocks of eight according to the Moses-Oakford assignment algorithm."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>"...randomly allocated". No further details given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Randomised. No further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:11:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>"Identification numbers were generated by computer at the data management centre at John Hopkins University in Baltimore, and assigned as random permuted blocks of size eight."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:12:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>"A separate team at Johns Hopkins University prepared the study capsule packets. Study identification numbers were randomly allocated to the treatment groups by computer in blocks of 12. The numbers were printed on adhesive labels and affixed to amber-colored zip-lock plastic bags that were packed with the assigned capsules. Capsule packets were prepared separately for each of the 4 treatment groups and were then merged into numeric order before shipping to Zimbabwe, where a series of packets were distributed to each recruitment site. As each mother-infant pair was recruited, the capsules in the next sequential bag were administered, and the associated study number was assigned to the pair."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-03-17 13:42:39 +0000" MODIFIED_BY="Heather Maxwell" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-12 14:04:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>"The randomisation codes were concealed for the entire trial duration and only revealed after completion of data analysis."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-17 13:42:39 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>No details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>"All members of the trial team were unaware of allocation until the data had been cleaned and locked."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-12 14:05:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>&#8220;The randomization codes were kept secret during the whole study...&#8221;; &#8220;The placebo capsules had the same consistency, vehicle, coloration and flavour as the vitamin A capsules.&#8221;; "The research members were only informed of the allocation of the supplementation groups after the completion of data analysis.&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 09:58:51 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>"A compact disk containing the cleaned and locked database files was exchanged for the treatment randomization code, held by the Data and Safety Monitoring Board."</P>
<P>All members of the trial team were unaware of allocation until the data had been cleaned and locked.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-10 19:58:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>Not mentioned at all.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>Details not provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 09:59:30 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>"The study capsules were manufactured by Tischon Corporation (Salisbury, MD) and delivered to the field and to study participants coded as type A, B or C."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:02:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>No details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>"The allocation of treatment codes A and B to vitamin A or placebo capsules was done by the Sight and Life Task Force, Hoffmann-LaRoche (Basel, Switzerland), who prepared the capsules."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>" the Medical Officer...administered the appropriate capsules to the mother from the sealed envelope supplied by the Statistical Section at the Camp Office."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>No details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>"Three sealed copies of study codes were prepared and kept at WHO in Geneva, with the ethics committee of the All India Institute of Medical Sciences in New Delhi, and at the data management centre in Baltimore. Access was limited to one data manager, who had no direct involvement in the data analysis, and who prepared information requested by the treatment effects monitoring committee."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-27 23:33:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>"Lists linking the study number to the treatment were kept in sealed envelopes and encrypted computer files."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2016-02-11 08:31:25 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-02-12 14:05:07 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 19:55:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>"...prepared and supplied the vitamin A and identical-looking placebo supplements as oily capsules in brown bottles coded as X or Y."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 19:55:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>"Vitamin A and placebo were coded by a person who had no connection with the investigation and the dose was administered by an auxiliary nurse midwife who was not aware of the code."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-12 14:05:07 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>"Vitamin A in vegetable oil and vegetable oil placebo were prepared by Hoffmann La Roche (Basel, Switzerland). An independent senior scientist packed and labelled the supplements, and did a block randomisation procedure (16 per block) to allow for possible effects of season of birth. Supplements or placebo were directly administered at home by field staff , apart from supplements at 2, 9, and 12 months, which were given at the clinic during follow-up. All members of the trial team were unaware of allocation until the data had been cleaned and locked."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 19:57:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>Identical capsules were used in the trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 19:58:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>"Vitamin A capsules providing different doses were manufactured by Accucaps Industries (Windsor, Canada) (25,000 and 50,000 IU) and RpScherer (Aprilia, Italy) (200,000 IU), and were supplied to the project by the WHO."</P>
<P>Not enough detail to judge whether participants were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 19:59:05 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>&#8220;double-blind trial&#8221; &#8220;who received identical capsules containing soy oil [&#8230;]&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:00:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>"The test and placebo capsules were identical in size colour and shape."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:00:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>Capsules: packaged in blister pack strips. Vitamin A and placebo capsules differed in colour slightly - authors considered that foil packaging would reduce direct comparisons between groups. Beta-carotene and placebo capsules identical in colour.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:00:31 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>Women in the control group did not receive a placebo. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:00:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>Vitamin A and placebo capsules "looked practically identical" and were prepared by "Sight and Life Task Force, Hoffmann-LaRoche" - in labelled foil packs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:00:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>Capsules were "similar in colour". Infant syrup matched for colour and consistency.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:01:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Women in the control group did not receive a placebo. No other details provided on blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:01:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>"The supplements and placebo, in identical opaque gelatin capsules, were packaged in individually coded blister packs in Baltimore."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-10 20:01:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>"Placebo and treatment capsules appeared identical. Preparation, randomisation and packing of capsules were performed at The Johns Hopkins University in the USA before shipping to HaTarea."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-02-14 16:53:31 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 19:54:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>"The randomisation codes were concealed for the entire trial duration and only revealed after completion of data analysis."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-14 16:53:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>Not reported, but outcomes (serum and breast milk retinol concentration) were unlikely to be influenced by blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 19:56:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>&#8220;All members of the trial team were unaware of allocation until the data had been cleaned and locked.&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 19:57:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>Blinding was kept until end of the trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 19:58:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>No details were given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 19:59:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>&#8220;double-blind trial&#8221;, not specified, but reported outcomes unlikely to be influenced by blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-14 15:08:27 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>Not specified, but outcomes were unlikely to be influenced by blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-14 15:09:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>Not specified, but outcomes were unlikely to be influenced by blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 20:00:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>Field workers who assessed the outcomes were not aware of the objective of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 20:00:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>"All investigators, field and laboratory staff and study participants were blinded to the randomization code until field work was completed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 20:01:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>Outcome assessors did not know about the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-14 15:09:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Probably not blinded, but outcomes were unlikely to be influenced by blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 20:01:27 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>Outcome assessors were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-10 20:02:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>Outcome assessors were blinded to intervention or control.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-03-17 13:56:10 +0000" MODIFIED_BY="Heather Maxwell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:54:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>All analyses were by ITT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:53:59 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>Reasons for attrition and exclusions not reported. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:53:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>Reasons for attrition and exclusions were reported in detail, although ITT analysis was not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-03-17 13:46:02 +0000" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>"However, those who did not breastfeed their infants were not excluded from the study and received the normal follow-up for illness in their infants (i.e. follow-up was on an intention-to-treat basis).&#8221;</P>
<P>"The nursing mothers who were not exclusively breastfeeding were not excluded from the research, and were still followed up and assessed based on the study design, that is, in terms of &#8220;intention to treat&#8221;."</P>
<P>The authors probably performed an available-case ITT. It is possible to notice an imbalanced loss of follow-up comparing the arms. In the publication about breast milk; only 4-month data are reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:52:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>Reasons for attrition and exclusions not reported. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-10 19:59:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>&#8220;Data analysis was based on intent to treat because the mothers who interrupted exclusive breast-feeding were not excluded.&#8221;</P>
<P>Similar missing data in both groups, dropout explained, available case ITT performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-01 22:10:19 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>Only infants of women for which blood sample was obtained in the end of the study were included in the analysis. Attrition was 34.6%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:50:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>Reasons for attrition and exclusions not reported. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-09-06 05:02:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>All randomised participants were accounted for in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:48:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>Reasons for attrition and exclusions not reported. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:48:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>Exclusions and attrition were 23%. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-02 01:48:07 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Reasons for attrition and exclusions not reported. ITT analyses not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>"All analyses were by intent to treat from the time of first administration of study capsule to the mother."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-03-17 13:56:10 +0000" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>"Only infants of mothers who remained HIV-negative to 12 months postpartum were included in the current analysis."</P>
<P>Attrition was 11.3% (in both the vitamin A and placebo groups) for HIV-negative women (985/9562).</P>
<P>Adverse event data were only available for a subset of 788 women-infant pairs.</P>
<P>The analyses were not by ITT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-02-17 15:06:40 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-27 23:33:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>Not all clinically relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 09:58:19 +0100" MODIFIED_BY="Denise Atherton" RESULT="NO" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>Not all clinically relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-17 15:06:40 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>Not all clinically relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-10 19:57:29 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>Fetal growth as outcome in trial registration, only baseline data reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:00:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>Not all clinically relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-12 14:06:20 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>CRP levels only reported as baseline level. Febrile or diarrhoeic episodes not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-08 06:25:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>Not all expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-09 02:00:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>All expected clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:13:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>Not all clinically relevant outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-02-17 15:03:01 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-08 06:16:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ayah-2007">
<DESCRIPTION>
<P>Supported by Hoffmann-La Roche Ltd (Basel Switzerland).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhaskaram-2000">
<DESCRIPTION>
<P>Source of funding not mentioned. No mention of any research protocol published a priori.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-15 13:07:43 +0000" MODIFIED_BY="Nancy  Medley" RESULT="YES" STUDY_ID="STD-Darboe-2007">
<DESCRIPTION>
<P>Trial registered a priori (No. ISRCTN 98554309). The UK Medical Research Council funded the study, and laboratory analyses in Coleraine were supported by BASF Aktiengesellschaft (Ludwigshafen, Germany).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-17 15:03:01 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandes-2012">
<DESCRIPTION>
<P>In the 4 papers the authors reported different number of randomisation and baseline characteristics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 09:59:00 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Idindili-2007">
<DESCRIPTION>
<P>Post hoc analyses were conducted because of concerns that the capsules did not contain the necessary amount of vitamin A (in a sample of capsules vitamin degraded).</P>
<P>Supported by Immunization Vaccines &amp; Biologicals (the World Health Organization and the United Nations Foundation), Sight&amp;Life (Hoffman-la Roche Ltd), Micronutrient Initiative, the Canadian International Development Agency, and the United Nations Children&#8217;s Fund (UNICEF).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-10 19:59:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martins-2010">
<DESCRIPTION>
<P>No other source of bias could be detected.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-06 05:01:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Newton-2005">
<DESCRIPTION>
<P>Enrolment of participants was extended to higher than planned lost to follow-up. Sample size calculation provided, but unclear whether a protocol was published a priori. Supported by a grant from the Wellcome Trust.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RETIBETA-Project">
<DESCRIPTION>
<P>Supported by cooperative agreements between The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD, USA and the Office of Health and Nutrition, U.S. Agency for International Development, Washington, DC (DAN-5116-1-00-8051-00 and HRN-A-00-97-00015-00). Research protocol not published a priori.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-08 06:22:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roy-1997">
<DESCRIPTION>
<P>Study supported by the International Centre for Diarrhoeal Disease Research and the United States Agency for International Development. Research protocol not published a priori.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-08 06:22:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stoltzfus-1993a">
<DESCRIPTION>
<P>Supported by a grant from the Thrasher Research Fund and a National Science Foundation Graduate Fellowship to Rebecca I. Stoltzfus. Study protocol not published a priori.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatarao-1996">
<DESCRIPTION>
<P>Source of funding not provided. No mention of research protocol.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-30 12:16:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vinutha-2000">
<DESCRIPTION>
<P>Funded by the Lokmanya Tilak Municipal Medical College and Hospital in Mumbai. Study protocol not published a priori.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-11 04:25:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO_x002f_CHD-IVASSG">
<DESCRIPTION>
<P>Trial supported by the Child Health and Development Division of WHO, the Johns Hopkins Family Health and Child Survival Cooperative Agreement (HRN 5986-A-00-6006-00) with funding from the United States Agency for International Development, and the Indian Council of Medical Research. A study protocol was not mentioned but study described in detail.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-27 23:33:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-ZVITAMBO-Study-Group">
<DESCRIPTION>
<P>"The ZVITAMBO Project was primarily supported by the Canadian International Development Agency (R/C Project 690/M3688), the US Agency for International Development (cooperative agreement no. HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition of the USAID), and a grant from the Bill and Melinda Gates Foundation (Seattle); additional support was provided by the Rockefeller Foundation (New York) and BASF (Ludwigshafen, Germany)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-03-23 14:27:30 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-03-23 14:27:30 +0000" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-03-04 19:02:06 +0000" MODIFIED_BY="[Empty name]">Vitamin A supplementation (200,000 to 400,000 IU) compared to placebo or no treatment in postpartum women</TITLE>
<TABLE COLS="7" ROWS="18">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Vitamin A supplementation (200,000 to 400,000 IU) compared to placebo or no treatment in postpartum women</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>Postpartum women<BR/>
<B>Setting: </B>Low- and middle-income settings (India, Bangladesh, Indonesia, Tanzania, Gambia, Zimbabwe, Kenya, Ghana, Peru and Brazil)<BR/>
<B>Intervention: </B>Vitamin A supplementation (200,000 to 400,000 IU)<BR/>
<B>Comparison: </B>Placebo or No treatment</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Placebo or No treatment</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Vitamin A supplementation (200 000 to 400 000 IU)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Maternal mortality<BR/>follow-up: 12 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>HR 1.01<BR/>(0.44 to 2.21)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>8577<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>: We calculated HR from Kaplan-Meier-Curve using Cox model. <LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>: Effects on maternal mortality at 6 months were imprecise (0.50, 95% CI 0.09 to 2.71; 6 deaths, N = 564)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000<BR/>(1 to 6)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Maternal morbidity (diarrhoea, respiratory infections, fever)<BR/>follow-up: 3 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Effect is uncertain because the quality of evidence available is very low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>50<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; diarrhoea: 27/2281 days with vitamin A vs 15/2281 with placebo</P>
<P>respiratory infections 82/2281 days with vitamin A vs 125/2281 with placebo</P>
<P>fever: 30/2281 days with vitamin A vs 28/2281 with placebo; no statistical comparison performed<SUP>11</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Maternal adverse effects after administration: abdominal pain<BR/>follow-up: 1.25 days</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.28<BR/>(0.95 to 1.73)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>786<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Subset of participants from the <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>162 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>207 per 1000<BR/>(153 to 279)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Maternal breast milk retinol concentration<BR/>follow-up: mean 3-3.5 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal breast milk retinol concentration ranged from 0.44 to 1.82 mcmol/L</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal breast milk retinol concentration in the intervention group was 0.2 mcmol/L higher (0.08 higher to 0.31 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>837<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>5 6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-RETIBETA-Project" TYPE="STUDY">RETIBETA Project</LINK>; <LINK REF="STD-Roy-1997" TYPE="STUDY">Roy 1997</LINK>; <LINK REF="STD-Stoltzfus-1993a" TYPE="STUDY">Stoltzfus 1993a</LINK>; <LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>
</P>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Infant mortality<BR/>follow-up: range 2 months to 12 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.08<BR/>(0.77 to 1.52)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>6090<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>7 8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>; <LINK REF="STD-Martins-2010" TYPE="STUDY">Martins 2010</LINK>; <LINK REF="STD-Newton-2005" TYPE="STUDY">Newton 2005</LINK>; <LINK REF="STD-Venkatarao-1996" TYPE="STUDY">Venkatarao 1996</LINK>; <LINK REF="STD-ZVITAMBO-Study-Group" TYPE="STUDY">ZVITAMBO Study Group</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>20 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>22 per 1000<BR/>(16 to 31)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Infant morbidity (gastroenteritis)<BR/>follow-up: 3 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 6.03<BR/>(0.30 to 121.82)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>84<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>2 9</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-Vinutha-2000" TYPE="STUDY">Vinutha 2000</LINK>. There were zero events for gastroenteritis in the control group and so it was not possible to calculate anticipated absolute effects.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>see comment</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>see comment</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Infant adverse effects: bulging fontanelle<BR/>follow-up: range 1 days to 2 days</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 2.00<BR/>(0.61 to 6.55)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>444<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>10</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-Ayah-2007" TYPE="STUDY">Ayah 2007</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>18 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>36 per 1000<BR/>(11 to 118)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; <B>OR:</B> Odds ratio; <B>HR:</B> Hazard ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Downgraded one level due to serious imprecision (95% CI includes both appreciable benefit and harm)</P>
<P>
<SUP>2</SUP> Downgraded one level due to serious risk of bias (unclear allocation sequence generation and concealment; participants and personnel not blinded)</P>
<P>
<SUP>3</SUP> Downgraded two levels due to very serious imprecision (very small size, N = 50)</P>
<P>
<SUP>4</SUP> Downgraded two levels due to very serious imprecision (95% CI includes both appreciable benefit and harm)</P>
<P>
<SUP>5</SUP> Downgraded one level due to serious risk of bias (allocation sequence generation and concealment unclear in three of six studies)</P>
<P>
<SUP>6</SUP> Downgraded one level due to serious inconsistency (I² = 58%)</P>
<P>
<SUP>7</SUP> Not downgraded for risk of bias (sensitivity analysis excluding three trials with unclear allocation randomisation did not change effect estimate)</P>
<P>
<SUP>8</SUP> Downgraded one level due to serious imprecision (95% CI includes both appreciable benefit and harm)</P>
<P>
<SUP>9</SUP> Downgraded two levels due to very serious imprecision (very few events, N = 2; 95% CI includes appreciable benefit and harm)</P>
<P>
<SUP>10</SUP> Downgraded two levels due to very serious imprecision (very few events, N = 12; 95% CI includes both appreciable benefit and harm)</P>
<P>
<SUP>11</SUP>Numerator: number of cumulative days of illness, denominator: number of people-days of follow-up. The number of people-days has been extracted from the original reference.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-03-17 16:57:09 +0000" MODIFIED_BY="Heather Maxwell">
<COMPARISON ID="CMP-001" MODIFIED="2016-03-17 16:57:09 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Supplement (vitamin A as retinyl, water-miscible or beta-carotene) 200,000 to 400,000 IU versus control (placebo, no treatment, other)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.7079365573881216" CI_START="0.09232121754031483" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.4326384853088923" LOG_CI_START="-1.0346984766368548" LOG_EFFECT_SIZE="-0.3010299956639812" METHOD="MH" MODIFIED="2016-02-18 10:38:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.42128797353408987" Q="0.0" RANDOM="NO" SCALE="946.23" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="282" TOTAL_2="282" WEIGHT="100.0" Z="0.8041887651835308">
<NAME>Maternal mortality to 6 months</NAME>
<GROUP_LABEL_1>Vitamin A</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7079365573881216" CI_START="0.09232121754031483" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.4326384853088923" LOG_CI_START="-1.0346984766368548" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2016-02-18 10:38:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.42128797353408987" STUDIES="1" TAU2="0.0" TOTAL_1="282" TOTAL_2="282" WEIGHT="100.0" Z="0.8041887651835308">
<NAME>400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="2.707936557388122" CI_START="0.09232121754031483" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.43263848530889243" LOG_CI_START="-1.0346984766368548" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2008-11-05 15:04:43 +0000" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="0.8619209948820367" STUDY_ID="STD-Ayah-2007" TOTAL_1="282" TOTAL_2="282" VAR="0.7429078014184398" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.02" MODIFIED="2010-09-08 10:25:28 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Maternal fever at 3 months postpartum</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Supplement</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.02.01" MODIFIED="2010-09-08 10:25:28 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2010-09-08 10:25:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Number of cumulative episodes;</P>
<P>(cumulative duration of illness in days)</P>
</TD>
<TD>
<P>10 (30);</P>
<P>n = 25</P>
</TD>
<TD>
<P>10 (28);</P>
<P>n = 25</P>
</TD>
<TD>
<P>Report states no significant difference</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.03" MODIFIED="2016-02-18 09:44:16 +0000" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Maternal respiratory tract infection at 3 months postpartum</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Supplement</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.03.01" MODIFIED="2016-02-18 09:44:16 +0000" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2016-02-15 12:34:29 +0000" MODIFIED_BY="Nancy  Medley" ORDER="3" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Number of cumulative episodes;</P>
<P>(cumulative duration of illness in days)</P>
</TD>
<TD>
<P>23 (82);</P>
<P>n = 25</P>
</TD>
<TD>
<P>25 (125); </P>
<P>n = 25</P>
</TD>
<TD>
<P>Report states no significant difference</P>
</TD>
</TR>
<TR>
<TD/>
<TD/>
<TD/>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.04" MODIFIED="2016-02-18 09:44:22 +0000" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Maternal diarrhoea at 3 months postpartum</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Vitamin A</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P value</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.04.01" MODIFIED="2016-02-18 09:44:22 +0000" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2010-09-08 10:18:55 +0100" MODIFIED_BY="[Empty name]" ORDER="4" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Number of cumulative episodes;</P>
<P>(cumulative duration of illness in days)</P>
</TD>
<TD>
<P>10 (27);</P>
<P>n = 25</P>
</TD>
<TD>
<P>2 (15);</P>
<P>n = 25</P>
</TD>
<TD>
<P>Report states no significant difference</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="3.636303361364991" CI_END="1.6910973496184352" CI_START="1.0703284012214827" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3453733766233769" ESTIMABLE="YES" EVENTS_1="153" EVENTS_2="112" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.22816860888998322" LOG_CI_START="0.029517049606825062" LOG_EFFECT_SIZE="0.12884282924840418" METHOD="MH" MODIFIED="2016-02-22 14:01:57 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.7257556828354297" P_Q="0.7261403496945782" P_Z="0.011008952360812112" Q="3.633435687719146" RANDOM="NO" SCALE="90.36" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2772" TOTAL_2="2730" WEIGHT="700.0" Z="2.542414526262675">
<NAME>Maternal adverse effects of supplementation</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.99493656459759" CI_START="0.7364834847119888" DF="0" EFFECT_SIZE="1.2121212121212122" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="26" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.29992909045723626" LOG_CI_START="-0.1328369875570864" LOG_EFFECT_SIZE="0.08354605145007492" MODIFIED="2016-02-18 09:45:37 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4492013566358757" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="100.0" Z="0.7567471676338642">
<NAME>Headache within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.99493656459759" CI_START="0.7364834847119888" EFFECT_SIZE="1.2121212121212122" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="26" LOG_CI_END="0.29992909045723626" LOG_CI_START="-0.1328369875570864" LOG_EFFECT_SIZE="0.08354605145007492" ORDER="144" O_E="0.0" SE="0.2542089364522486" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.06462218337218337" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.821420350775209" CI_START="0.3949676526426261" DF="0" EFFECT_SIZE="1.6414141414141414" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.8338748125273762" LOG_CI_START="-0.40343847109268954" LOG_EFFECT_SIZE="0.21521817071734328" MODIFIED="2016-02-18 09:45:44 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4953452246383804" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="99.99999999999999" Z="0.6818319483169978">
<NAME>Blurred vision within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="6.821420350775209" CI_START="0.3949676526426261" EFFECT_SIZE="1.6414141414141414" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8338748125273762" LOG_CI_START="-0.40343847109268954" LOG_EFFECT_SIZE="0.21521817071734328" ORDER="145" O_E="0.0" SE="0.7268039475979601" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.5282439782439783" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.792813516185084" CI_START="0.9138316166183191" DF="0" EFFECT_SIZE="2.0928030303030303" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="0.6805905313353384" LOG_CI_START="-0.039133820360703994" LOG_EFFECT_SIZE="0.32072835548731726" MODIFIED="2016-02-18 09:50:05 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.08066780458412216" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="100.0" Z="1.7468243893500535">
<NAME>Drowsiness within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="4.792813516185084" CI_START="0.9138316166183191" EFFECT_SIZE="2.0928030303030303" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" LOG_CI_END="0.6805905313353384" LOG_CI_START="-0.039133820360703994" LOG_EFFECT_SIZE="0.32072835548731726" ORDER="146" O_E="0.0" SE="0.4227696468792546" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.17873417432240965" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.307219543165568" CI_START="0.4413650141676334" DF="0" EFFECT_SIZE="1.378787878787879" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-001.05.04" LOG_CI_END="0.6341970087385359" LOG_CI_START="-0.355202095180086" LOG_EFFECT_SIZE="0.13949745677922495" MODIFIED="2016-02-18 09:50:10 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5804833246183394" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="100.0" Z="0.5526788737514395">
<NAME>Nausea within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="4.307219543165568" CI_START="0.4413650141676334" EFFECT_SIZE="1.378787878787879" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6341970087385359" LOG_CI_START="-0.355202095180086" LOG_EFFECT_SIZE="0.13949745677922495" ORDER="147" O_E="0.0" SE="0.5811779312463505" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.33776778776778776" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.1423417322348577" CI_START="0.034295956496344" DF="0" EFFECT_SIZE="0.3282828282828283" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.05.05" LOG_CI_END="0.49725341315258864" LOG_CI_START="-1.4647570803899397" LOG_EFFECT_SIZE="-0.4837518336186755" MODIFIED="2016-02-18 09:50:15 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.33379681205535916" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="99.99999999999999" Z="0.9664944957923234">
<NAME>Vomiting within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="3.1423417322348577" CI_START="0.034295956496344" EFFECT_SIZE="0.3282828282828283" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49725341315258864" LOG_CI_START="-1.4647570803899397" LOG_EFFECT_SIZE="-0.4837518336186755" ORDER="148" O_E="0.0" SE="1.152494676015459" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="1.328243978243978" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.135807399231988" CI_START="0.6881145782749172" DF="0" EFFECT_SIZE="2.215909090909091" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="0.0" ID="CMP-001.05.06" LOG_CI_END="0.8534431195940232" LOG_CI_START="-0.16233924116932447" LOG_EFFECT_SIZE="0.3455519392123494" MODIFIED="2016-02-18 09:50:20 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.18237005704461065" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="100.0" Z="1.3334930430081882">
<NAME>Poor appetite within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="7.135807399231988" CI_START="0.6881145782749172" EFFECT_SIZE="2.215909090909091" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.8534431195940232" LOG_CI_START="-0.16233924116932447" LOG_EFFECT_SIZE="0.3455519392123494" ORDER="149" O_E="0.0" SE="0.5966755869161701" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.356021756021756" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7253383403203075" CI_START="0.9523819915116652" DF="0" EFFECT_SIZE="1.2818662818662818" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="63" I2="0.0" ID="CMP-001.05.07" LOG_CI_END="0.23687427327926897" LOG_CI_START="-0.021188825217025278" LOG_EFFECT_SIZE="0.10784272403112187" MODIFIED="2016-02-18 09:50:25 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.10139877524237229" STUDIES="1" TAU2="0.0" TOTAL_1="396" TOTAL_2="390" WEIGHT="100.0" Z="1.638109875664585">
<NAME>Abdominal pain within 30 hours of dosing: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.7253383403203075" CI_START="0.9523819915116652" EFFECT_SIZE="1.2818662818662818" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="63" LOG_CI_END="0.23687427327926897" LOG_CI_START="-0.021188825217025278" LOG_EFFECT_SIZE="0.10784272403112187" ORDER="150" O_E="0.0" SE="0.15158754148966297" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="396" TOTAL_2="390" VAR="0.022978782734880295" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.128763341139562" CI_END="0.11786999672884527" CI_START="0.04138063593397226" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="MD" EFFECT_SIZE="0.07962531633140876" ESTIMABLE="YES" I2="23.83136370000245" I2_Q="53.1706358275113" ID="CMP-001.06" MODIFIED="2016-02-25 14:21:27 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.21656150604340318" P_Q="0.09343467349632129" P_Z="4.4911971484336306E-5" Q="6.40623688365694" RANDOM="YES" SCALE="0.51" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0010987701833855951" TOTALS="SUB" TOTAL_1="766" TOTAL_2="696" UNITS="" WEIGHT="400.0" Z="4.080639467904427">
<NAME>Maternal serum retinol (mcmol/L) at 3 - 3.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.533890389820395" CI_END="0.19211039456347087" CI_START="0.03021100304609642" DF="4" EFFECT_SIZE="0.11116069880478364" ESTIMABLE="YES" I2="38.78072998849384" ID="CMP-001.06.01" MODIFIED="2016-02-18 09:50:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1626675725236666" P_Z="0.007114503996805843" STUDIES="5" TAU2="0.0032125832944388108" TOTAL_1="365" TOTAL_2="339" WEIGHT="100.0" Z="2.691436504013043">
<NAME>200,000 - 400,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.09046673635734857" CI_START="-0.010466736357348502" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.05" MEAN_2="1.01" MODIFIED="2010-07-30 02:35:55 +0100" MODIFIED_BY="[Empty name]" ORDER="507" SD_1="0.22" SD_2="0.29" SE="0.025748808016587913" STUDY_ID="STD-Ayah-2007" TOTAL_1="205" TOTAL_2="197" WEIGHT="44.01463042042233"/>
<CONT_DATA CI_END="0.3060895135655889" CI_START="-0.006089513565589094" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.17" MEAN_2="1.02" MODIFIED="2016-02-03 11:48:24 +0000" MODIFIED_BY="[Empty name]" ORDER="272" SD_1="0.34" SD_2="0.28" SE="0.07963897030598682" STUDY_ID="STD-Martins-2010" TOTAL_1="31" TOTAL_2="30" WEIGHT="17.85278157432625"/>
<CONT_DATA CI_END="0.3702088734817733" CI_START="-0.1302088734817735" EFFECT_SIZE="0.11999999999999988" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" MODIFIED="2016-02-12 05:14:49 +0000" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="0.47" SD_2="0.42" SE="0.12765993429235897" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="34" TOTAL_2="18" WEIGHT="8.743492801212838"/>
<CONT_DATA CI_END="0.4762009965985498" CI_START="0.04379900340145021" EFFECT_SIZE="0.26" ESTIMABLE="YES" MEAN_1="1.59" MEAN_2="1.33" MODIFIED="2010-07-30 02:33:42 +0100" MODIFIED_BY="[Empty name]" ORDER="505" SD_1="0.39" SD_2="0.39" SE="0.11030865786510143" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.090763734192818"/>
<CONT_DATA CI_END="0.3031998692170338" CI_START="-0.0031998692170339404" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.39" MEAN_2="1.24" MODIFIED="2010-07-30 02:33:42 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SD_1="0.49" SD_2="0.43" SE="0.07816463487362771" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="70" TOTAL_2="69" WEIGHT="18.29833146984576"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.938147594877376" CI_END="0.2563882502647007" CI_START="0.07458391097552845" DF="3" EFFECT_SIZE="0.16548608062011458" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.02" MODIFIED="2016-02-18 09:50:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8162135137672966" P_Z="3.5959849929189215E-4" STUDIES="4" TAU2="0.0" TOTAL_1="160" TOTAL_2="142" WEIGHT="100.0" Z="3.5680859898753097">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.3060895135655889" CI_START="-0.006089513565589094" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.17" MEAN_2="1.02" MODIFIED="2016-02-10 11:42:57 +0000" MODIFIED_BY="[Empty name]" ORDER="273" SD_1="0.34" SD_2="0.28" SE="0.07963897030598682" STUDY_ID="STD-Martins-2010" TOTAL_1="31" TOTAL_2="30" WEIGHT="33.91572019788336"/>
<CONT_DATA CI_END="0.3702088734817733" CI_START="-0.1302088734817735" EFFECT_SIZE="0.11999999999999988" ESTIMABLE="YES" MEAN_1="1.45" MEAN_2="1.33" MODIFIED="2016-02-12 05:16:09 +0000" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="0.47" SD_2="0.42" SE="0.12765993429235897" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="34" TOTAL_2="18" WEIGHT="13.199062427139701"/>
<CONT_DATA CI_END="0.4762009965985498" CI_START="0.04379900340145021" EFFECT_SIZE="0.26" ESTIMABLE="YES" MEAN_1="1.59" MEAN_2="1.33" MODIFIED="2016-02-11 12:51:21 +0000" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="0.39" SD_2="0.39" SE="0.11030865786510143" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="17.677999407505958"/>
<CONT_DATA CI_END="0.3031998692170338" CI_START="-0.0031998692170339404" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.39" MEAN_2="1.24" ORDER="154" SD_1="0.49" SD_2="0.43" SE="0.07816463487362771" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="70" TOTAL_2="69" WEIGHT="35.20721796747099"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.09046673635734857" CI_START="-0.010466736357348502" DF="0" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.03" MODIFIED="2016-02-25 14:20:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.12031089828456977" STUDIES="1" TAU2="0.0" TOTAL_1="205" TOTAL_2="197" WEIGHT="100.0" Z="1.5534699693372684">
<NAME>400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.09046673635734857" CI_START="-0.010466736357348502" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.05" MEAN_2="1.01" MODIFIED="2016-02-25 14:20:49 +0000" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="0.22" SD_2="0.29" SE="0.025748808016587913" STUDY_ID="STD-Ayah-2007" TOTAL_1="205" TOTAL_2="197" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.33953383012561134" CI_START="-0.13953383012561163" DF="0" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.04" MODIFIED="2016-02-25 14:21:27 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.4132196011207385" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="18" WEIGHT="100.0" Z="0.8182409906409658">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.33953383012561134" CI_START="-0.13953383012561163" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.43" MEAN_2="1.33" MODIFIED="2016-02-25 14:21:26 +0000" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="0.43" SD_2="0.42" SE="0.12221338351879105" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="36" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.984806501130993" CI_END="0.0663909733325456" CI_START="-0.02409163827461892" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="0.02114966752896334" ESTIMABLE="YES" I2="49.952475186772105" I2_Q="54.98922107570511" ID="CMP-001.07" MODIFIED="2016-02-22 16:26:44 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.042598123311745284" P_Q="0.08337503186900508" P_Z="0.3595330126543379" Q="6.665070171404496" RANDOM="YES" SCALE="0.97" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.003585834160788503" TOTALS="SUB" TOTAL_1="582" TOTAL_2="534" UNITS="" WEIGHT="400.0" Z="0.9162553092904344">
<NAME>Maternal serum retinol (mcmol/L) at 6 - 6.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.970574472503636" CI_END="0.17792813033883473" CI_START="-0.06474621718782966" DF="3" EFFECT_SIZE="0.05659095657550253" ESTIMABLE="YES" I2="62.361558626053835" ID="CMP-001.07.01" MODIFIED="2016-02-18 09:50:58 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04662388111970772" P_Z="0.36065597232854707" STUDIES="4" TAU2="0.008278691351586348" TOTAL_1="275" TOTAL_2="258" WEIGHT="100.0" Z="0.9141158747853887">
<NAME>200,000 - 400,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.036298903588739856" CI_START="-0.07629890358873989" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="0.98" MODIFIED="2016-02-08 13:00:42 +0000" MODIFIED_BY="[Empty name]" ORDER="511" SD_1="0.25" SD_2="0.24" SE="0.028724458221078775" STUDY_ID="STD-Ayah-2007" TOTAL_1="148" TOTAL_2="143" WEIGHT="42.09878234675742"/>
<CONT_DATA CI_END="0.23770733526653376" CI_START="-0.33770733526653385" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.47" MEAN_2="1.52" MODIFIED="2016-02-12 05:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="508" SD_1="0.38" SD_2="0.56" SE="0.1467921541089186" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="35" TOTAL_2="18" WEIGHT="12.849535016377569"/>
<CONT_DATA CI_END="0.46754749113254374" CI_START="-0.10754749113254386" EFFECT_SIZE="0.17999999999999994" ESTIMABLE="YES" MEAN_1="1.54" MEAN_2="1.36" MODIFIED="2010-07-30 05:08:35 +0100" MODIFIED_BY="[Empty name]" ORDER="509" SD_1="0.65" SD_2="0.34" SE="0.14671059948074644" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="12.859855325817797"/>
<CONT_DATA CI_END="0.26803413474349846" CI_START="0.03196586525650137" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.23" MEAN_2="1.08" MODIFIED="2010-07-30 05:08:35 +0100" MODIFIED_BY="[Empty name]" ORDER="510" SD_1="0.34" SD_2="0.37" SE="0.06022260392259079" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="67" TOTAL_2="72" WEIGHT="32.19182731104722"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7293427634555671" CI_END="0.23068786804554023" CI_START="0.02651275834819003" DF="2" EFFECT_SIZE="0.12860031319686513" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" MODIFIED="2016-02-18 09:51:02 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42119028360924005" P_Z="0.013549934361548402" STUDIES="3" TAU2="0.0" TOTAL_1="127" TOTAL_2="115" WEIGHT="100.0" Z="2.4689785414103085">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.23770733526653376" CI_START="-0.33770733526653385" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.47" MEAN_2="1.52" MODIFIED="2016-02-12 05:24:18 +0000" MODIFIED_BY="[Empty name]" ORDER="158" SD_1="0.38" SD_2="0.56" SE="0.1467921541089186" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="35" TOTAL_2="18" WEIGHT="12.590521953312622"/>
<CONT_DATA CI_END="0.46754749113254374" CI_START="-0.10754749113254386" EFFECT_SIZE="0.17999999999999994" ESTIMABLE="YES" MEAN_1="1.54" MEAN_2="1.36" MODIFIED="2007-12-13 04:36:22 +0000" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="0.65" SD_2="0.34" SE="0.14671059948074644" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="12.604523678301483"/>
<CONT_DATA CI_END="0.26803413474349846" CI_START="0.03196586525650137" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.23" MEAN_2="1.08" ORDER="160" SD_1="0.34" SD_2="0.37" SE="0.06022260392259079" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="67" TOTAL_2="72" WEIGHT="74.80495436838589"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.036298903588739856" CI_START="-0.07629890358873989" DF="0" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.03" MODIFIED="2016-02-22 16:26:44 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.48625929383405464" STUDIES="1" TAU2="0.0" TOTAL_1="148" TOTAL_2="143" WEIGHT="100.0" Z="0.6962707476001578">
<NAME>400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.036298903588739856" CI_START="-0.07629890358873989" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="0.98" MODIFIED="2016-02-22 16:26:44 +0000" MODIFIED_BY="[Empty name]" ORDER="161" SD_1="0.25" SD_2="0.24" SE="0.028724458221078775" STUDY_ID="STD-Ayah-2007" TOTAL_1="148" TOTAL_2="143" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.37971899924862096" CI_START="-0.27971899924862087" DF="0" EFFECT_SIZE="0.050000000000000044" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.04" MODIFIED="2016-02-22 16:26:42 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.7663005955426191" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="18" WEIGHT="100.0" Z="0.29721732581478677">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.37971899924862096" CI_START="-0.27971899924862087" EFFECT_SIZE="0.050000000000000044" ESTIMABLE="YES" MEAN_1="1.57" MEAN_2="1.52" MODIFIED="2016-02-22 16:26:42 +0000" MODIFIED_BY="[Empty name]" ORDER="162" SD_1="0.59" SD_2="0.56" SE="0.16822707042037624" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="32" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.291229103322127" CI_END="0.19473686982667945" CI_START="-0.08715880393541334" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="0.05378903294563306" ESTIMABLE="YES" I2="12.710605975625239" I2_Q="25.6410736745449" ID="CMP-001.08" MODIFIED="2016-02-18 09:51:50 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.31802879335528644" P_Q="0.24618440980883727" P_Z="0.4544790559544756" Q="1.3448284549230676" RANDOM="YES" SCALE="0.4806008897938535" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.002342365371893132" TOTALS="SUB" TOTAL_1="92" TOTAL_2="57" UNITS="" WEIGHT="200.0" Z="0.7479686788357937">
<NAME>Maternal serum retinol (mcmol/L) at 9 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9464006483990592" CI_END="0.16799693988479777" CI_START="-0.1625376162829084" DF="1" EFFECT_SIZE="0.002729661800944682" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" MODIFIED="2016-02-18 09:51:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33063734836035275" P_Z="0.9741753602076553" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="41" WEIGHT="100.0" Z="0.03237203929208433">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.3820663699380169" CI_START="-0.16206636993801715" EFFECT_SIZE="0.10999999999999988" ESTIMABLE="YES" MEAN_1="1.47" MEAN_2="1.36" MODIFIED="2016-02-12 05:25:32 +0000" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="0.46" SD_2="0.45" SE="0.1388119231190174" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="32" TOTAL_2="16" WEIGHT="36.89980105937927"/>
<CONT_DATA CI_END="0.14805181564115558" CI_START="-0.26805181564115566" EFFECT_SIZE="-0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.29" MEAN_2="1.35" MODIFIED="2007-12-13 04:34:38 +0000" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="0.39" SD_2="0.36" SE="0.1061508360777248" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="63.10019894062072"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.45993250296380617" CI_START="-0.07993250296380627" DF="0" EFFECT_SIZE="0.18999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" MODIFIED="2016-02-18 09:51:50 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.1677163702292156" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="16" WEIGHT="100.0" Z="1.3795787946016356">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.45993250296380617" CI_START="-0.07993250296380627" EFFECT_SIZE="0.18999999999999995" ESTIMABLE="YES" MEAN_1="1.55" MEAN_2="1.36" MODIFIED="2016-02-12 05:25:36 +0000" MODIFIED_BY="[Empty name]" ORDER="165" SD_1="0.47" SD_2="0.45" SE="0.13772319547348796" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="35" TOTAL_2="16" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.227086945348706" CI_END="1.206400081718309" CI_START="0.4289041050094751" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7193260368794869" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="26" I2="52.68609267191182" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.08149135794364432" LOG_CI_START="-0.36763979714066164" LOG_EFFECT_SIZE="-0.14307421959850863" METHOD="MH" MODIFIED="2016-03-03 21:02:49 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.12080918041962141" P_Q="0.7215715918173071" P_Z="0.21176624094772223" Q="0.1269919389592802" RANDOM="YES" SCALE="73.36" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.18270418327492408" TOTALS="SUB" TOTAL_1="140" TOTAL_2="105" WEIGHT="200.0" Z="1.2487235158585885">
<NAME>Maternal low hepatic vitamin A reserves 3 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.6661632966502573" CI_END="2.0807380791478307" CI_START="0.16284807533767492" DF="1" EFFECT_SIZE="0.5821032481192961" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="72.72352813870316" ID="CMP-001.09.01" LOG_CI_END="0.31821741517563507" LOG_CI_START="-0.788217369891044" LOG_EFFECT_SIZE="-0.23499997735770453" MODIFIED="2016-03-03 19:32:55 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05552807825498551" P_Z="0.4050880189716627" STUDIES="2" TAU2="0.6164765269650821" TOTAL_1="104" TOTAL_2="87" WEIGHT="100.0" Z="0.8325687120566652">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="0.7324530037075454" CI_START="0.1377558061315918" EFFECT_SIZE="0.3176470588235294" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="-0.13522023566362562" LOG_CI_START="-0.8608900874469854" LOG_EFFECT_SIZE="-0.49805516155530544" MODIFIED="2016-02-12 05:27:11 +0000" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.4262620630612449" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="34" TOTAL_2="18" VAR="0.18169934640522875" WEIGHT="52.92102533697315"/>
<DICH_DATA CI_END="3.248706275307824" CI_START="0.407085124947065" EFFECT_SIZE="1.15" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5117104473315932" LOG_CI_START="-0.3903147666243699" LOG_EFFECT_SIZE="0.06069784035361165" MODIFIED="2016-03-03 19:18:32 +0000" MODIFIED_BY="[Empty name]" ORDER="210" O_E="0.0" SE="0.529854075774554" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="70" TOTAL_2="69" VAR="0.28074534161490683" WEIGHT="47.07897466302684"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3206325080361108" CI_START="0.42593226849798194" DF="0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="10" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.12078198344656103" LOG_CI_START="-0.3706594566631609" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2016-02-18 10:25:50 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3189781762054468" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="18" WEIGHT="99.99999999999999" Z="0.9965599318263906">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.3206325080361108" CI_START="0.42593226849798194" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="10" LOG_CI_END="0.12078198344656103" LOG_CI_START="-0.3706594566631609" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2016-02-12 05:27:15 +0000" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.2886751345948129" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="36" TOTAL_2="18" VAR="0.08333333333333334" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.326815900177603" CI_END="1.491516207970042" CI_START="0.44492962383398527" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8146285935040598" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.1736279771038516" LOG_CI_START="-0.3517086775530892" LOG_EFFECT_SIZE="-0.08904035022461886" METHOD="MH" MODIFIED="2016-03-03 21:02:24 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.5150929667453332" P_Q="0.341051006128008" P_Z="0.5064366685270938" Q="0.9064770971541074" RANDOM="YES" SCALE="10.45" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="134" TOTAL_2="108" WEIGHT="200.0" Z="0.6643963563709426">
<NAME>Maternal low hepatic vitamin A reserves 6 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4247506267392577" CI_END="2.225729537147796" CI_START="0.4752234224159494" DF="1" EFFECT_SIZE="1.0284545726553227" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.3474723892616371" LOG_CI_START="-0.32310216235490274" LOG_EFFECT_SIZE="0.012185113453367166" MODIFIED="2016-03-03 19:33:08 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5145760609337124" P_Z="0.9432150120384617" STUDIES="2" TAU2="0.0" TOTAL_1="102" TOTAL_2="90" WEIGHT="100.0" Z="0.07122961483868254">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="2.1327863272978544" CI_START="0.41681605909534886" EFFECT_SIZE="0.9428571428571428" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.3289473479371284" LOG_CI_START="-0.3800555568819048" LOG_EFFECT_SIZE="-0.025554104472388168" MODIFIED="2016-02-12 05:27:57 +0000" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.4164718159116814" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="35" TOTAL_2="18" VAR="0.17344877344877344" WEIGHT="89.45365841201827"/>
<DICH_DATA CI_END="23.15958958145973" CI_START="0.1994548126790197" EFFECT_SIZE="2.1492537313432836" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3647308588513118" LOG_CI_START="-0.7001554800624655" LOG_EFFECT_SIZE="0.3322876893944232" MODIFIED="2016-03-03 19:18:53 +0000" MODIFIED_BY="[Empty name]" ORDER="211" O_E="0.0" SE="1.2129244568301782" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="67" TOTAL_2="72" VAR="1.4711857379767828" WEIGHT="10.546341587981722"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.999822638724723E-32" CI_END="1.4885293533433566" CI_START="0.2125629899667925" DF="0" EFFECT_SIZE="0.5625" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" I2="100.0" ID="CMP-001.10.02" LOG_CI_END="0.17275740322147454" LOG_CI_START="-0.6725123496546743" LOG_EFFECT_SIZE="-0.2498774732165999" MODIFIED="2016-02-18 10:26:07 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.2465362390492456" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="18" WEIGHT="100.0" Z="1.1588036751249216">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.4885293533433566" CI_START="0.21256298996679254" EFFECT_SIZE="0.5625" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.17275740322147454" LOG_CI_START="-0.6725123496546742" LOG_EFFECT_SIZE="-0.2498774732165999" MODIFIED="2016-02-12 05:28:00 +0000" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.4965156369922077" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="32" TOTAL_2="18" VAR="0.24652777777777776" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.02485287957787384" CI_END="1.07316248302859" CI_START="0.35233286514066076" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6149068322981367" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.03066548164949079" LOG_CI_START="-0.4530468445180903" LOG_EFFECT_SIZE="-0.21119068143429975" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.8747342269594971" P_Q="0.8747342360268409" P_Z="0.0869970066729406" Q="0.02485287594997196" RANDOM="NO" SCALE="59.82" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="67" TOTAL_2="32" WEIGHT="200.0" Z="1.7114557851407552">
<NAME>Maternal low hepatic vitamin A reserves 9 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4087282847613949" CI_START="0.2933605512098072" DF="0" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.1488272345512448" LOG_CI_START="-0.5325982870290711" LOG_EFFECT_SIZE="-0.1918855262389131" MODIFIED="2016-02-18 10:26:22 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.26966721952837447" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="100.0" Z="1.103829277513956">
<NAME>200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.4087282847613949" CI_START="0.2933605512098072" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.1488272345512448" LOG_CI_START="-0.5325982870290711" LOG_EFFECT_SIZE="-0.1918855262389131" MODIFIED="2016-02-12 05:28:59 +0000" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.4002727244870102" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="32" TOTAL_2="16" VAR="0.16021825396825395" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.296419117411134" CI_START="0.26646942746791963" DF="0" EFFECT_SIZE="0.5877551020408164" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.11274542665278817" LOG_CI_START="-0.5743526111913536" LOG_EFFECT_SIZE="-0.23080359226928276" MODIFIED="2016-02-18 10:26:26 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.18792384541816315" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="16" WEIGHT="99.99999999999999" Z="1.316745801718835">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.296419117411134" CI_START="0.26646942746791963" EFFECT_SIZE="0.5877551020408164" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.11274542665278817" LOG_CI_START="-0.5743526111913536" LOG_EFFECT_SIZE="-0.23080359226928276" MODIFIED="2016-02-12 05:29:01 +0000" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.40360478861979" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="35" TOTAL_2="16" VAR="0.16289682539682537" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="24.732805884672732" CI_END="0.15230817963472307" CI_START="0.06941872879680677" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="MD" EFFECT_SIZE="0.11086345421576492" ESTIMABLE="YES" I2="51.481445105924806" I2_Q="67.24150224833434" ID="CMP-001.12" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.016141035982522367" P_Q="0.027263222153778854" P_Z="1.5811717021063461E-7" Q="9.157929105120397" RANDOM="YES" SCALE="0.37" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.004306269977756412" TOTALS="SUB" TOTAL_1="951" TOTAL_2="832" UNITS="" WEIGHT="400.0" Z="5.242847558237406">
<NAME>Maternal breast milk retinol (mcmol/L) at 3 - 3.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="11.929672136281447" CI_END="0.3113178880368102" CI_START="0.08154845754772465" DF="5" EFFECT_SIZE="0.19643317279226744" ESTIMABLE="YES" I2="58.08769978854984" ID="CMP-001.12.01" MODIFIED="2016-03-03 17:46:29 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.03576429109188661" P_Z="8.046144365015846E-4" STUDIES="6" TAU2="0.009024741374534101" TOTAL_1="439" TOTAL_2="398" WEIGHT="99.99999999999999" Z="3.3512024921876256">
<NAME>200,000 - 400,000 IU versus placebo no treatment</NAME>
<CONT_DATA CI_END="0.12917190936974318" CI_START="0.030828090630256842" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" MEAN_1="0.52" MEAN_2="0.44" MODIFIED="2016-03-03 17:46:26 +0000" MODIFIED_BY="[Empty name]" ORDER="469" SD_1="0.23" SD_2="0.28" SE="0.025088169863122445" STUDY_ID="STD-Ayah-2007" TOTAL_1="221" TOTAL_2="201" WEIGHT="35.588848482044135"/>
<CONT_DATA CI_END="0.5964150429120287" CI_START="-0.15641504291202885" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.56" MEAN_2="1.34" MODIFIED="2016-02-29 14:12:17 +0000" MODIFIED_BY="[Empty name]" ORDER="276" SD_1="0.57" SD_2="0.89" SE="0.19205202028258817" STUDY_ID="STD-Martins-2010" TOTAL_1="31" TOTAL_2="30" WEIGHT="7.483988978747963"/>
<CONT_DATA CI_END="0.6445969329285868" CI_START="0.09540306707141327" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="0.83" MODIFIED="2016-02-29 14:12:19 +0000" MODIFIED_BY="[Empty name]" ORDER="465" SD_1="1.0" SD_2="0.43" SE="0.14010305041040155" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="36" WEIGHT="11.990824199376494"/>
<CONT_DATA CI_END="0.5083212945306345" CI_START="-0.06832129453063451" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.34" MEAN_2="1.12" MODIFIED="2016-02-29 14:12:21 +0000" MODIFIED_BY="[Empty name]" ORDER="467" SD_1="0.53" SD_2="0.51" SE="0.14710540438746633" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.204410607373806"/>
<CONT_DATA CI_END="1.0848162705020248" CI_START="0.1751837294979755" EFFECT_SIZE="0.6300000000000001" ESTIMABLE="YES" MEAN_1="2.45" MEAN_2="1.82" MODIFIED="2016-03-03 17:46:29 +0000" MODIFIED_BY="[Empty name]" ORDER="466" SD_1="1.23" SD_2="1.28" SE="0.23205338163841646" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="57" TOTAL_2="60" WEIGHT="5.464627877020288"/>
<CONT_DATA CI_END="0.279652088584996" CI_START="0.06034791141500406" EFFECT_SIZE="0.17000000000000004" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.92" MODIFIED="2016-02-29 14:12:35 +0000" MODIFIED_BY="[Empty name]" ORDER="468" SD_1="0.26" SD_2="0.24" SE="0.05594597117595918" STUDY_ID="STD-Vinutha-2000" TOTAL_1="36" TOTAL_2="46" WEIGHT="28.267299855437305"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.065592765426958" CI_END="0.37141496839997534" CI_START="0.12292796213969767" DF="4" EFFECT_SIZE="0.2471714652698365" ESTIMABLE="YES" I2="21.03589480583016" ID="CMP-001.12.02" MODIFIED="2016-02-18 10:26:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2806333240679818" P_Z="9.65209697664743E-5" STUDIES="5" TAU2="0.004653678819519929" TOTAL_1="218" TOTAL_2="197" WEIGHT="99.99999999999999" Z="3.899175069359066">
<NAME>200,000 - 300,000 IU versus placebo no treatment</NAME>
<CONT_DATA CI_END="0.5964150429120287" CI_START="-0.15641504291202885" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.56" MEAN_2="1.34" MODIFIED="2016-02-03 17:13:34 +0000" MODIFIED_BY="[Empty name]" ORDER="271" SD_1="0.57" SD_2="0.89" SE="0.19205202028258817" STUDY_ID="STD-Martins-2010" TOTAL_1="31" TOTAL_2="30" WEIGHT="9.67406932230345"/>
<CONT_DATA CI_END="0.6445969329285868" CI_START="0.09540306707141327" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="0.83" MODIFIED="2016-02-12 05:30:28 +0000" MODIFIED_BY="[Empty name]" ORDER="172" SD_1="1.0" SD_2="0.43" SE="0.14010305041040155" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="36" WEIGHT="16.54843840607069"/>
<CONT_DATA CI_END="0.5083212945306345" CI_START="-0.06832129453063451" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.34" MEAN_2="1.12" MODIFIED="2016-02-11 12:55:17 +0000" MODIFIED_BY="[Empty name]" ORDER="173" SD_1="0.53" SD_2="0.51" SE="0.14710540438746633" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="15.282691292509172"/>
<CONT_DATA CI_END="1.0848162705020248" CI_START="0.1751837294979755" EFFECT_SIZE="0.6300000000000001" ESTIMABLE="YES" MEAN_1="2.45" MEAN_2="1.82" MODIFIED="2016-02-11 12:55:17 +0000" MODIFIED_BY="[Empty name]" ORDER="174" SD_1="1.23" SD_2="1.28" SE="0.23205338163841646" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="57" TOTAL_2="60" WEIGHT="6.8687409022366905"/>
<CONT_DATA CI_END="0.279652088584996" CI_START="0.06034791141500406" EFFECT_SIZE="0.17000000000000004" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.92" MODIFIED="2016-02-11 12:55:17 +0000" MODIFIED_BY="[Empty name]" ORDER="175" SD_1="0.26" SD_2="0.24" SE="0.05594597117595918" STUDY_ID="STD-Vinutha-2000" TOTAL_1="36" TOTAL_2="46" WEIGHT="51.62606007687999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.12917190936974318" CI_START="0.030828090630256842" DF="0" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.03" MODIFIED="2016-02-23 12:15:39 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0014288745696274972" STUDIES="1" TAU2="0.0" TOTAL_1="221" TOTAL_2="201" WEIGHT="100.0" Z="3.1887539201332284">
<NAME>400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.12917190936974318" CI_START="0.030828090630256842" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" MEAN_1="0.52" MEAN_2="0.44" MODIFIED="2016-02-23 12:15:39 +0000" MODIFIED_BY="[Empty name]" ORDER="178" SD_1="0.23" SD_2="0.28" SE="0.025088169863122445" STUDY_ID="STD-Ayah-2007" TOTAL_1="221" TOTAL_2="201" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.2971046608150974E-33" CI_END="0.2088081915916693" CI_START="-0.16880819159166927" DF="0" EFFECT_SIZE="0.02000000000000002" ESTIMABLE="YES" I2="100.0" ID="CMP-001.12.04" MODIFIED="2016-02-23 12:15:41 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.8355301414773977" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="36" WEIGHT="100.0" Z="0.20761429554696664">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.2088081915916693" CI_START="-0.16880819159166927" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.83" MODIFIED="2016-02-23 12:15:41 +0000" MODIFIED_BY="[Empty name]" ORDER="177" SD_1="0.55" SD_2="0.43" SE="0.09633248012767795" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="73" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="29.88499353738311" CI_END="0.12231372633529741" CI_START="0.02679077044585202" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="0.07455224839057471" ESTIMABLE="YES" I2="73.23071196253461" I2_Q="13.200457801164225" ID="CMP-001.13" MODIFIED="2016-03-06 01:59:34 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="2.215049891314269E-4" P_Q="0.32648233923898917" P_Z="0.002218078483925501" Q="3.4562394270787276" RANDOM="YES" SCALE="1.59" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.010271958323655217" TOTALS="SUB" TOTAL_1="759" TOTAL_2="635" UNITS="" WEIGHT="399.99999999999994" Z="3.0593634891517394">
<NAME>Maternal breast milk retinol (mcmol/L) at 6 - 6.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="14.89712932335231" CI_END="0.4096778718109704" CI_START="-0.0085654178207768" DF="3" EFFECT_SIZE="0.2005562269950968" ESTIMABLE="YES" I2="79.86189194654244" ID="CMP-001.13.01" MODIFIED="2016-03-03 17:49:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0019067063765504377" P_Z="0.060150914890434615" STUDIES="4" TAU2="0.033377106510198255" TOTAL_1="345" TOTAL_2="300" WEIGHT="99.99999999999999" Z="1.8796857787328964">
<NAME>200,000 - 400,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.11067549108722241" CI_START="0.009324508912777592" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.44" MODIFIED="2016-03-03 17:49:18 +0000" MODIFIED_BY="[Empty name]" ORDER="473" SD_1="0.21" SD_2="0.27" SE="0.02585531748896623" STUDY_ID="STD-Ayah-2007" TOTAL_1="184" TOTAL_2="170" WEIGHT="33.438034956893546"/>
<CONT_DATA CI_END="0.21718225171776204" CI_START="-0.2571822517177621" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.87" MODIFIED="2016-03-03 17:46:51 +0000" MODIFIED_BY="[Empty name]" ORDER="470" SD_1="0.53" SD_2="0.61" SE="0.1210135765700928" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="35" WEIGHT="23.706478349808275"/>
<CONT_DATA CI_END="0.5298778920621762" CI_START="0.13012210793782397" EFFECT_SIZE="0.33000000000000007" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="0.73" MODIFIED="2016-03-03 17:46:53 +0000" MODIFIED_BY="[Empty name]" ORDER="472" SD_1="0.46" SD_2="0.22" SE="0.10198039027185571" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="26.00487299982187"/>
<CONT_DATA CI_END="0.9523672757368302" CI_START="0.2276327242631695" EFFECT_SIZE="0.5899999999999999" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="1.77" MODIFIED="2016-03-03 17:49:17 +0000" MODIFIED_BY="[Empty name]" ORDER="471" SD_1="1.17" SD_2="0.97" SE="0.18488466043005747" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="66" TOTAL_2="70" WEIGHT="16.850613693476294"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.972009219157131" CI_END="0.5951033735644347" CI_START="-0.03630441629008169" DF="2" EFFECT_SIZE="0.27939947863717646" ESTIMABLE="YES" I2="77.70844912052054" ID="CMP-001.13.02" MODIFIED="2016-03-06 01:59:34 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.011265628285210494" P_Z="0.08281564370368093" STUDIES="3" TAU2="0.05935155570800502" TOTAL_1="161" TOTAL_2="130" WEIGHT="99.99999999999999" Z="1.7345776350155913">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.21718225171776204" CI_START="-0.2571822517177621" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.87" MODIFIED="2016-03-06 01:59:34 +0000" MODIFIED_BY="[Empty name]" ORDER="179" SD_1="0.53" SD_2="0.61" SE="0.1210135765700928" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="35" WEIGHT="35.06359043460917"/>
<CONT_DATA CI_END="0.5298778920621762" CI_START="0.13012210793782397" EFFECT_SIZE="0.33000000000000007" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="0.73" MODIFIED="2016-03-03 17:48:46 +0000" MODIFIED_BY="[Empty name]" ORDER="180" SD_1="0.46" SD_2="0.22" SE="0.10198039027185571" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="37.19716142757983"/>
<CONT_DATA CI_END="0.9523672757368302" CI_START="0.2276327242631695" EFFECT_SIZE="0.5899999999999999" ESTIMABLE="YES" MEAN_1="2.36" MEAN_2="1.77" MODIFIED="2016-03-03 17:48:48 +0000" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="1.17" SD_2="0.97" SE="0.18488466043005747" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="66" TOTAL_2="70" WEIGHT="27.739248137810996"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.11067549108722241" CI_START="0.009324508912777592" DF="0" EFFECT_SIZE="0.06" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.03" MODIFIED="2016-02-18 10:27:28 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.020308128307324994" STUDIES="1" TAU2="0.0" TOTAL_1="184" TOTAL_2="170" WEIGHT="99.99999999999999" Z="2.3206058106076255">
<NAME>400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.11067549108722241" CI_START="0.009324508912777592" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.44" MODIFIED="2016-02-08 13:03:34 +0000" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="0.21" SD_2="0.27" SE="0.02585531748896623" STUDY_ID="STD-Ayah-2007" TOTAL_1="184" TOTAL_2="170" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1886663861481346E-32" CI_END="0.36948149796266866" CI_START="-0.12948149796266867" DF="0" EFFECT_SIZE="0.11999999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-001.13.04" MODIFIED="2016-02-18 10:27:32 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.3458149638710043" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0" Z="0.9427379587884315">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.36948149796266866" CI_START="-0.12948149796266867" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.99" MEAN_2="0.87" MODIFIED="2016-02-12 05:31:23 +0000" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="0.62" SD_2="0.61" SE="0.12728881751427418" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.592784695177938" CI_END="0.3594314175110486" CI_START="0.021955563060968575" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1906934902860086" ESTIMABLE="YES" I2="46.35945841815474" I2_Q="0.0" ID="CMP-001.14" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.1331933134511054" P_Q="0.7352776650087502" P_Z="0.026760933306246334" Q="0.11432077391360244" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.017147943678677034" TOTALS="SUB" TOTAL_1="222" TOTAL_2="156" UNITS="" WEIGHT="200.0" Z="2.2149873427587785">
<NAME>Maternal breast milk retinol (mcmol/L) at 8 - 9 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.320517227734606" CI_END="0.4520876913944989" CI_START="-0.15847768814184401" DF="2" EFFECT_SIZE="0.14680500162632745" ESTIMABLE="YES" I2="62.40966969199028" ID="CMP-001.14.01" MODIFIED="2016-03-03 17:47:20 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06993028586864247" P_Z="0.3459307201058961" STUDIES="3" TAU2="0.04526276984593271" TOTAL_1="152" TOTAL_2="123" WEIGHT="100.00000000000001" Z="0.9425117295594029">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.34425676889283396" CI_START="-0.10425676889283397" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.91" MEAN_2="0.79" MODIFIED="2016-03-03 17:47:15 +0000" MODIFIED_BY="[Empty name]" ORDER="186" SD_1="0.68" SD_2="0.44" SE="0.114418821295566" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="64" TOTAL_2="33" WEIGHT="41.575195224928514"/>
<CONT_DATA CI_END="0.23216784841583754" CI_START="-0.5321678484158379" EFFECT_SIZE="-0.15000000000000013" ESTIMABLE="YES" MEAN_1="0.94" MEAN_2="1.09" MODIFIED="2016-03-03 17:47:17 +0000" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="0.44" SD_2="0.87" SE="0.19498717906570165" STUDY_ID="STD-Roy-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="29.130840565703156"/>
<CONT_DATA CI_END="0.8598298919167198" CI_START="0.1001701080832802" EFFECT_SIZE="0.48" ESTIMABLE="YES" MEAN_1="2.04" MEAN_2="1.56" MODIFIED="2016-03-03 17:47:20 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="1.19" SD_2="0.99" SE="0.19379432219814727" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="63" TOTAL_2="65" WEIGHT="29.29396420936834"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.218370307358906E-32" CI_END="0.41247842341180896" CI_START="0.0075215765881910535" DF="0" EFFECT_SIZE="0.21" ESTIMABLE="YES" I2="100.0" ID="CMP-001.14.02" MODIFIED="2016-02-18 10:27:49 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.042075579682041245" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="33" WEIGHT="100.0" Z="2.0327718372060697">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.4124784234118089" CI_START="0.007521576588191026" EFFECT_SIZE="0.20999999999999996" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="0.79" MODIFIED="2016-02-12 05:33:47 +0000" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="0.58" SD_2="0.44" SE="0.10330721636159282" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="13.259574902838335" CI_END="1.0120296754473215" CI_START="0.6993256272992308" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8412718274301327" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="109" I2="77.37484027969991" I2_Q="79.5218366107433" ID="CMP-001.15" LOG_CI_END="0.005193247379337708" LOG_CI_START="-0.15532055642913056" LOG_EFFECT_SIZE="-0.07506365452489641" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.004107618636531085" P_Q="0.027118634337880754" P_Z="0.06678189792636748" Q="4.883250421395809" RANDOM="YES" SCALE="7.23" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10295694633963472" TOTALS="SUB" TOTAL_1="235" TOTAL_2="178" WEIGHT="200.0" Z="1.833139031360893">
<NAME>Maternal breast milk retinol (&lt; 1.05 mcmol/L) at 3 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.4030061988064" CI_END="0.8395498972312714" CI_START="0.37143957435472885" DF="2" EFFECT_SIZE="0.558428201720812" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="80" I2="54.57648911459233" ID="CMP-001.15.01" LOG_CI_END="-0.07595348719927611" LOG_CI_START="-0.4301118270144497" LOG_EFFECT_SIZE="-0.25303265710686285" MODIFIED="2016-03-03 17:47:35 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11063682857378876" P_Z="0.005100147912379692" STUDIES="3" TAU2="0.06985033788386327" TOTAL_1="162" TOTAL_2="142" WEIGHT="100.0" Z="2.800639369953791">
<NAME>200,000 - 300,000 IU versus placebo or no treatment</NAME>
<DICH_DATA CI_END="0.9117047552604605" CI_START="0.5399901256587237" EFFECT_SIZE="0.7016491754122939" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="29" LOG_CI_END="-0.04014578000571201" LOG_CI_START="-0.26761418167913775" LOG_EFFECT_SIZE="-0.1538799808424249" MODIFIED="2016-03-03 17:47:31 +0000" MODIFIED_BY="[Empty name]" ORDER="196" O_E="0.0" SE="0.13361606512971824" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="36" VAR="0.01785325286074911" WEIGHT="49.34609332618171"/>
<DICH_DATA CI_END="0.7724608174743274" CI_START="0.14304465311938833" EFFECT_SIZE="0.33240997229916897" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.11212354062320638" LOG_CI_START="-0.8445283710928597" LOG_EFFECT_SIZE="-0.4783259558580331" MODIFIED="2016-03-03 17:47:33 +0000" MODIFIED_BY="[Empty name]" ORDER="197" O_E="0.0" SE="0.43021822288025596" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="57" TOTAL_2="60" VAR="0.1850877192982456" WEIGHT="16.97600437440146"/>
<DICH_DATA CI_END="0.8344522883511049" CI_START="0.3229207108429046" EFFECT_SIZE="0.5190972222222222" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="32" LOG_CI_END="-0.07859849001913605" LOG_CI_START="-0.4909041001784287" LOG_EFFECT_SIZE="-0.2847512950987824" MODIFIED="2016-03-03 17:47:35 +0000" MODIFIED_BY="[Empty name]" ORDER="198" O_E="0.0" SE="0.24219035635325478" STUDY_ID="STD-Vinutha-2000" TOTAL_1="36" TOTAL_2="46" VAR="0.05865616871051654" WEIGHT="33.677902299416836"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3943329517152616E-30" CI_END="1.1507459212209015" CI_START="0.7601673640057449" DF="0" EFFECT_SIZE="0.9352857817666509" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="29" I2="99.99999999999999" ID="CMP-001.15.02" LOG_CI_END="0.06097944422697669" LOG_CI_START="-0.1190907797427385" LOG_EFFECT_SIZE="-0.02905566775788089" MODIFIED="2016-02-18 10:28:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.5270540159535886" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="36" WEIGHT="100.0" Z="0.6325094854303722">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.1507459212209015" CI_START="0.7601673640057449" EFFECT_SIZE="0.9352857817666509" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="29" LOG_CI_END="0.06097944422697669" LOG_CI_START="-0.1190907797427385" LOG_EFFECT_SIZE="-0.02905566775788089" MODIFIED="2016-02-12 05:35:00 +0000" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="0.10577414092179506" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="73" TOTAL_2="36" VAR="0.011188168887743759" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.595029664482376" CI_END="1.0724409366470127" CI_START="0.6375214534142184" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8268640182231352" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="69" I2="64.25398755799037" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.03037338328602289" LOG_CI_START="-0.1955051960820149" LOG_EFFECT_SIZE="-0.08256590639799602" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.060961422747092486" P_Q="0.6552022413841808" P_Z="0.15189781935775146" Q="0.19940414747826823" RANDOM="YES" SCALE="19.09" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.05412573656859749" TOTALS="SUB" TOTAL_1="205" TOTAL_2="140" WEIGHT="200.0" Z="1.4328601086808155">
<NAME>Maternal breast milk retinol (&lt; 1.05 mcmol/L) at 6 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.050329245669648" CI_END="1.942408996431044" CI_START="0.21660294212362646" DF="1" EFFECT_SIZE="0.6486381914706879" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="43" I2="83.4719738481055" ID="CMP-001.16.01" LOG_CI_END="0.28834068087133286" LOG_CI_START="-0.6643356486369304" LOG_EFFECT_SIZE="-0.18799748388279877" MODIFIED="2016-03-03 17:47:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.01390376261441828" P_Z="0.43920079359611575" STUDIES="2" TAU2="0.5334794226687118" TOTAL_1="136" TOTAL_2="105" WEIGHT="100.0" Z="0.7735435135343918">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.248970691543045" CI_START="0.7701608136498991" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="26" LOG_CI_END="0.09655224730089966" LOG_CI_START="-0.11341858237462525" LOG_EFFECT_SIZE="-0.008433167536862813" MODIFIED="2016-03-03 17:47:49 +0000" MODIFIED_BY="[Empty name]" ORDER="200" O_E="0.0" SE="0.12333790472377303" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="35" VAR="0.015212238741650511" WEIGHT="57.073905697426355"/>
<DICH_DATA CI_END="0.8915595084379095" CI_START="0.15716742247687326" EFFECT_SIZE="0.37433155080213903" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" LOG_CI_END="-0.04984966390344692" LOG_CI_START="-0.8036374691410374" LOG_EFFECT_SIZE="-0.42674356652224216" MODIFIED="2016-03-03 17:47:51 +0000" MODIFIED_BY="[Empty name]" ORDER="201" O_E="0.0" SE="0.44277868810637433" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="66" TOTAL_2="70" VAR="0.19605296664120192" WEIGHT="42.92609430257364"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.096398119200006" CI_START="0.6418888629905062" DF="0" EFFECT_SIZE="0.8389074693422519" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="26" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.0399682818640318" LOG_CI_START="-0.19254015942045405" LOG_EFFECT_SIZE="-0.07628593877821115" MODIFIED="2016-02-18 10:28:18 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.19839874105819835" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0" Z="1.286127004302427">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.096398119200006" CI_START="0.6418888629905062" EFFECT_SIZE="0.8389074693422519" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="26" LOG_CI_END="0.0399682818640318" LOG_CI_START="-0.19254015942045405" LOG_EFFECT_SIZE="-0.07628593877821115" MODIFIED="2016-02-12 05:36:04 +0000" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="0.13657660934585342" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" VAR="0.018653170220409857" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.8704002482840605" CI_END="1.0045581395784564" CI_START="0.633697913237628" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7978636454788135" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="70" I2="30.32330591541685" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.0019750769403324812" LOG_CI_START="-0.1981177230008064" LOG_EFFECT_SIZE="-0.09807132303023694" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.23806807615560788" P_Q="0.9988356496716422" P_Z="0.05469753339791306" Q="2.1295514733481267E-6" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.011134169738791095" TOTALS="SUB" TOTAL_1="197" TOTAL_2="131" WEIGHT="200.0" Z="1.9212711413104537">
<NAME>Maternal breast milk retinol (&lt; 1.05 mcmol/L) at 8 - 9 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.638256472132272" CI_END="1.4006480617240844" CI_START="0.4548415249522019" DF="1" EFFECT_SIZE="0.7981684661247451" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="44" I2="62.09617940625054" ID="CMP-001.17.01" LOG_CI_END="0.1463290246133152" LOG_CI_START="-0.3421398930732122" LOG_EFFECT_SIZE="-0.09790543422994849" MODIFIED="2016-02-18 10:28:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10431802387680389" P_Z="0.4320526017846895" STUDIES="2" TAU2="0.11276509676982868" TOTAL_1="127" TOTAL_2="98" WEIGHT="100.0" Z="0.7856840754178727">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.1940254140213502" CI_START="0.7589097633415157" EFFECT_SIZE="0.9519230769230769" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="26" LOG_CI_END="0.07701357055530607" LOG_CI_START="-0.11980985995776695" LOG_EFFECT_SIZE="-0.021398144701230463" MODIFIED="2016-02-12 10:58:53 +0000" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="0.11561505737507329" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="64" TOTAL_2="33" VAR="0.013366841491841489" WEIGHT="65.27156145158209"/>
<DICH_DATA CI_END="1.143929232990344" CI_START="0.28721124905218987" EFFECT_SIZE="0.5731922398589065" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="18" LOG_CI_END="0.058399158484613425" LOG_CI_START="-0.5417985543126778" LOG_EFFECT_SIZE="-0.24169969791403217" MODIFIED="2008-02-01 05:28:30 +0000" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.3525591075237233" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="63" TOTAL_2="65" VAR="0.1242979242979243" WEIGHT="34.72843854841792"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0269873533045955" CI_START="0.619762594709616" DF="0" EFFECT_SIZE="0.7978021978021979" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="26" I2="0.0" ID="CMP-001.17.02" LOG_CI_END="0.011565095570164262" LOG_CI_START="-0.20777463881216396" LOG_EFFECT_SIZE="-0.09810477162099986" MODIFIED="2016-02-18 10:28:30 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.07955421594068261" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="33" WEIGHT="100.0" Z="1.753278489464412">
<NAME>Beta-carotene: 7.8mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.0269873533045955" CI_START="0.619762594709616" EFFECT_SIZE="0.7978021978021979" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="26" LOG_CI_END="0.011565095570164262" LOG_CI_START="-0.20777463881216396" LOG_EFFECT_SIZE="-0.09810477162099986" MODIFIED="2016-02-12 10:59:19 +0000" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="0.12884124572537556" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="33" VAR="0.016600066600066604" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.375946401210133" CI_END="1.090943726777351" CI_START="0.750637394835209" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9049326809105552" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="52" I2="27.3227504268692" I2_Q="26.86524408625913" ID="CMP-001.18" LOG_CI_END="0.03780234932310219" LOG_CI_START="-0.12456980394365404" LOG_EFFECT_SIZE="-0.04338372731027591" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.24079302018493431" P_Q="0.24226979623764233" P_Z="0.2949364625810791" Q="1.367338945083039" RANDOM="NO" SCALE="2.38" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="142" TOTAL_2="72" WEIGHT="200.0" Z="1.0473537651933884">
<NAME>Maternal breast milk retinol (&lt; 0.28 mcmol/g of fat) at 3 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0677032860488298" CI_START="0.6034336539280797" DF="0" EFFECT_SIZE="0.802675585284281" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="26" I2="0.0" ID="CMP-001.18.01" LOG_CI_END="0.02845057934491693" LOG_CI_START="-0.21937047257056413" LOG_EFFECT_SIZE="-0.09545994661282362" MODIFIED="2016-02-18 10:28:37 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.13105750375645045" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="36" WEIGHT="100.0" Z="1.5099448241472246">
<NAME>200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.0677032860488298" CI_START="0.6034336539280797" EFFECT_SIZE="0.802675585284281" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="26" LOG_CI_END="0.02845057934491693" LOG_CI_START="-0.21937047257056413" LOG_EFFECT_SIZE="-0.09545994661282362" MODIFIED="2016-02-12 05:38:28 +0000" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="0.14557131262914502" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="36" VAR="0.021191007060572274" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2866369685656922" CI_START="0.7854314711359536" DF="0" EFFECT_SIZE="1.0052687038988408" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="26" I2="0.0" ID="CMP-001.18.02" LOG_CI_END="0.10945602570062045" LOG_CI_START="-0.10489170114701561" LOG_EFFECT_SIZE="0.0022821622768024173" MODIFIED="2016-02-18 10:28:44 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9667095455693934" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="36" WEIGHT="99.99999999999999" Z="0.04173551019356655">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.2866369685656922" CI_START="0.7854314711359536" EFFECT_SIZE="1.0052687038988408" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="26" LOG_CI_END="0.10945602570062045" LOG_CI_START="-0.10489170114701561" LOG_EFFECT_SIZE="0.0022821622768024173" MODIFIED="2016-02-12 05:38:32 +0000" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.12590891578866156" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="73" TOTAL_2="36" VAR="0.01585305507507627" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3495254050983697" CI_END="0.9899052709430304" CI_START="0.7515386067809033" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8625265376610726" ESTIMABLE="YES" EVENTS_1="186" EVENTS_2="163" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-0.0044063632561039635" LOG_CI_START="-0.12404870465625163" LOG_EFFECT_SIZE="-0.0642275339561778" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.8396562794898272" P_Q="0.8174226651938931" P_Z="0.035349424284437325" Q="0.053296876299858756" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="479" TOTAL_2="404" WEIGHT="200.0" Z="2.1043328289423875">
<NAME>Maternal breast milk retinol (&lt; 0.28 mcmol/g of fat) at 6 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.26957809915078446" CI_END="1.0084341031417725" CI_START="0.7213460055585095" DF="1" EFFECT_SIZE="0.8528950182585753" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="136" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="0.0036475241879160656" LOG_CI_START="-0.14185636876231258" LOG_EFFECT_SIZE="-0.06910442228719829" MODIFIED="2016-02-18 10:28:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6036149780296651" P_Z="0.06264562102706311" STUDIES="2" TAU2="0.0" TOTAL_1="410" TOTAL_2="369" WEIGHT="100.0" Z="1.8616983519703527">
<NAME>200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.1301703403575285" CI_START="0.6991189102876019" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="27" LOG_CI_END="0.05314390569760701" LOG_CI_START="-0.1554489505923696" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2016-02-12 05:39:23 +0000" MODIFIED_BY="[Empty name]" ORDER="190" O_E="0.0" SE="0.12252847633602366" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="70" TOTAL_2="35" VAR="0.01501322751322751" WEIGHT="48.657564164205404"/>
<DICH_DATA CI_END="1.0361323866856813" CI_START="0.6491568430084846" EFFECT_SIZE="0.8201295196977874" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="109" LOG_CI_END="0.015415248781661372" LOG_CI_START="-0.1876503604821028" LOG_EFFECT_SIZE="-0.0861175558502207" ORDER="191" O_E="0.0" SE="0.11928174407251245" STUDY_ID="STD-WHO_x002f_CHD-IVASSG" TOTAL_1="340" TOTAL_2="334" VAR="0.014228134468980358" WEIGHT="51.342435835794596"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1247779406819407" CI_START="0.6931692754392296" DF="0" EFFECT_SIZE="0.8829844337090714" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="27" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="0.051066790309059855" LOG_CI_START="-0.15916069552955886" LOG_EFFECT_SIZE="-0.05404695261024951" MODIFIED="2016-02-18 10:28:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3135667143378216" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0" Z="1.0077662315911387">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.1247779406819407" CI_START="0.6931692754392296" EFFECT_SIZE="0.8829844337090714" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="27" LOG_CI_END="0.051066790309059855" LOG_CI_START="-0.15916069552955886" LOG_EFFECT_SIZE="-0.05404695261024951" MODIFIED="2016-02-12 05:39:30 +0000" MODIFIED_BY="[Empty name]" ORDER="192" O_E="0.0" SE="0.12348866582444282" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" VAR="0.01524945058710091" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.7533412812619513" CI_END="0.9606946669542868" CI_START="0.7231435508083164" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8334987418730372" ESTIMABLE="YES" EVENTS_1="162" EVENTS_2="140" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-0.01741462016411619" LOG_CI_START="-0.1407754826008406" LOG_EFFECT_SIZE="-0.07909505138247841" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.4161665586384483" P_Q="0.37334062923768563" P_Z="0.011959644766420767" Q="0.7925154837589781" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="409" TOTAL_2="360" WEIGHT="200.0" Z="2.5133328188998196">
<NAME>Maternal breast milk retinol (&lt; 0.28 mcmol/g of fat) at 9 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7484512360172173" CI_END="1.0394813041842135" CI_START="0.7330008751801638" DF="1" EFFECT_SIZE="0.8728921500967038" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="113" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="0.016816682640409825" LOG_CI_START="-0.13489550682450796" LOG_EFFECT_SIZE="-0.05903941209204905" MODIFIED="2016-02-18 10:29:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.38696705425836575" P_Z="0.12714544445725398" STUDIES="2" TAU2="0.0" TOTAL_1="340" TOTAL_2="327" WEIGHT="100.00000000000001" Z="1.5254558223298584">
<NAME>200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.03862314586818" CI_START="0.6492610024195594" EFFECT_SIZE="0.8211805555555556" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="27" LOG_CI_END="0.01645799668270601" LOG_CI_START="-0.18758068205350698" LOG_EFFECT_SIZE="-0.08556134268540047" MODIFIED="2016-02-12 05:40:38 +0000" MODIFIED_BY="[Empty name]" ORDER="193" O_E="0.0" SE="0.11985332989740044" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="64" TOTAL_2="33" VAR="0.014364820687495103" WEIGHT="55.28609897074683"/>
<DICH_DATA CI_END="1.2223460354535503" CI_START="0.7249576056827804" EFFECT_SIZE="0.9413549039433772" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="86" LOG_CI_END="0.08719416827507405" LOG_CI_START="-0.1396873895067476" LOG_EFFECT_SIZE="-0.02624661061583677" ORDER="194" O_E="0.0" SE="0.13327135012286587" STUDY_ID="STD-WHO_x002f_CHD-IVASSG" TOTAL_1="276" TOTAL_2="294" VAR="0.017761252763571503" WEIGHT="44.713901029253186"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9721499346855996" CI_START="0.5967684156943105" DF="0" EFFECT_SIZE="0.7616747181964574" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="27" I2="0.0" ID="CMP-001.20.02" LOG_CI_END="-0.012266748669468036" LOG_CI_START="-0.2241941702080692" LOG_EFFECT_SIZE="-0.1182304594387686" MODIFIED="2016-02-18 10:29:08 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.028752992586720486" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="33" WEIGHT="100.0" Z="2.18685662">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="0.9721499346855996" CI_START="0.5967684156943105" EFFECT_SIZE="0.7616747181964574" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="27" LOG_CI_END="-0.012266748669468036" LOG_CI_START="-0.2241941702080692" LOG_EFFECT_SIZE="-0.1182304594387686" MODIFIED="2016-02-12 05:40:41 +0000" MODIFIED_BY="[Empty name]" ORDER="195" O_E="0.0" SE="0.12448721646942988" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="33" VAR="0.015497067064306695" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.80400847395356" CI_START="0.5543211212353444" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.2562385732184659" LOG_CI_START="-0.25623857321846594" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="74" TOTAL_2="74" WEIGHT="100.0" Z="0.0">
<NAME>Maternal abnormal conjunctival impression cytology 3 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.80400847395356" CI_START="0.5543211212353444" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="0.2562385732184659" LOG_CI_START="-0.25623857321846594" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-18 10:29:15 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="74" WEIGHT="100.0" Z="0.0">
<NAME>300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.80400847395356" CI_START="0.5543211212353444" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.2562385732184659" LOG_CI_START="-0.25623857321846594" LOG_EFFECT_SIZE="0.0" ORDER="142" O_E="0.0" SE="0.3010316126198416" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="74" TOTAL_2="74" VAR="0.09062003179650238" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.171479173740271" CI_START="0.2677935685951214" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5601023017902813" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="0.06873457222442333" LOG_CI_START="-0.5721998573359203" LOG_EFFECT_SIZE="-0.2517326425557485" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="1.0" P_Q="1.0" P_Z="0.1236612424951424" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="69" TOTAL_2="73" WEIGHT="100.0" Z="1.5395862365540467">
<NAME>Maternal abnormal conjunctival impression cytology 6 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.171479173740271" CI_START="0.2677935685951214" DF="0" EFFECT_SIZE="0.5601023017902813" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" I2="0.0" ID="CMP-001.22.01" LOG_CI_END="0.06873457222442333" LOG_CI_START="-0.5721998573359203" LOG_EFFECT_SIZE="-0.2517326425557485" MODIFIED="2016-02-18 10:29:21 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1236612424951424" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="73" WEIGHT="100.0" Z="1.5395862365540467">
<NAME>300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.171479173740271" CI_START="0.2677935685951214" EFFECT_SIZE="0.5601023017902813" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.06873457222442333" LOG_CI_START="-0.5721998573359203" LOG_EFFECT_SIZE="-0.2517326425557485" ORDER="143" O_E="0.0" SE="0.3764880566003404" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="69" TOTAL_2="73" VAR="0.1417432567627011" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.608580607456031" CI_END="1.5158936353231356" CI_START="0.7702012076293456" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0805290873287576" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="62" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.18066872951977425" LOG_CI_START="-0.11339580476502774" LOG_EFFECT_SIZE="0.03363646237737326" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.6253040031083688" P_Q="0.6253394491153337" P_Z="0.6538793334762713" Q="2.608380314643948" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3039" TOTAL_2="3051" WEIGHT="100.0" Z="0.4483795027328145">
<NAME>Infant mortality</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5421636810277206" CI_START="0.3261271737254035" DF="0" EFFECT_SIZE="0.7091836734693877" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" I2="0.0" ID="CMP-001.23.01" LOG_CI_END="0.18813047098768368" LOG_CI_START="-0.4866130131924456" LOG_EFFECT_SIZE="-0.149241271102381" MODIFIED="2016-02-18 10:29:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3859319236518549" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="139" WEIGHT="22.476454457181763" Z="0.8670184247071807">
<NAME>Deaths to 14 weeks: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.5421636810277204" CI_START="0.3261271737254035" EFFECT_SIZE="0.7091836734693877" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.18813047098768362" LOG_CI_START="-0.4866130131924456" LOG_EFFECT_SIZE="-0.149241271102381" MODIFIED="2016-02-08 12:49:55 +0000" MODIFIED_BY="[Empty name]" ORDER="517" O_E="0.0" SE="0.396347662641522" STUDY_ID="STD-Ayah-2007" TOTAL_1="140" TOTAL_2="139" VAR="0.15709146968139773" WEIGHT="22.476454457181763"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2425697194103718" CI_START="0.3430274768086672" DF="0" EFFECT_SIZE="0.8770764119601329" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" I2="0.0" ID="CMP-001.23.02" LOG_CI_END="0.3507459537382175" LOG_CI_START="-0.46467109118624217" LOG_EFFECT_SIZE="-0.05696256872401231" MODIFIED="2016-02-23 13:05:17 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7842119534301137" STUDIES="1" TAU2="0.0" TOTAL_1="301" TOTAL_2="297" WEIGHT="14.49384983937701" Z="0.27383431303252825">
<NAME>Deaths to 12 months: 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="2.2425697194103718" CI_START="0.3430274768086673" EFFECT_SIZE="0.8770764119601329" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.3507459537382175" LOG_CI_START="-0.46467109118624206" LOG_EFFECT_SIZE="-0.05696256872401231" MODIFIED="2016-02-23 13:05:17 +0000" MODIFIED_BY="[Empty name]" ORDER="516" O_E="0.0" SE="0.47898000856809786" STUDY_ID="STD-Venkatarao-1996" TOTAL_1="301" TOTAL_2="297" VAR="0.2294218486078951" WEIGHT="14.49384983937701"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.171324656980048" CI_START="0.2601389774939763" DF="0" EFFECT_SIZE="1.5446096654275092" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-001.23.03" LOG_CI_END="0.9624320673678247" LOG_CI_START="-0.584794571132381" LOG_EFFECT_SIZE="0.18881874811772179" MODIFIED="2016-02-23 13:05:20 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6323827053525443" STUDIES="1" TAU2="0.0" TOTAL_1="269" TOTAL_2="277" WEIGHT="3.1525760324922416" Z="0.47837587165046175">
<NAME>Death to 6 months: 200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="9.171324656980048" CI_START="0.2601389774939763" EFFECT_SIZE="1.5446096654275092" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9624320673678247" LOG_CI_START="-0.584794571132381" LOG_EFFECT_SIZE="0.18881874811772179" MODIFIED="2016-02-23 13:05:20 +0000" MODIFIED_BY="[Empty name]" ORDER="518" O_E="0.0" SE="0.9088485863504024" STUDY_ID="STD-Newton-2005" TOTAL_1="269" TOTAL_2="277" VAR="0.826005752911125" WEIGHT="3.1525760324922416"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9765006525159416" CI_START="0.8325528115493546" DF="0" EFFECT_SIZE="1.2827864885791715" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="36" I2="0.0" ID="CMP-001.23.04" LOG_CI_END="0.29589696205567856" LOG_CI_START="-0.0795882082276428" LOG_EFFECT_SIZE="0.10815437691401786" MODIFIED="2016-02-18 10:29:52 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.2588589711281789" STUDIES="1" TAU2="0.0" TOTAL_1="2296" TOTAL_2="2305" WEIGHT="57.47752880606874" Z="1.1290921735305677">
<NAME>Deaths to 12 months: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.9765006525159416" CI_START="0.8325528115493546" EFFECT_SIZE="1.2827864885791715" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="36" LOG_CI_END="0.29589696205567856" LOG_CI_START="-0.0795882082276428" LOG_EFFECT_SIZE="0.10815437691401786" MODIFIED="2010-07-30 09:25:24 +0100" MODIFIED_BY="[Empty name]" ORDER="515" O_E="0.0" SE="0.2205618477059923" STUDY_ID="STD-ZVITAMBO-Study-Group" TOTAL_1="2296" TOTAL_2="2305" VAR="0.04864752866348134" WEIGHT="57.47752880606874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.897117532359623" CI_START="0.014069831258787349" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.23.05" LOG_CI_END="0.8974686016417053" LOG_CI_START="-1.8517111110810305" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2016-02-18 10:29:59 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.4963113070323152" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="33" WEIGHT="2.399590864880247" Z="0.6803050896828817">
<NAME>Deaths to 2 months: 200,000 IU versus placebo</NAME>
<DICH_DATA CI_END="7.897117532359623" CI_START="0.014069831258787349" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8974686016417053" LOG_CI_START="-1.8517111110810305" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2016-02-14 05:36:54 +0000" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="1.6148817719123905" STUDY_ID="STD-Martins-2010" TOTAL_1="33" TOTAL_2="33" VAR="2.607843137254902" WEIGHT="2.399590864880247"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0631336736954304" CI_START="0.9846665183882457" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0231481481481481" ESTIMABLE="YES" EVENTS_1="221" EVENTS_2="216" I2="0.0" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="0.02658787421138532" LOG_CI_START="-0.006710829143025779" LOG_EFFECT_SIZE="0.009938522534179796" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="1.0" P_Q="1.0" P_Z="0.24201537684975172" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="228" TOTAL_2="228" WEIGHT="100.0" Z="1.1699642487101067">
<NAME>Infant diarrhoea (one or more episodes) to 12 months</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0631336736954304" CI_START="0.9846665183882457" DF="0" EFFECT_SIZE="1.0231481481481481" ESTIMABLE="YES" EVENTS_1="221" EVENTS_2="216" I2="0.0" ID="CMP-001.24.01" LOG_CI_END="0.02658787421138532" LOG_CI_START="-0.006710829143025779" LOG_EFFECT_SIZE="0.009938522534179796" MODIFIED="2016-02-18 10:30:08 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.24201537684975172" STUDIES="1" TAU2="0.0" TOTAL_1="228" TOTAL_2="228" WEIGHT="100.0" Z="1.1699642487101067">
<NAME>300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.0631336736954307" CI_START="0.9846665183882457" EFFECT_SIZE="1.0231481481481481" ESTIMABLE="YES" EVENTS_1="221" EVENTS_2="216" LOG_CI_END="0.02658787421138541" LOG_CI_START="-0.006710829143025779" LOG_EFFECT_SIZE="0.009938522534179796" MODIFIED="2010-07-30 10:09:07 +0100" MODIFIED_BY="[Empty name]" ORDER="519" O_E="0.0" SE="0.019559823181621094" STUDY_ID="STD-Venkatarao-1996" TOTAL_1="228" TOTAL_2="228" VAR="3.825866828962819E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.25" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="25" ROWS_PER_STUDY="3" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Infant diarrhoea episodes and duration</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Supplement</P>
</TH>
<TH>
<P>No treatment</P>
</TH>
<TH>
<P>Significance</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.25.01" MODIFIED="2016-02-18 10:30:13 +0000" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2016-02-10 17:01:59 +0000" MODIFIED_BY="[Empty name]" ORDER="95" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Diarrhoea episodes</P>
<P>(mean episodes per child-week of observation)</P>
</TD>
<TD>
<P>0.12 (95% CI 0.09 to 0.15)</P>
</TD>
<TD>
<P>0.11 (95% CI 0.08 to 0.14)</P>
</TD>
<TD>
<P>P = 0.59</P>
</TD>
</TR>
<TR>
<TD>
<P>Diarrhoea duration</P>
<P>(duration (days) per child-week of observation)</P>
</TD>
<TD>
<P>0.74 (95% CI 0.53 to 0.95)</P>
</TD>
<TD>
<P>0.71 (95% CI 0.50 to 0.92)</P>
</TD>
<TD>
<P>P = 0.78</P>
</TD>
</TR>
<TR>
<TD>
<P>Child-weeks</P>
</TD>
<TD>
<P>515</P>
</TD>
<TD>
<P>522</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="121.82207609459164" CI_START="0.29804408965823037" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="6.0256410256410255" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="2.085725996484908" LOG_CI_START="-0.5257194859944339" LOG_EFFECT_SIZE="0.7800032552452371" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="1.0" P_Q="1.0" P_Z="0.24166746614214696" Q="0.0" RANDOM="NO" SCALE="22.578153899327482" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="38" TOTAL_2="46" WEIGHT="100.0" Z="1.1708291812802654">
<NAME>Infant gastroenteritis to 3 months</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="121.82207609459164" CI_START="0.29804408965823037" DF="0" EFFECT_SIZE="6.0256410256410255" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-001.26.01" LOG_CI_END="2.085725996484908" LOG_CI_START="-0.5257194859944339" LOG_EFFECT_SIZE="0.7800032552452371" MODIFIED="2016-02-18 10:30:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.24166746614214696" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="46" WEIGHT="100.0" Z="1.1708291812802654">
<NAME>200,000 IU versus no treatment</NAME>
<DICH_DATA CI_END="121.82207609459152" CI_START="0.2980440896582305" EFFECT_SIZE="6.0256410256410255" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0857259964849075" LOG_CI_START="-0.5257194859944336" LOG_EFFECT_SIZE="0.7800032552452371" MODIFIED="2016-02-08 12:35:24 +0000" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="1.5339760032719851" STUDY_ID="STD-Vinutha-2000" TOTAL_1="38" TOTAL_2="46" VAR="2.3530823786142934" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0342765497128563" CI_START="0.9580497889640395" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9954337899543378" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="219" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.01463667798021277" LOG_CI_START="-0.018611920451239796" LOG_EFFECT_SIZE="-0.001987621235513532" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="1.0" P_Q="1.0" P_Z="0.8147244083266425" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="228" TOTAL_2="228" WEIGHT="100.0" Z="0.23433565445142512">
<NAME>Infant acute respiratory infection (one or more episodes) to 12 months</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0342765497128563" CI_START="0.9580497889640395" DF="0" EFFECT_SIZE="0.9954337899543378" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="219" I2="0.0" ID="CMP-001.27.01" LOG_CI_END="0.01463667798021277" LOG_CI_START="-0.018611920451239796" LOG_EFFECT_SIZE="-0.001987621235513532" MODIFIED="2016-02-18 10:30:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8147244083266425" STUDIES="1" TAU2="0.0" TOTAL_1="228" TOTAL_2="228" WEIGHT="100.0" Z="0.23433565445142512">
<NAME>300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.0342765497128563" CI_START="0.9580497889640395" EFFECT_SIZE="0.9954337899543378" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="219" LOG_CI_END="0.01463667798021277" LOG_CI_START="-0.018611920451239796" LOG_EFFECT_SIZE="-0.001987621235513532" ORDER="213" O_E="0.0" SE="0.019530391301851833" STUDY_ID="STD-Venkatarao-1996" TOTAL_1="228" TOTAL_2="228" VAR="3.8143618440344973E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.808883868329363" CI_START="0.21640797716080928" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9078947368421053" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.28" LOG_CI_END="0.5807977313607091" LOG_CI_START="-0.6647267344477812" LOG_EFFECT_SIZE="-0.041964501543536016" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="1.0" P_Q="1.0" P_Z="0.8949280310125695" Q="0.0" RANDOM="NO" SCALE="11.17451716980626" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="38" TOTAL_2="46" WEIGHT="100.0" Z="0.13207112973267365">
<NAME>Infant upper respiratory tract infection to 3 months</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.808883868329363" CI_START="0.21640797716080928" DF="0" EFFECT_SIZE="0.9078947368421053" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.28.01" LOG_CI_END="0.5807977313607091" LOG_CI_START="-0.6647267344477812" LOG_EFFECT_SIZE="-0.041964501543536016" MODIFIED="2016-02-18 10:30:30 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8949280310125695" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="46" WEIGHT="100.0" Z="0.13207112973267365">
<NAME>200,000 IU versus treatment</NAME>
<DICH_DATA CI_END="3.808883868329363" CI_START="0.21640797716080928" EFFECT_SIZE="0.9078947368421053" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5807977313607091" LOG_CI_START="-0.6647267344477812" LOG_EFFECT_SIZE="-0.041964501543536016" MODIFIED="2009-03-11 07:46:11 +0000" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.731627236661448" STUDY_ID="STD-Vinutha-2000" TOTAL_1="38" TOTAL_2="46" VAR="0.5352784134248665" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.29" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="29" ROWS_PER_STUDY="3" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Infant acute respiratory tract infection episodes and duration</NAME>
<TR>
<TH>
<P>Outcome / Details</P>
</TH>
<TH>
<P>Vitamin A</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>Significance</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.29.01" MODIFIED="2016-02-18 10:30:36 +0000" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2010-09-08 10:24:28 +0100" MODIFIED_BY="[Empty name]" ORDER="99" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Acute respiratory tract infection episodes</P>
<P>(mean episodes per child-week of observation)</P>
</TD>
<TD>
<P>0.42 (95% CI 0.38 to 0.46)</P>
</TD>
<TD>
<P>0.45 (95% CI 0.41 to 0.49)</P>
</TD>
<TD>
<P>P = 0.51</P>
</TD>
</TR>
<TR>
<TD>
<P>Acute respiratory tract infection duration</P>
<P>(duration (days) per child-week of observation)</P>
</TD>
<TD>
<P>3.1 (95% CI 2.7 to 3.5)</P>
</TD>
<TD>
<P>3.7 (95% CI 3.25 to 4.15)</P>
</TD>
<TD>
<P>P = 0.03</P>
</TD>
</TR>
<TR>
<TD>
<P>Child-weeks</P>
</TD>
<TD>
<P>515</P>
</TD>
<TD>
<P>522</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.30" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="30" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Infant febrile illness episodes</NAME>
<TR>
<TH>
<P>Outcome / Details</P>
</TH>
<TH>
<P>Vitamin A</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>Significance</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.30.01" MODIFIED="2016-02-18 10:30:41 +0000" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>200,000 IU versus no treatment</NAME>
<OTHER_DATA MODIFIED="2010-09-08 10:23:08 +0100" MODIFIED_BY="[Empty name]" ORDER="100" STUDY_ID="STD-Roy-1997">
<TR>
<TD>
<P>Febrile illness episodes</P>
<P>(mean episodes per child-week of observation)</P>
</TD>
<TD>
<P>0.1 (95% CI 0.09 to 0.11)</P>
</TD>
<TD>
<P>0.3 (95% CI 0.27 to 0.30)</P>
</TD>
<TD>
<P>P &lt; 0.002</P>
</TD>
</TR>
<TR>
<TD>
<P>Child-weeks</P>
</TD>
<TD>
<P>515</P>
</TD>
<TD>
<P>522</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.54610556090753" CI_START="0.6110503356205355" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.31" LOG_CI_END="0.8159830043557319" LOG_CI_START="-0.2139230130277696" LOG_EFFECT_SIZE="0.3010299956639812" METHOD="MH" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="31" P_CHI2="1.0" P_Q="1.0" P_Z="0.2518981941851707" Q="0.0" RANDOM="YES" SCALE="200.91948244537667" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="222" TOTAL_2="222" WEIGHT="100.00000000000001" Z="1.1457510487540983">
<NAME>Infant adverse effects of supplementation</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.54610556090753" CI_START="0.6110503356205355" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" I2="0.0" ID="CMP-001.31.01" LOG_CI_END="0.8159830043557319" LOG_CI_START="-0.2139230130277696" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2016-02-18 10:30:47 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2518981941851707" STUDIES="1" TAU2="0.0" TOTAL_1="222" TOTAL_2="222" WEIGHT="100.00000000000001" Z="1.1457510487540983">
<NAME>Bulging fontanelle: 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="6.54610556090753" CI_START="0.6110503356205355" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8159830043557319" LOG_CI_START="-0.2139230130277696" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2008-12-11 00:20:04 +0000" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="0.6049718927280763" STUDY_ID="STD-Ayah-2007" TOTAL_1="222" TOTAL_2="222" VAR="0.36599099099099097" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="45.99500376345671" CI_END="0.08367422502556027" CI_START="-0.008166672670114457" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="0.03775377617772291" ESTIMABLE="YES" I2="84.78095569684127" I2_Q="48.33755729643453" ID="CMP-001.32" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="32" P_CHI2="8.761599035178591E-8" P_Q="0.14433170499861903" P_Z="0.10709337211770842" Q="3.871284235388991" RANDOM="YES" SCALE="0.5" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.01292460470306829" TOTALS="SUB" TOTAL_1="390" TOTAL_2="368" UNITS="" WEIGHT="300.0" Z="1.6113963048122086">
<NAME>Infant serum retinol (mcmol/L) at 3 - 3.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="23.04303413575939" CI_END="0.25814442904278645" CI_START="-0.04508865012633721" DF="3" EFFECT_SIZE="0.10652788945822463" ESTIMABLE="YES" I2="86.98088115338751" ID="CMP-001.32.01" MODIFIED="2016-03-03 18:14:05 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.955779370634627E-5" P_Z="0.16848196472870078" STUDIES="4" TAU2="0.019390231942360486" TOTAL_1="195" TOTAL_2="184" WEIGHT="99.99999999999999" Z="1.377097955534953">
<NAME>200,000 - 400,000 IU versus no treatment</NAME>
<CONT_DATA CI_END="0.06971094608696915" CI_START="-0.02971094608696912" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.92" MEAN_2="0.9" MODIFIED="2016-03-03 18:05:28 +0000" MODIFIED_BY="[Empty name]" ORDER="456" SD_1="0.18" SD_2="0.14" SE="0.02536319365002762" STUDY_ID="STD-Ayah-2007" TOTAL_1="78" TOTAL_2="86" WEIGHT="29.870303686148148"/>
<CONT_DATA CI_END="0.2706676560247118" CI_START="-0.17066765602471196" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.94" MEAN_2="0.89" MODIFIED="2016-03-03 18:05:29 +0000" MODIFIED_BY="[Empty name]" ORDER="457" SD_1="0.55" SD_2="0.51" SE="0.11258760761182868" STUDY_ID="STD-Bhaskaram-2000" TOTAL_1="49" TOTAL_2="40" WEIGHT="18.66162523331958"/>
<CONT_DATA CI_END="0.19344983779417715" CI_START="-0.09344983779417729" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.69" MEAN_2="0.64" MODIFIED="2016-03-03 18:05:31 +0000" MODIFIED_BY="[Empty name]" ORDER="274" SD_1="0.26" SD_2="0.3" SE="0.07319003763624803" STUDY_ID="STD-Martins-2010" TOTAL_1="30" TOTAL_2="29" WEIGHT="24.180995845503467"/>
<CONT_DATA CI_END="0.3887758975815949" CI_START="0.19122410241840515" EFFECT_SIZE="0.29000000000000004" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="0.77" MODIFIED="2016-03-03 18:14:05 +0000" MODIFIED_BY="[Empty name]" ORDER="460" SD_1="0.21" SD_2="0.2" SE="0.05039679216594108" STUDY_ID="STD-Vinutha-2000" TOTAL_1="38" TOTAL_2="29" WEIGHT="27.287075235028787"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.787310865530169" CI_END="0.39450876734252494" CI_START="0.0027400903919617414" DF="2" EFFECT_SIZE="0.19862442886724332" ESTIMABLE="YES" I2="47.19208242970494" ID="CMP-001.32.02" MODIFIED="2016-03-03 18:06:02 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15052069646605482" P_Z="0.04688023988852542" STUDIES="3" TAU2="0.013589789043412175" TOTAL_1="117" TOTAL_2="98" WEIGHT="100.0" Z="1.9873805637542572">
<NAME>200,000 IU versus placebo or no treatment</NAME>
<CONT_DATA CI_END="0.2706676560247118" CI_START="-0.17066765602471196" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.94" MEAN_2="0.89" MODIFIED="2008-04-20 02:57:19 +0100" MODIFIED_BY="[Empty name]" ORDER="929" SD_1="0.55" SD_2="0.51" SE="0.11258760761182868" STUDY_ID="STD-Bhaskaram-2000" TOTAL_1="49" TOTAL_2="40" WEIGHT="38.02885948743978"/>
<CONT_DATA CI_END="9.354450218133698" CI_START="-9.254450218133696" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.69" MEAN_2="0.64" MODIFIED="2016-02-03 18:57:10 +0000" MODIFIED_BY="[Empty name]" ORDER="275" SD_1="26.0" SD_2="0.3" SE="4.747255710577344" STUDY_ID="STD-Martins-2010" TOTAL_1="30" TOTAL_2="29" WEIGHT="0.04429515120881695"/>
<CONT_DATA CI_END="0.3887758975815949" CI_START="0.19122410241840515" EFFECT_SIZE="0.29000000000000004" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="0.77" MODIFIED="2016-03-03 18:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="240" SD_1="0.21" SD_2="0.2" SE="0.05039679216594108" STUDY_ID="STD-Vinutha-2000" TOTAL_1="38" TOTAL_2="29" WEIGHT="61.926845361351404"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.06971094608696915" CI_START="-0.02971094608696912" DF="0" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-001.32.03" MODIFIED="2016-02-18 10:31:07 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.43037844486686183" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="86" WEIGHT="100.0" Z="0.7885442297199918">
<NAME>400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.06971094608696915" CI_START="-0.02971094608696912" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.92" MEAN_2="0.9" MODIFIED="2009-03-05 03:07:35 +0000" MODIFIED_BY="[Empty name]" ORDER="242" SD_1="0.18" SD_2="0.14" SE="0.02536319365002762" STUDY_ID="STD-Ayah-2007" TOTAL_1="78" TOTAL_2="86" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.508864805394209" CI_END="0.06965801745541668" CI_START="0.009235832649169492" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="0.03944692505229309" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.33" MODIFIED="2016-03-03 19:20:36 +0000" MODIFIED_BY="[Empty name]" NO="33" P_CHI2="0.8085456809814472" P_Q="0.9471263586253436" P_Z="0.010493010123916624" Q="0.36623193900806317" RANDOM="YES" SCALE="0.5" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="537" TOTAL_2="427" UNITS="" WEIGHT="400.0" Z="2.559144547694393">
<NAME>Infant serum retinol (mcmol/L) at 6 - 6.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplement</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.2285472752123496" CI_END="0.08632323413823617" CI_START="-0.004825290938057836" DF="3" EFFECT_SIZE="0.04074897160008917" ESTIMABLE="YES" I2="0.0" ID="CMP-001.33.01" MODIFIED="2016-02-18 10:31:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5263474534229828" P_Z="0.07969683593472163" STUDIES="4" TAU2="0.0" TOTAL_1="234" TOTAL_2="196" WEIGHT="100.0" Z="1.7524478136397632">
<NAME>200,000 - 400,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.1412667371541061" CI_START="-0.021266737154106" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.02" MODIFIED="2016-02-08 13:07:10 +0000" MODIFIED_BY="[Empty name]" ORDER="464" SD_1="0.31" SD_2="0.17" SE="0.04146338289638366" STUDY_ID="STD-Ayah-2007" TOTAL_1="75" TOTAL_2="66" WEIGHT="31.449493334251564"/>
<CONT_DATA CI_END="0.12014864939681122" CI_START="-0.26014864939681115" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.81" MEAN_2="0.88" MODIFIED="2010-07-31 10:54:06 +0100" MODIFIED_BY="[Empty name]" ORDER="462" SD_1="0.35" SD_2="0.31" SE="0.09701639973830103" STUDY_ID="STD-Bhaskaram-2000" TOTAL_1="22" TOTAL_2="25" WEIGHT="5.7445076169033955"/>
<CONT_DATA CI_END="0.158234667468481" CI_START="-0.018234667468481097" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.77" MODIFIED="2016-02-12 05:45:30 +0000" MODIFIED_BY="[Empty name]" ORDER="461" SD_1="0.23" SD_2="0.21" SE="0.04501851470969102" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" WEIGHT="26.678462243203175"/>
<CONT_DATA CI_END="0.095822914469072" CI_START="-0.05582291446907196" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.67" MEAN_2="0.65" MODIFIED="2010-07-31 10:54:06 +0100" MODIFIED_BY="[Empty name]" ORDER="463" SD_1="0.19" SD_2="0.26" SE="0.038685871305367575" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="68" TOTAL_2="70" WEIGHT="36.12753680564186"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.914085591173797" CI_END="0.08696156384258352" CI_START="-0.023127533537829287" DF="2" EFFECT_SIZE="0.03191701515237712" ESTIMABLE="YES" I2="0.0" ID="CMP-001.33.02" MODIFIED="2016-02-18 10:31:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.38402692903528934" P_Z="0.2557620460526677" STUDIES="3" TAU2="0.0" TOTAL_1="159" TOTAL_2="130" WEIGHT="100.00000000000001" Z="1.136464948504672">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<CONT_DATA CI_END="0.12014864939681122" CI_START="-0.26014864939681115" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.81" MEAN_2="0.88" MODIFIED="2008-04-20 03:00:12 +0100" MODIFIED_BY="[Empty name]" ORDER="930" SD_1="0.35" SD_2="0.31" SE="0.09701639973830103" STUDY_ID="STD-Bhaskaram-2000" TOTAL_1="22" TOTAL_2="25" WEIGHT="8.379963761484005"/>
<CONT_DATA CI_END="0.158234667468481" CI_START="-0.018234667468481097" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.77" MODIFIED="2016-02-12 05:43:32 +0000" MODIFIED_BY="[Empty name]" ORDER="246" SD_1="0.23" SD_2="0.21" SE="0.04501851470969102" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" WEIGHT="38.917965075425464"/>
<CONT_DATA CI_END="0.095822914469072" CI_START="-0.05582291446907196" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.67" MEAN_2="0.65" ORDER="247" SD_1="0.19" SD_2="0.26" SE="0.038685871305367575" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="68" TOTAL_2="70" WEIGHT="52.70207116309054"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.11680337908275626" CI_START="-0.056803379082756206" DF="0" EFFECT_SIZE="0.030000000000000027" ESTIMABLE="YES" I2="0.0" ID="CMP-001.33.03" MODIFIED="2016-02-18 10:31:24 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.49816454837594804" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0" Z="0.6773805369966557">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<CONT_DATA CI_END="0.11680337908275626" CI_START="-0.056803379082756206" EFFECT_SIZE="0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.77" MODIFIED="2016-02-12 05:43:48 +0000" MODIFIED_BY="[Empty name]" ORDER="249" SD_1="0.22" SD_2="0.21" SE="0.04428825211455425" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1412667371541061" CI_START="-0.021266737154106" DF="0" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-001.33.04" MODIFIED="2016-02-18 10:31:29 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.1478801390411028" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="66" WEIGHT="100.0" Z="1.4470599311671966">
<NAME>400,00 IU versus placebo</NAME>
<CONT_DATA CI_END="0.1412667371541061" CI_START="-0.021266737154106" EFFECT_SIZE="0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.02" MODIFIED="2016-02-08 13:05:30 +0000" MODIFIED_BY="[Empty name]" ORDER="253" SD_1="0.31" SD_2="0.17" SE="0.04146338289638366" STUDY_ID="STD-Ayah-2007" TOTAL_1="75" TOTAL_2="66" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="11.492804512553253" CI_END="1.0394635568431176" CI_START="0.8719282641989918" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9520176756848213" ESTIMABLE="YES" EVENTS_1="346" EVENTS_2="271" I2="47.79342158438024" I2_Q="0.0" ID="CMP-001.34" LOG_CI_END="0.016809267751779492" LOG_CI_START="-0.059519244131741096" LOG_EFFECT_SIZE="-0.021354988189980807" METHOD="MH" MODIFIED="2016-03-03 21:04:16 +0000" MODIFIED_BY="[Empty name]" NO="34" P_CHI2="0.07428868151217194" P_Q="0.3933559829313802" P_Z="0.27276950003546807" Q="2.9887962984882988" RANDOM="YES" SCALE="7.18" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.006345206457725828" TOTALS="SUB" TOTAL_1="533" TOTAL_2="419" WEIGHT="400.0" Z="1.0967070288626204">
<NAME>Infant low hepatic vitamin A reserves at 6 - 6.5 months postpartum</NAME>
<GROUP_LABEL_1>Supplement</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplement</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.364852951454461" CI_END="1.1452292341957397" CI_START="0.7764353823668205" DF="2" EFFECT_SIZE="0.9429721620230527" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="119" I2="62.72032023808255" ID="CMP-001.34.01" LOG_CI_END="0.05889242569940654" LOG_CI_START="-0.10989468191770775" LOG_EFFECT_SIZE="-0.025501128109150593" MODIFIED="2016-03-03 21:04:00 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0683971569471783" P_Z="0.5536894593982826" STUDIES="3" TAU2="0.015848876835773688" TOTAL_1="232" TOTAL_2="192" WEIGHT="99.99999999999999" Z="0.5922406440242753">
<NAME>200,000 - 400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.2213443256065548" CI_START="0.9037536513180255" EFFECT_SIZE="1.0506161971830985" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="71" LOG_CI_END="0.08683811900605272" LOG_CI_START="-0.04394993507050619" LOG_EFFECT_SIZE="0.021444091967773256" MODIFIED="2016-03-03 21:04:00 +0000" MODIFIED_BY="[Empty name]" ORDER="453" O_E="0.0" SE="0.07682555037587971" STUDY_ID="STD-Ayah-2007" TOTAL_1="96" TOTAL_2="93" VAR="0.005902165190556832" WEIGHT="45.19326088233342"/>
<DICH_DATA CI_END="1.0424406869123388" CI_START="0.8159455430294144" EFFECT_SIZE="0.922266139657444" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="33" LOG_CI_END="0.018051353737408245" LOG_CI_START="-0.08833882549985529" LOG_EFFECT_SIZE="-0.03514373588122354" MODIFIED="2016-03-03 21:03:58 +0000" MODIFIED_BY="[Empty name]" ORDER="454" O_E="0.0" SE="0.06249411792384935" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" VAR="0.0039055147750799886" WEIGHT="49.76111318044652"/>
<DICH_DATA CI_END="1.0214448235118216" CI_START="0.19454003632645447" EFFECT_SIZE="0.445771144278607" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.00921491184800783" LOG_CI_START="-0.7109910073647351" LOG_EFFECT_SIZE="-0.3508880477583637" MODIFIED="2016-03-03 21:03:56 +0000" MODIFIED_BY="[Empty name]" ORDER="455" O_E="0.0" SE="0.4230525220223621" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="67" TOTAL_2="64" VAR="0.17897343638948116" WEIGHT="5.045625937220042"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.204771950047133" CI_END="2.0519293626126243" CI_START="0.22067764444838853" DF="1" EFFECT_SIZE="0.6729152534426881" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="48" I2="86.12031016480046" ID="CMP-001.34.02" LOG_CI_END="0.31216240616902796" LOG_CI_START="-0.6562416604244959" LOG_EFFECT_SIZE="-0.17203962712773396" MODIFIED="2016-03-03 21:04:16 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.007271022626938017" P_Z="0.4861871900566799" STUDIES="2" TAU2="0.5673610932199524" TOTAL_1="136" TOTAL_2="99" WEIGHT="100.0" Z="0.6963859089732444">
<NAME>200,000 - 300,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.0424406869123388" CI_START="0.8159455430294144" EFFECT_SIZE="0.922266139657444" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="33" LOG_CI_END="0.018051353737408245" LOG_CI_START="-0.08833882549985529" LOG_EFFECT_SIZE="-0.03514373588122354" MODIFIED="2016-02-12 05:47:38 +0000" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.06249411792384935" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" VAR="0.0039055147750799886" WEIGHT="56.64343391250757"/>
<DICH_DATA CI_END="1.0214448235118216" CI_START="0.19454003632645447" EFFECT_SIZE="0.445771144278607" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.00921491184800783" LOG_CI_START="-0.7109910073647351" LOG_EFFECT_SIZE="-0.3508880477583637" MODIFIED="2016-03-03 21:04:16 +0000" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="0.4230525220223621" STUDY_ID="STD-Stoltzfus-1993a" TOTAL_1="67" TOTAL_2="64" VAR="0.17897343638948116" WEIGHT="43.35656608749243"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2213443256065548" CI_START="0.9037536513180255" DF="0" EFFECT_SIZE="1.0506161971830985" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="71" I2="0.0" ID="CMP-001.34.03" LOG_CI_END="0.08683811900605272" LOG_CI_START="-0.04394993507050619" LOG_EFFECT_SIZE="0.021444091967773256" MODIFIED="2016-02-18 10:31:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5204097858271874" STUDIES="1" TAU2="0.0" TOTAL_1="96" TOTAL_2="93" WEIGHT="100.0" Z="0.6427138661058066">
<NAME>400,000 IU versus placebo</NAME>
<DICH_DATA CI_END="1.2213443256065548" CI_START="0.9037536513180255" EFFECT_SIZE="1.0506161971830985" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="71" LOG_CI_END="0.08683811900605272" LOG_CI_START="-0.04394993507050619" LOG_EFFECT_SIZE="0.021444091967773256" MODIFIED="2016-02-12 05:48:42 +0000" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.07682555037587971" STUDY_ID="STD-Ayah-2007" TOTAL_1="96" TOTAL_2="93" VAR="0.005902165190556832" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0165008773318736" CI_START="0.7819126814411035" DF="0" EFFECT_SIZE="0.8915239350021958" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="33" I2="0.0" ID="CMP-001.34.04" LOG_CI_END="0.0071077578094996645" LOG_CI_START="-0.10684174321335947" LOG_EFFECT_SIZE="-0.04986699270192989" MODIFIED="2016-02-18 10:31:53 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.0862621956874467" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="35" WEIGHT="100.0" Z="1.715453053076511">
<NAME>Beta-carotene: 7.8 mg daily versus placebo</NAME>
<DICH_DATA CI_END="1.0165008773318736" CI_START="0.7819126814411036" EFFECT_SIZE="0.8915239350021958" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="33" LOG_CI_END="0.0071077578094996645" LOG_CI_START="-0.10684174321335942" LOG_EFFECT_SIZE="-0.04986699270192989" MODIFIED="2016-02-12 05:48:57 +0000" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.06693450095995453" STUDY_ID="STD-RETIBETA-Project" TOTAL_1="69" TOTAL_2="35" VAR="0.004480227418758153" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-03-04 00:28:59 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Supplement (vitamin A as retinyl) 400,000 IU versus 200,000 IU</NAME>
<CONT_OUTCOME CHI2="3.7044060909081726" CI_END="0.057206763432752605" CI_START="-0.09075551216192881" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.016774374364588108" ESTIMABLE="YES" I2="19.01535829554476" I2_Q="40.68834360869544" ID="CMP-002.01" MODIFIED="2016-03-04 00:27:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2952030526457554" P_Q="0.18525760477646247" P_Z="0.6567538839580692" Q="3.372018455875078" RANDOM="NO" SCALE="1.97" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="413" TOTAL_2="429" UNITS="" WEIGHT="300.0" Z="0.44439935092437083">
<NAME>Maternal serum retinol (mcmol/L)</NAME>
<GROUP_LABEL_1>High dose</GROUP_LABEL_1>
<GROUP_LABEL_2>Low dose</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours low dose</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours high dose</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.3323876350330952" CI_END="0.1368302574251461" CI_START="-0.056210813159961945" DF="1" EFFECT_SIZE="0.04030972213259208" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2016-02-18 10:32:23 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5642566889045237" P_Z="0.4130507839273573" STUDIES="2" TAU2="0.0" TOTAL_1="215" TOTAL_2="214" WEIGHT="100.00000000000001" Z="0.8185367328023139">
<NAME>400,000 IU versus 200,000 IU at 2 months postpartum</NAME>
<CONT_DATA CI_END="0.13867337054200102" CI_START="-0.09867337054200098" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.43" MEAN_2="1.41" MODIFIED="2010-07-27 03:49:40 +0100" MODIFIED_BY="[Empty name]" ORDER="281" SD_1="0.44" SD_2="0.4" SE="0.060548750629134715" STUDY_ID="STD-Darboe-2007" TOTAL_1="96" TOTAL_2="97" WEIGHT="66.15046311234661"/>
<CONT_DATA CI_END="0.24589884260027894" CI_START="-0.0858988426002788" EFFECT_SIZE="0.08000000000000007" ESTIMABLE="YES" MEAN_1="2.04" MEAN_2="1.96" MODIFIED="2016-02-02 19:00:31 +0000" MODIFIED_BY="[Empty name]" ORDER="268" SD_1="0.67" SD_2="0.63" SE="0.08464382198288732" STUDY_ID="STD-Fernandes-2012" TOTAL_1="119" TOTAL_2="117" WEIGHT="33.8495368876534"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.05136155504746848" CI_START="-0.2913615550474687" DF="0" EFFECT_SIZE="-0.1200000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" MODIFIED="2016-02-18 10:32:29 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.16990431005214007" STUDIES="1" TAU2="0.0" TOTAL_1="103" TOTAL_2="110" WEIGHT="100.0" Z="1.372511343513751">
<NAME>400,000 IU versus 200,000 IU at 4 months postpartum</NAME>
<CONT_DATA CI_END="0.05136155504746848" CI_START="-0.2913615550474687" EFFECT_SIZE="-0.1200000000000001" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="2.22" MODIFIED="2016-02-02 19:01:14 +0000" MODIFIED_BY="[Empty name]" ORDER="269" SD_1="0.71" SD_2="0.55" SE="0.08743097138475332" STUDY_ID="STD-Fernandes-2012" TOTAL_1="103" TOTAL_2="110" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.07557907668636923" CI_START="-0.23557907668636938" DF="0" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.03" MODIFIED="2016-02-18 10:32:36 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.31353653334360476" STUDIES="1" TAU2="0.0" TOTAL_1="95" TOTAL_2="105" WEIGHT="100.0" Z="1.0078290866791209">
<NAME>400,000 IU versus 200,000 IU at 6 months postpartum</NAME>
<CONT_DATA CI_END="0.07557907668636923" CI_START="-0.23557907668636938" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" MEAN_1="2.14" MEAN_2="2.22" MODIFIED="2016-02-02 19:02:31 +0000" MODIFIED_BY="[Empty name]" ORDER="270" SD_1="0.57" SD_2="0.55" SE="0.07937853854129831" STUDY_ID="STD-Fernandes-2012" TOTAL_1="95" TOTAL_2="105" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2396364313647228" CI_END="0.05771748150506931" CI_START="-0.08350306199266685" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.012892790243798777" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2016-03-04 00:28:23 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.941018747377028" P_Q="0.7835476829834552" P_Z="0.7204394733839115" Q="1.0731986412149337" RANDOM="NO" SCALE="1.85" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="559" TOTAL_2="548" UNITS="" WEIGHT="400.0" Z="0.3578715095156119">
<NAME>Maternal breast milk retinol (mcmol/L)</NAME>
<GROUP_LABEL_1>High dose</GROUP_LABEL_1>
<GROUP_LABEL_2>Low dose</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours low dose</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours high dose</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.14238272426035906" CI_END="0.11273978325249315" CI_START="-0.13667705782442366" DF="1" EFFECT_SIZE="-0.011968637285965254" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2016-02-18 10:32:47 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7059237822404381" P_Z="0.8507954695313467" STUDIES="2" TAU2="0.0" TOTAL_1="193" TOTAL_2="184" WEIGHT="100.0" Z="0.18810356127701064">
<NAME>400,000 IU versus 200,000 IU at 2 months postpartum</NAME>
<CONT_DATA CI_END="0.22766653002376774" CI_START="-0.1876665300237677" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.69" MEAN_2="1.67" MODIFIED="2016-02-06 12:56:32 +0000" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="0.79" SD_2="0.67" SE="0.10595425817097397" STUDY_ID="STD-Darboe-2007" TOTAL_1="96" TOTAL_2="95" WEIGHT="36.06272542806952"/>
<CONT_DATA CI_END="0.1259619723890488" CI_START="-0.18596197238904885" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.53" MEAN_2="0.56" MODIFIED="2016-02-02 18:43:52 +0000" MODIFIED_BY="[Empty name]" ORDER="263" SD_1="0.51" SD_2="0.57" SE="0.07957389708140403" STUDY_ID="STD-Fernandes-2012" TOTAL_1="97" TOTAL_2="89" WEIGHT="63.93727457193048"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.710315306957968E-33" CI_END="0.16327131443731432" CI_START="-0.2832713144373144" DF="0" EFFECT_SIZE="-0.060000000000000046" ESTIMABLE="YES" I2="100.0" ID="CMP-002.02.02" MODIFIED="2016-02-18 10:32:54 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.5983993317211742" STUDIES="1" TAU2="0.0" TOTAL_1="94" TOTAL_2="96" WEIGHT="100.0" Z="0.5267037521984048">
<NAME>400,000 IU versus 200,000 IU at 3 months postpartum</NAME>
<CONT_DATA CI_END="0.1632713144373143" CI_START="-0.2832713144373144" EFFECT_SIZE="-0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.68" MEAN_2="1.74" MODIFIED="2016-02-06 13:08:57 +0000" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="0.79" SD_2="0.78" SE="0.11391602917117354" STUDY_ID="STD-Darboe-2007" TOTAL_1="94" TOTAL_2="96" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.024055065889429978" CI_END="0.07643092918697557" CI_START="-0.12817226081250235" DF="1" EFFECT_SIZE="-0.02587066581276339" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.03" MODIFIED="2016-02-18 10:33:00 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8767448978330447" P_Z="0.6201428358240718" STUDIES="2" TAU2="0.0" TOTAL_1="176" TOTAL_2="172" WEIGHT="100.0" Z="0.4956479246410311">
<NAME>400,000 IU versus 200,000 IU at 4 months postpartum</NAME>
<CONT_DATA CI_END="0.21514244952874564" CI_START="-0.23514244952874566" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.54" MEAN_2="1.55" MODIFIED="2016-02-06 12:57:45 +0000" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="0.75" SD_2="0.84" SE="0.11487070747454574" STUDY_ID="STD-Darboe-2007" TOTAL_1="95" TOTAL_2="97" WEIGHT="20.646670936183174"/>
<CONT_DATA CI_END="0.0848417572765942" CI_START="-0.14484175727659426" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.37" MEAN_2="0.4" MODIFIED="2016-02-02 18:44:42 +0000" MODIFIED_BY="[Empty name]" ORDER="264" SD_1="0.28" SD_2="0.43" SE="0.05859380997939317" STUDY_ID="STD-Fernandes-2012" TOTAL_1="81" TOTAL_2="75" WEIGHT="79.35332906381683"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3100145055680441" CI_START="-0.13001450556804395" DF="0" EFFECT_SIZE="0.09000000000000008" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.04" MODIFIED="2016-02-18 10:33:07 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.42269725529667446" STUDIES="1" TAU2="0.0" TOTAL_1="96" TOTAL_2="96" WEIGHT="100.00000000000001" Z="0.8017505852769816">
<NAME>400,000 IU versus 200,000 IU at 6 months postpartum</NAME>
<CONT_DATA CI_END="0.3100145055680441" CI_START="-0.13001450556804395" EFFECT_SIZE="0.09000000000000008" ESTIMABLE="YES" MEAN_1="1.56" MEAN_2="1.47" MODIFIED="2016-02-06 13:04:07 +0000" MODIFIED_BY="[Empty name]" ORDER="149" SD_1="0.84" SD_2="0.71" SE="0.11225436145944026" STUDY_ID="STD-Darboe-2007" TOTAL_1="96" TOTAL_2="96" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.436117620770957" CI_END="1.3605060801444282" CI_START="0.6891602356001933" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9683009298393913" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="50" I2="30.36782046701956" I2_Q="30.115946382867314" ID="CMP-002.03" LOG_CI_END="0.13370048699580145" LOG_CI_START="-0.16167978920082965" LOG_EFFECT_SIZE="-0.01398965110251408" METHOD="MH" MODIFIED="2016-03-04 00:28:47 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.23076889315708848" P_Q="0.23161108646058692" P_Z="0.8527163830566601" Q="1.4309416071921182" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="190" TOTAL_2="192" WEIGHT="200.0" Z="0.18565364397557824">
<NAME>Maternal breast milk retinol (&lt; 1.05 mcmol/L)</NAME>
<GROUP_LABEL_1>High dose</GROUP_LABEL_1>
<GROUP_LABEL_2>Low dose</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours high dose</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours low dose</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.172612088907691" CI_START="0.7171416045903114" DF="0" EFFECT_SIZE="1.24822695035461" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="18" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.3369821917206295" LOG_CI_START="-0.14439508140308963" LOG_EFFECT_SIZE="0.09629355515876993" MODIFIED="2016-02-18 10:33:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4329620868825621" STUDIES="1" TAU2="0.0" TOTAL_1="94" TOTAL_2="96" WEIGHT="100.0" Z="0.7841329892032692">
<NAME>400,000 IU versus 200,000 IU at 3 months postpartum</NAME>
<DICH_DATA CI_END="2.172612088907691" CI_START="0.7171416045903114" EFFECT_SIZE="1.24822695035461" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="18" LOG_CI_END="0.3369821917206295" LOG_CI_START="-0.14439508140308963" LOG_EFFECT_SIZE="0.09629355515876993" MODIFIED="2016-02-06 12:07:40 +0000" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.28276339308880477" STUDY_ID="STD-Darboe-2007" TOTAL_1="94" TOTAL_2="96" VAR="0.07995513647109391" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.253171606929488" CI_START="0.5267883874400171" DF="0" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="32" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.09801054652443167" LOG_CI_START="-0.27836380722260773" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2016-02-18 10:33:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3476347600528432" STUDIES="1" TAU2="0.0" TOTAL_1="96" TOTAL_2="96" WEIGHT="100.0" Z="0.9391869874863087">
<NAME>400,000 IU versus 200,000 IU at 6 months postpartum</NAME>
<DICH_DATA CI_END="1.2531716069294883" CI_START="0.5267883874400171" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="32" LOG_CI_END="0.09801054652443174" LOG_CI_START="-0.27836380722260773" LOG_EFFECT_SIZE="-0.09017663034908802" MODIFIED="2016-02-06 12:09:13 +0000" MODIFIED_BY="[Empty name]" ORDER="143" O_E="0.0" SE="0.22108415847410945" STUDY_ID="STD-Darboe-2007" TOTAL_1="96" TOTAL_2="96" VAR="0.048878205128205135" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.1487838502791645" CI_END="0.054824238280517114" CI_START="-0.05818274972336312" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0016792557214230035" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2016-03-04 00:28:59 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7653124451072336" P_Q="0.7064290651169973" P_Z="0.9535501677695554" Q="0.6950652242158483" RANDOM="NO" SCALE="0.47" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="362" TOTAL_2="365" UNITS="" WEIGHT="300.0" Z="0.05824915419759535">
<NAME>Infant serum retinol (mcmol/L )</NAME>
<GROUP_LABEL_1>High dose</GROUP_LABEL_1>
<GROUP_LABEL_2>Low dose</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours low dose</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours high dose</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.4537186260633162" CI_END="0.07432479811687574" CI_START="-0.05343210363700689" DF="1" EFFECT_SIZE="0.010446347239934423" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2016-02-18 10:38:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5005743361972592" P_Z="0.7485724720052134" STUDIES="2" TAU2="0.0" TOTAL_1="177" TOTAL_2="185" WEIGHT="100.00000000000001" Z="0.32052224309124083">
<NAME>400,000 IU versus 200,000 IU at 2 months postpartum</NAME>
<CONT_DATA CI_END="0.08966507968121205" CI_START="-0.04966507968121202" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.74" MEAN_2="0.72" MODIFIED="2010-07-27 08:23:25 +0100" MODIFIED_BY="[Empty name]" ORDER="297" SD_1="0.21" SD_2="0.2" SE="0.03554406113108266" STUDY_ID="STD-Darboe-2007" TOTAL_1="63" TOTAL_2="71" WEIGHT="84.0772453998907"/>
<CONT_DATA CI_END="0.12008302213193534" CI_START="-0.2000830221319354" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.18" MEAN_2="1.22" MODIFIED="2016-02-02 18:50:50 +0000" MODIFIED_BY="[Empty name]" ORDER="265" SD_1="0.57" SD_2="0.66" SE="0.08167651211688062" STUDY_ID="STD-Fernandes-2012" TOTAL_1="114" TOTAL_2="114" WEIGHT="15.922754600109313"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14295537358341068" CI_START="-0.20295537358341073" DF="0" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.02" MODIFIED="2016-02-18 10:38:31 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7338822507637214" STUDIES="1" TAU2="0.0" TOTAL_1="93" TOTAL_2="99" WEIGHT="99.99999999999999" Z="0.33996584389351103">
<NAME>400,000 IU versus 200,000 IU at 4 months postpartum</NAME>
<CONT_DATA CI_END="0.14295537358341068" CI_START="-0.20295537358341073" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="1.51" MODIFIED="2016-02-02 18:53:10 +0000" MODIFIED_BY="[Empty name]" ORDER="266" SD_1="0.55" SD_2="0.67" SE="0.08824415904968694" STUDY_ID="STD-Fernandes-2012" TOTAL_1="93" TOTAL_2="99" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.421731262192261E-33" CI_END="0.10971189178566015" CI_START="-0.22971189178566026" DF="0" EFFECT_SIZE="-0.060000000000000046" ESTIMABLE="YES" I2="100.0" ID="CMP-002.04.03" MODIFIED="2016-02-18 10:38:37 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.48835578709227245" STUDIES="1" TAU2="0.0" TOTAL_1="92" TOTAL_2="81" WEIGHT="100.0" Z="0.692926334360382">
<NAME>400,000 IU versus 200,000 IU at 6 months postpartum</NAME>
<CONT_DATA CI_END="0.10971189178566015" CI_START="-0.22971189178566026" EFFECT_SIZE="-0.06000000000000005" ESTIMABLE="YES" MEAN_1="1.51" MEAN_2="1.57" MODIFIED="2016-02-02 18:54:20 +0000" MODIFIED_BY="[Empty name]" ORDER="267" SD_1="0.53" SD_2="0.6" SE="0.08658929098918447" STUDY_ID="STD-Fernandes-2012" TOTAL_1="92" TOTAL_2="81" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-03-17 13:56:11 +0000" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-02-14 12:07:41 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Systematic review flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0sAAALbCAYAAAArVRuBAABxgUlEQVR42uzdAcQVafs4/i9JkiSS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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-03-17 13:56:11 +0000" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-03-17 13:56:11 +0000" MODIFIED_BY="Heather Maxwell" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWoAAAL5CAIAAAAWoPnEAAAsYElEQVR42u3dPY4VSdbG8ZKQEAYG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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-02-17 10:40:23 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-02-17 10:40:23 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-06-22 21:06:51 +0100" MODIFIED_BY="[Empty name]">Additional search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2016-02-17 10:40:23 +0000" MODIFIED_BY="[Empty name]">
<P>LILACS - Latin American and Caribbean Health Sciences by Bireme (1982 to December 2015)<BR/>#1: ((Pt ENSAIO CONTROLADO ALEATORIO OR Pt ENSAIO CLINICO CONTROLADO OR Mh ENSAIOS CONTROLADOS ALEATORIOS OR Mh DISTRIBUICAO ALEATORIA OR Mh MÉTODO DUPLO-CEGO OR Mh MÉTODO SIMPLES-CEGO) AND NOT (Ct ANIMAIS AND NOT (Ct HUMANO AND Ct ANIMAIS)) OR (Pt ENSAIO CLÍNICO OR Ex E05.318.760.535$) OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh PLACEBOS OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR (Mh PROJETOS DE PESQUISA) AND NOT (Ct ANIMAIS AND NOT (Ct HUMANO AND Ct ANIMAIS)) OR (Ct ESTUDO COMPARATIVO OR Ex E05.337$ OR Mh SEGUIMENTOS OR Mh ESTUDOS PROSPECTIVOS OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct ANIMAIS AND NOT (Ct HUMANO AND Ct ANIMAIS))) AND NOT Mh ANIMAIS [Palavras]<BR/>#2: retinol or "vitamin A" or caroten$ [Palavras]<BR/>#3: #1 AND #2</P>
<P>WEB OF SCIENCE by ISI (1945 to December 2015)<BR/>#1: TS=(randomised controlled trial) OR TS=(controlled clinical trial) OR TS=(randomised controlled trials) OR TS=(random allocation) OR TS=(double-blind method) OR TS=(single-blind method) OR TS=(clinical trial) OR TS=(clinical trials) OR TS=(clinical trial) OR ((TS=singl* OR TS=doubl* OR TS=trebl* OR TS=tripl*) AND (TS=mask* OR TS=blind*)) OR (TS=(latin square) OR TS=placebo* OR TS=random* OR TS=(research design) or TS=(comparative study) OR TS=(evaluation studies) OR TS=(follow-up studies) OR TS=(prospective studies) OR TS=(cross-over studies) OR TS=control* OR TS=prospectiv* OR TS=volunteer*)<BR/>#2: TS=puerp* or TS=matern* or TS=lacta* or TS=breastfe* or TS=(breast fee*) or TS=breast-fee* or TS=(human milk) or TS=postnatal or TS=postpart* or TS=newborn* or TS=infant* or TS=newborn<BR/>#3: TS=retinol* or TS=(vitamin A) or TS=caroten*<BR/>#4: #3 AND #2 AND #1</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>

<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 studies included for review update&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;12 studies included in previous version of the review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 studies (described in 5 articles) included for synthesis in update&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 records eligible&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 records screened in fulltext&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;691 records screened&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 records identified through specialised register search&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;664 records identified through additional database search&lt;/p&gt;"/>
<OUT TEXT="&lt;p&gt;673 records excluded in title-abstract screening&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;10 records excluded:&lt;/p&gt;&lt;p&gt;4 for food based intervention&lt;/p&gt;&lt;p&gt;4 for supplementation at the wrong time&lt;/p&gt;&lt;p&gt;1 for non randomised study design&lt;/p&gt;&lt;p&gt;1 for only HIV-positive participants&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1 ongoing study&lt;/p&gt;&lt;p&gt;2 studies awaiting classification&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_z1509230952520599057946483679068_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="z1509230952520599057946483679068"><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>University Hospital Frankfurt, Goethe University</ORGANISATION><ADDRESS_1>Theodor-Stern-Kai 7</ADDRESS_1><CITY>Frankfurt</CITY><ZIP>60596</ZIP><REGION>Hessen</REGION><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>